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Summary 
This report builds on previous work undertaken by the AIHW for the Maternity Services 
Inter-Jurisdictional Committee (MSIJC) of the Australian Health Ministers’ Advisory Council 
(AHMAC) on the development of a set of National Core Maternity Indicators (NCMIs) to 
monitor the quality of maternity care in Australia.  
This report represents the second stage of the project, which was undertaken by the AIHW 
during 2012–13. It involved exploring the validity and feasibility of a possible 8 additional 
NCMIs to be added to the current set of 10 NCMIs. Clinical advice and input was provided 
by an Expert Commentary Group (ECG). 
In consultation with key stakeholders and experts, definitions and technical specifications 
were developed for the 8 additional NCMIs, and existing and potential data sources for 
reporting were investigated. Recommendations for next steps were then made for each 
proposed NCMI.  
The 8 potential additional indicators developed and investigated were: 
• High risk women undergoing caesarean section who receive appropriate 
pharmacological thromboprophylaxis (Indicator 11) 
• Babies born at or after 37 completed weeks gestation admitted to a neonatal intensive 
care nursery or special care nursery for reasons other than congenital anomaly (Indicator 
12) 
• Third and fourth degree tears for (a) all first births and (b) all births (Indicator 13) 
• Blood loss of (i) greater than 1,000 mL and less than 1,500 mL, and (ii) 1,500 mL or more 
during first 24 hours after the birth of the baby (that is, major primary postpartum 
haemorrhage) for (a) vaginal births and (b) caesarean sections (Indicator 14) 
• Women having their second birth vaginally whose first birth was by caesarean section 
(Indicator 15) 
• Separation of baby from the mother after birth for additional care (Indicator 16) 
• One-to-one care in labour (Indicator 17) 
• Caesarean sections at less than 39 completed weeks gestation (273 days) without 
obstetric/medical indication (Indicator 18). 
During consideration of Indicator 16, the ECG proposed an additional new indicator for 
further investigation, ‘Skin-to-skin contact between mother and baby after birth’. 
Recommendations 
• Indicators 13, 15 and 18 should be added to the current set of 10 NCMIs for reporting 
using the National Perinatal Data Collection. 
• Indicator 14 to be: aligned with items on postpartum haemorrhage in the 2014–15 
Perinatal Data Set Specification (lower limit now to include 1,000 mL blood loss and be 
reflected in the Indicator title); and added to the current set of 10 NCMIs for reporting. 
• Indicator 12 and the ECG-suggested indicator ‘Skin-to-skin contact between mother and 
baby after birth’ require further data development, and this development should be 
undertaken to enable future reporting against these 2 indicators.  
• Indicators 11, 16 and 17 should not be further developed or added to the current set of 
NCMIs at this stage. 
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1 Introduction 
This report extends the work undertaken by the Australian Institute of Health Welfare 
(AIHW) on the first 10 National Core Maternity Indicators (NCMIs) (AIHW NPESU & 
AIHW 2013) to scope, develop, agree definitions and assess the feasibility of implementing 
and reporting for a further 8 indicators. 
The National Core Maternity Indicators are clinical indicators that apply to the field of 
maternity care. A clinical indicator is defined as a measure of the clinical management and 
outcome of care, and should be based on evidence that confirms the underlying causal 
relationship between a particular process or intervention and health outcome (WHA 2007). 
Clinical indicators have a key role in the assessment, monitoring and evaluation of patient 
care. Most importantly, they allow for monitoring change in practice and outcomes of 
individual and peer organisations over time, with the objective of improving patient care 
(AIHW NPESU & AIHW 2013). In Australia many jurisdictions and professional 
organisations report on maternity services using clinical or performance indicators (see 
AIHW NPESU & AIHW 2013 for a summary of these maternity-related indicators). 
1.1 Background 
The foundation for the development of the National Core Maternity Indicators was a 
recommendation of the Douglas Inquiry into Obstetric and Gynaecology Services provided 
between 1990 and 2000 at the King Edward Memorial Hospital for Women, Perth. The 
Inquiry recommended that Australia establish annual benchmarking and/or reporting of 
performance indicators for obstetric and gynaecological practice and outcomes (KEMH 
2001). This led to Australian Health Ministers supporting a ‘proof of concept’ project that 
demonstrated the potential to improve the quality of maternity care through benchmarking; 
and funding by the Australian Council on Safety and Quality in Health Care for a national 
project to progress development of maternity indicators. The development of a set of 
national maternity indicators was further progressed by Women’s Healthcare Australasia 
and the Department of Health, Western Australia. In 2008, responsibility for the project was 
transferred to the Maternity Services Inter-Jurisdictional Committee (MSIJC). The National 
Maternity Services Plan (AHMC 2011) provides a strategic national framework to guide 
policy and program development over five years (2011 to 2015), and includes development 
and implementation of NCMIs as an action item. 
1.2 Project objectives 
The MSIJC engaged the AIHW to build on previous work undertaken by the MSIJC on the 
development of a set of NCMIs to monitor the quality of maternity care in Australia. The 
MSIJC Expert Working Group proposed a set of 20 core maternity indicators. The first 10, for 
which data are available, formed the basis of a report released earlier this year by the AIHW, 
National core maternity indicators, based on data from the National Perinatal Data 
Collection (NPDC). Of the remaining 10 indicators, 2 have been referred to other areas for 
further work as they form part of their work plans, and work on the other 8 (Indicators  
11–18) forms the basis of this report (see Table 1.1). The objectives of the project were in two 
main parts: 
• develop definitions and criteria and assess the feasibility of existing data to support 
national reporting for indicators 12–15 
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• explore the plausibility of developing and reporting on indicators 11, 16, 17 and 18 as 
part of the framework for improving maternity care. 
Table 1.1: Current status of NCMIs at commencement of the project 
 Indicator Status 
1 Smoking in pregnancy for all women giving birth Reported in online data portal
(a)
 
2 Antenatal care in the first trimester for all women giving birth Reported in online data portal
(a)
 
3 Episiotomy for women having their first baby and giving birth vaginally Reported in online data portal
(a)
 
4 Apgar score of less than 7 at 5 minutes for births at term Reported in online data portal
(a)
 
5 Induction of labour for selected women giving birth for the first time Reported in online data portal
(a)
 
6 Caesarean section for selected women giving birth for the first time Reported in online data portal
(a)
 
7 Non-instrumental vaginal birth for selected women giving birth for the first time Reported in online data portal
(a)
 
8 Instrumental vaginal birth for selected women giving birth for the first time Reported in online data portal
(a)
 
9 General anaesthetic for women giving birth by caesarean section Reported in online data portal
(a)
 
10 Small babies among births at or after 40 weeks gestation Reported in online data portal
(a)
 
11 High risk women undergoing caesarean section who receive appropriate 
pharmacological thromboprophylaxis 
Scoping and developmental work 
required to agree definitions and identify 
potential data sources and reporting 
measures 
12 Babies born ≥37completed weeks gestation admitted to a neonatal intensive 
care nursery or special care nursery for reasons other than congenital 
anomaly 
Development and agreement on 
definitions, and assessment of the 
feasibility of standardising existing data 
for national reporting 
13 Third and fourth degree tears for (a) all first births and (b) all births Development and agreement on 
definitions, and assessment of the 
feasibility of standardising existing data 
for national reporting 
14 Blood loss of (i) > 1,000 mL and < 1,500 mL and (ii) ≥ 1,500 mL during first 24 
hours after the birth of the baby (i.e. major primary PPH) for (a) vaginal births 
and (b) caesarean sections 
Development and agreement on 
definitions, and assessment of the 
feasibility of standardising existing data 
for national reporting 
15 Women having their second birth vaginally whose first birth was by caesarean 
section 
Development and agreement on 
definitions, and assessment of the 
feasibility of standardising existing data 
for national reporting 
16 Separation of baby from the mother after birth for additional care Scoping and developmental work 
required to agree definitions and identify 
potential data sources and reporting 
measures 
17 One-to-one care in labour Scoping and developmental work 
required to agree definitions and identify 
potential data sources and reporting 
measures 
18 Caesarean sections <39 completed weeks (273 days) without 
obstetric/medical indication 
Development and agreement on 
definitions, and assessment of the 
feasibility of standardising existing data 
for national reporting 
19 Supporting breastfeeding Referred for further work
(b) 
20 Models of care Referred for further work
(c) 
(a) NCMI data portal at http://www.aihw.gov.au/ncmi/. 
(b) Work on this indicator was referred to the Child Health and Wellbeing Subcommittee. 
(c) Work on this indicator will be covered by the National Maternity Data Development Project. 
 National core maternity indicators—stage 2 report: 2007–2011 3 
1.3 Project methods and steps 
The following steps were undertaken for the development of the indicators: 
• literature review to help clarify the rationale for, and evidence to support, each indicator 
• review of existing measures and indicator reporting, both national and international, to 
inform the development of indicator definitions and collection specifications  
• development and agreement on associated definitions 
• development of technical specifications  
• analysis of available data 
• assessment of the feasibility of standardising existing data for national reporting 
• consultation with members of the Expert Commentary Group and other key experts and 
stakeholders 
• developing and writing this report, including providing recommendations for next steps 
for each indicator. 
Consultation 
An Expert Commentary Group (ECG) (see Acknowledgments section) was established to 
provide clinical advice and input on the development of the NCMIs and on the drafting of 
this report. The ECG met twice during the course of the project, with members also 
providing out-of-session input as required.  
Further consultation was undertaken in the development of Indicators 11 and 16–18. A 
survey was circulated to ECG members and other key experts and stakeholders, including 
clinicians and data managers (see Appendix A for a list of stakeholders consulted).  
Twenty-three responses were received and were used to inform the development process. 
Data sources 
Data to inform the development of Indicators 12–15 is available from the AIHW National 
Perinatal Data Collection (NPDC) and the National Hospital Morbidity Database (NHMD). 
The NPDC is a national population-based cross-sectional data collection of pregnancy and 
childbirth. The data are based on births reported to the perinatal data collection in each state 
and territory in Australia. Midwives and other staff, using information obtained from 
mothers and from hospital or other records, complete notification forms for each birth. 
Selected information is then compiled annually into this national data set by the AIHW 
National Perinatal Epidemiology and Statistics Unit. Information is included in the NPDC on 
all babies born at or after 20 weeks gestation or weighing 400 grams or more at birth in 
hospitals, birth centres, and in the community. 
The NHMD is compiled by the AIHW from data supplied by the state and territory health 
authorities. It is a collection of electronic confidentialised summary records for separations 
(that is, episodes of care) in public and private hospitals in Australia. Almost all hospitals in 
Australia are included in the database: public acute and public psychiatric hospitals, private 
acute and psychiatric hospitals, and private free-standing day hospital facilities.  
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Hospital records are for ‘separations’ and not individuals, and as there can be multiple 
admissions for the same individuals, hospital separation rates do not usually reflect the 
actual incidence or prevalence of the disease or condition in question. 
The collection contains establishment data (information about the hospital), patient 
demographic data, administrative data, length of stay data, and clinical and related data. 
Diagnoses are coded to the International statistical classification of diseases and related health 
problems, 10th revision, Australian modification (ICD-10-AM), which extends the World Health 
Organization’s ICD-10 to provide classifications appropriate for current Australian practice. 
Procedures are classified using the Australian Classification of Health Interventions (ACHI), 
which includes, but is not restricted to, interventions captured by the Medicare Benefits 
Schedule. Standardisation of coding using ICD-10-AM and ACHI relies on the use of 
Australian Coding Standards (ACS) by coders in all public and private hospitals in Australia. 
ICD-10-AM, ACHI and ACS are regularly revised by the Australian Consortium for 
Classification Development to ensure that they reflect current clinical practice and 
classifications, and meet the needs of users of inpatient data collections. For the NHMD, the 
5th editions of ICD-10-AM/ACHI/ACS were applied to hospital episodes in 2007–08, the 6th 
editions to episodes in 2008–09 and 2009–10, and the 7th editions to episodes in 2010–11 and 
2011–12. 
1.4 Related work 
Other national maternity data development and definitional work is underway, including 
the National Maternity Data Development Project (NMDDP), and work being undertaken by 
the Australian Commission on Safety and Quality in Health Care (the Commission) on a 
national approach to defining maternal morbidity and postpartum haemorrhage (PPH). 
The NMDDP aims to develop a nationally consistent and comprehensive maternal and 
perinatal data collection in Australia. The AIHW was commissioned by the Department of 
Health to undertake this project. The project commenced in 2010 in response to actions under 
the National Maternity Services Plan. Among other things, in its first 2 years, the project has 
scoped a set of 20 priority maternity data items for data development and inclusion in the 
NPDC. Severe primary postpartum haemorrhage and Indicators for caesarean section are 2 of the 
priority data items. A consistent national definition and a national data standard will be 
developed for both these items for use in the NPDC, in consultation with clinicians and data 
managers across Australia. The objective is for these data standards to be included in the 
Perinatal National Minimum Data Set, which requires agreement by all states and territories 
to collect it according to the national standard. This will promote national consistency in data 
collection, recording and reporting.  
The Commission has established a Maternal Sentinel Events and PPH Working Group 
(MSE/PPH Working Group) to investigate issues raised at their Inter-Jurisdictional 
Committee meeting in relation to the classification of maternal sentinel events and issues 
surrounding PPH. The MSE/PPH Working Group has recommended that the maternal 
sentinel event definition be revised and is working on a national approach to defining severe 
acute maternal morbidity (SAMM) to support local safety review mechanisms. In addition, 
the group has recommended that PPH data be captured routinely in perinatal data 
collections according to national health data standards developed as part of the NMDDP. 
This work is expected to be completed by February 2015. 
Alignment of work on the NCMIs with the work of both of these projects is critical to ensure 
consistent national direction is achieved in national maternity data development. 
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2 Development of indicators 
This project involved the further development of 8 NCMIs. Four indicators required the 
development of definitions and ways to standardise data for national reporting. The other 4 
NCMIs required further scoping and development. During the initial stages of scoping, an 
additional indicator was proposed by the ECG for further consideration and development, 
‘Skin-to-skin contact between mother and baby after birth’, and is included here. 
2.1 Indicators requiring development of definitions 
and standardisation for national reporting  
(12–15) 
The following 4 indicators required the development of definitions and an assessment of 
options for standardising the data for national reporting: 
• Babies born ≥37 completed weeks gestation admitted to a neonatal intensive care nursery 
or special care nursery for reasons other than congenital anomaly 
• Third and fourth degree tears for (a) all first births and (b) all births 
• Blood loss of (i) > 1,000 mL and < 1,500 mL and (ii) ≥ 1,500 mL during first 24 hours after 
the birth of the baby (i.e. major primary PPH) for (a) vaginal births and (b) caesarean 
sections 
• Women having their second birth vaginally whose first birth was by caesarean section. 
In consultation with the ECG, technical specifications were developed for these 4 indicators 
using a standard set of attributes, including: description, purpose, numerator, denominator, 
notes and exceptions, data source and data items, and disaggregation levels. These attributes 
enabled the scope and inclusion/exclusion criteria to be defined. The content of 
corresponding indicators used by the Australian Council on Healthcare Standards (ACHS) 
and Women’s Health Australasia (WHA) was taken into account. Parameters for analysis of 
the data were then set, again in consultation with the ECG. Data to support the reporting of 
these 4 indicators were sourced from the NPDC and NHMD, and analysed to test the 
validity of the indicator and assess data quality. Results for each indicator are provided 
below. 
2.1.1 Indicator 12: Babies born ≥ 37 completed weeks gestation 
admitted to a neonatal intensive care nursery or special care 
nursery for reasons other than congenital anomaly  
This indicator was originally proposed by the MSIJC Expert Working Group as ‘Inborn term 
babies transferred/admitted to a neonatal intensive care nursery/unit or special care nursery 
for reasons other than congenital condition’. Following discussion, the ECG’s views were 
that: 
• the purpose of the indicator is to provide a measure of intrapartum morbidity 
• the indicator should not be restricted to ‘term’ births, that is, post-term births should also 
be captured, and that all births are in scope, including home births and births before 
arrival to hospital 
• the term ‘congenital condition’ be replaced with ‘congenital anomaly’. 
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The Australian Council on Healthcare Standards (ACHS) already has an indicator for ‘All 
admissions of a term baby to special care nursery or neonatal intensive care nursery’. 
Following consultation with the MSIJC, they recommended that the existing ACHS indicator 
definition be used. The following technical specification incorporates this recommendation. 
12. Babies born ≥ 37 completed weeks gestation admitted to a neonatal 
intensive care nursery/unit or special care nursery for reasons other than 
congenital anomaly 
Indicator details 
Description The proportion of live infants born at ≥ 37 completed weeks gestation at the reporting hospital 
who were transferred/admitted to a neonatal intensive care nursery/unit or special care nursery 
for reasons other than congenital anomaly. 
Purpose This is an outcome indicator that measures intrapartum morbidity. 
Numerator The number of live babies born at ≥37 completed weeks gestation at the reporting hospital who 
were transferred/admitted to a neonatal intensive care nursery/unit or special care nursery for 
reasons other than congenital anomaly. 
Denominator The number of live babies born at ≥37 completed weeks gestation at the reporting hospital. 
Computation/Presentation Numerator/denominator x 100 
Presentation Percentage 
Notes and exceptions A birth is defined as the event in which a baby comes out of the uterus after a pregnancy of at 
least 20 weeks gestation or weighing 400 grams or more. 
A live birth is defined by the World Health Organization to be the complete expulsion or 
extraction from the mother of a baby, irrespective of the duration of the pregnancy, which, after 
such separation, breathes or shows any other evidence of life, such as beating of the heart, 
pulsation of the umbilical cord, or definite movement of the voluntary muscles, whether or not the 
umbilical cord has been cut or the placenta is attached. Each product of such a birth is 
considered live born. 
A stillbirth is a fetal death prior to the complete expulsion or extraction from its mother of a 
product of conception of 20 or more completed weeks of gestation or of 400 grams or more 
birthweight. The death is indicated by the fact that after such separation the fetus does not 
breathe or show any other evidence of life, such as beating of the heart, pulsation of the 
umbilical cord, or definite movement of voluntary muscles. 
Gestational age is a clinical measure of the duration of the pregnancy. For the National Perinatal 
Data Collection, gestational age is reported as completed weeks.  
Births included are live births of babies born at ≥37 completed weeks gestation at the reporting 
hospital. 
Births excluded are stillbirths, babies with a congenital anomaly, babies born before 37 
completed weeks gestation and babies not born at the reporting hospital. 
The Australian and New Zealand Neonatal Network (ANZNN 2013) defines the following as 
high-level neonatal care units: 
A neonatal intensive care nursery/unit (NICN/NICU) is a Level III unit which cares for newborn 
infants who require more specialised care and treatment. It includes most babies born at less 
than 32 weeks gestation or less than 1,500 grams birthweight, and others who may require such 
interventions as intravenous feeding, and/or surgery, and/or cardiorespiratory monitoring for 
management of apnoea or seizures, and/or require assisted ventilation, and/or supplemental 
oxygen over 40% or long-term oxygen. 
A special care nursery (SCN) is a Level II nursery which generally cares for babies born at 32–
36 weeks gestation weighing around 1,500 to 2,500 grams at birth. It includes care for babies 
who require intravenous therapy or antibiotics, and/or those who are convalescing after intensive 
care, and/or those who need their heart rate or breathing monitored, and/or those who need 
short-term oxygen therapy. 
Data collection details 
Data source National Perinatal Data Collection 
Data source type Perinatal NMDS and voluntarily-supplied items 
Data items—indicator Gestational age at birth 
Birth status 
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Neonate transfer to special/neonatal intensive care (item under development) 
Data items— 
disaggregation variables 
Year of birth 
State or territory of birth 
Hospital annual number of births 
Hospital sector 
Level of hospital 
Hospital location by remoteness 
Place of birth 
Indigenous status of mother 
Indigenous status of baby 
Labour/non-labour 
Plurality 
Frequency of data source 
collection(s) 
Annual 
Additional details 
Comments Source of definition: ACHS indicator 10.1; Report of the Australian and New Zealand Neonatal 
Network 2010 (published 2013). 
Based on the technical specification, analysis of the NHMD was undertaken to assess the 
availability of information to support national reporting of this indicator and the quality of 
data relative to the NPDC to inform the development of this indicator. In the future, data 
will be available to support the reporting of this indicator from the NPDC—see ‘Feasibility of 
standardising existing data sources’ section below. 
Data analysis and results 
Table 2.1 shows that the main reason for admission to hospital for term babies is Respiratory 
conditions (8,071 babies or 24% of babies admitted). Birth trauma, birth asphyxia is the second 
most common reason for admission (6% of all babies admitted). The least common condition 
for admission was Convulsions and other cerebral status disturbances (0.5% of all babies 
admitted). Of babies with congenital anomalies, 2,315 were admitted to hospital, comprising 
7% of all babies admitted to hospital. These patterns are similar across all years from 2008 to 
2011.  
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Table 2.1: Main reason for admission to hospital for live born babies ≥37 completed weeks 
gestation, 2011 
 Newborn episodes 
 
Description (ICD-10-AM) 
Qualified Qualified & 
unqualified 
Not 
qualified 
 
Total 
 Number 
Perinatal conditions     
Respiratory conditions (P22–P29) 5,804 2,267 4,968 13,039 
Birth trauma, birth asphyxia (P10–P15, P20, P21) 1,498 479 4,399 6,376 
Feeding problems (P92) 728 349 4,695 5,772 
Transitory disorders of carbohydrate metabolism (P70) 2,604 995 2,001 5,600 
Jaundice and complications of jaundice (P57–P59) 1,053 1,064 2,513 4,630 
Perinatal infections (P35–P39) 732 458 2,378 3,568 
Other specified perinatal conditions (P75–78, P83, P94, P96) 661 263 2,608 3,532 
Slow fetal growth or development (P05) 1,481 368 1,460 3,309 
Large baby and post-term (P07, P08) 801 251 2,098 3,150 
Hypothermia and other temperature regulation (P80, P81) 797 337 2,009 3,143 
Perinatal haematological disorders (P60, P61, P50–P56) 300 261 515 1,076 
Maternal conditions in pregnancy or childbirth (P00–P04) 173 27 469 669 
Other metabolic disorders (P71–P74) 51 42 153 246 
Convulsions and other cerebral status disturbances (P90, 
P91) 139 30 33 202 
Congenital anomalies     
(Q00–Q99) 1,954 361 9,220 11,535 
Other conditions     
Well baby (Z38) 218 0 151,003 151,221 
Observation only, with no other pathology (Z03) 3,911 1,282 14,257 19,450 
Any other diagnosis 1,003 483 5,290 6,776 
Total number of birth episodes  23,908 9,317 210,069 243,294 
(continued) 
 
  
 National core maternity indicators—stage 2 report: 2007–2011 9 
Table 2.1 (continued): Main reason for admission to hospital for live born babies greater ≥37 
completed weeks gestation, 2011 
 Newborn episodes 
 
Description (ICD-10-AM) 
Qualified Qualified & 
unqualified 
Not 
qualified 
 
Total 
 Per cent 
Perinatal conditions     
Respiratory conditions (P22–P29) 24.3 24.3 2.4 5.4 
Birth trauma, birth asphyxia (P10–P15, P20, P21) 6.3 5.1 2.1 2.6 
Feeding problems (P92) 3.0 3.7 2.2 2.4 
Transitory disorders of carbohydrate metabolism (P70) 10.9 10.7 1.0 2.3 
Jaundice and complications of jaundice (P57–P59) 4.4 11.4 1.2 1.9 
Perinatal infections (P35–P39) 3.1 4.9 1.1 1.5 
Other specified perinatal conditions (P75–78, P83, P94, P96) 2.8 2.8 1.2 1.5 
Slow fetal growth or development (P05) 6.2 3.9 0.7 1.4 
Hypothermia and other temperature regulation (P80, P81) 3.3 3.6 1.0 1.3 
Large baby and post-term (P07, P08) 3.4 2.7 1.0 1.3 
Perinatal haematological disorders (P60, P61, P50–P56) 1.3 2.8 0.2 0.4 
Maternal conditions in pregnancy or childbirth (P00–P04) 0.7 0.3 0.2 0.3 
Convulsions and other cerebral status disturbances (P90, P91) 0.6 0.3 0.0 0.1 
Other metabolic disorders (P71–P74) 0.2 0.5 0.1 0.1 
Congenital anomalies     
(Q00–Q99) 8.2 3.9 4.4 4.7 
Other conditions     
Well baby (Z38) 0.9 0.0 71.9 62.2 
Observation only, with no other pathology (Z03) 16.4 13.8 6.8 8.0 
Any other diagnosis 4.2 5.2 2.5 2.8 
Total  100.0 100.0 100.0 100.0 
Source: AIHW National Hospital Morbidity Database. 
Quality of data 
• The number of birth episodes for term babies was derived from a number of codes: 
– diagnostic code Z38 was used to capture inborn and outborn babies 
– qualification status: the number of babies with all qualified or some qualified days 
was used to capture whether babies had been admitted to hospital 
– birth episodes that include a diagnosis of short gestation (preterm birth): in order to 
capture term babies, babies with short gestation were excluded.  
• Primary diagnoses in the birth episode were used to show the reason for admission. 
Note that about 30% of babies with unqualified days, that is non-admitted babies, also 
had primary diagnoses suggesting some pathology. Hence, the use of qualified days as a 
proxy for admission is not perfect. 
• There are a number of coding inconsistencies in the hospital data which draw into 
question the accuracy of the data: 
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– Inconsistencies were predominantly for birth episodes with qualified days, that is, 
babies who were admitted and the ones of interest in this analysis. Higher rates of 
inconsistency are evident when data are stratified by admission based on 
qualification status. 
– In the 4 years from 2008 to 2011, 5% of birth episodes contained inconsistent data. 
There is substantial variation in the proportions of birth episodes with inconsistent 
data across states and territories, for example 11% of birth episodes in New South 
Wales, 7% in Tasmania and 6% in South Australia.  
• When NHMD data are compared with the NDPC, there are discrepancies between the 
numbers of birth episodes for babies with qualified days (admitted babies) from NHMD 
and babies from NPDC reported to have been admitted for neonatal special or intensive 
care. This is predominantly among term babies, that is, the population of interest. The 
same pattern of results occurs across the 2008–2011 reporting period. 
• States other than New South Wales and Victoria have more birth admission episodes in 
the NHMD than babies reported as having been admitted for neonatal special or 
intensive care in the NPDC. This may partly reflect babies born outside of New South 
Wales and Victoria having NICU/SCN admission in these states. It may also reflect the 
timing of reporting NPDC data—if records are completed soon after birth, babies who 
were admitted later (that is, those with both qualified and unqualified days) could be 
missed, as data is collected from midwives and other staff using information obtained 
from the mother and from hospital or other records close to the time of birth.  
• Data on admission to SCN or NICU are submitted to the NPDC but are not routinely 
published. Table 2.2 summarises what jurisdictions currently collect on their data 
collection forms. There is jurisdictional variation in who is counted in the  
admissions—for example, in Victoria, babies born at a planned homebirth and then 
admitted to SCN/NICU, babies transferred to the SCN/NICU of another hospital, and 
babies who were discharged and then admitted to SCN/NICU are not included.  
• There are some slight differences in response category definitions for admission to 
SCN/NICU (Table 2.3). 
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Table 2.2: Summary of jurisdictional data on admission to SCN/NICU 
Response categories NSW Vic Qld WA SA Tas ACT NT 
Admitted (SCN or NICU) X X X X
(a)
 X
(b)
 X X X 
Number of days   X X X X X  
Main reason for admission   X      
Was congenital condition the main 
reason for admission? 
X    X    
Transferred to (specify/establishment 
code)
(c)
 
 X  X     
(a) Most jurisdictions have yes/no response categories for admission to SCN/NICU;  however WA would derive this from number of days, as 
they do not have a field for admission alone. 
(b) Most jurisdictions combine SCN and NICU in the admitted response category; however SA and Victoria specify the level of care which a 
baby is admitted to. 
(c) May be relevant for small hospitals without an SCN or NICU. 
Source: Maternity Information Matrix. 
Table 2.3: Summary of jurisdictional definitions for admission to SCN/NICU 
Jurisdiction Definitions 
NSW A baby separated from its mother for the purposes of receiving observation, special treatment or 
intensive care 
Vic Whether the neonate was admitted into SCN or NICU 
Qld No definition specified 
WA No definition specified 
SA If the baby required SCN, or was admitted to NICU 
Tas If the baby cared for in SCN, or intensive care unit because of a medical condition 
ACT No definition specified 
NT No definition specified 
Source: Maternity Information Matrix. 
In summary, there are problems with data quality in both hospital data and NPDC data. 
These two data sources should in theory align closely for the number of newborns admitted 
to hospital. Overall, it appears that the NPDC captures data better for pre-term than term 
babies; however this appears to be the case only in some states.  
Feasibility of standardising existing data sources 
The available data from both the NHMD and NPDC are currently too poor to permit any 
level of reporting on this indicator.  
A national standard data item, Neonate transfer to special/neonatal intensive care, has been 
proposed for inclusion in the Perinatal NMDS as part of the NMDDP work program. The 
technical specification for this NCMI (Indicator 12) incorporates definitions and guidelines 
from this data item. In addition, a data item to collect Reason for admission to SCN/NICU that 
includes congenital anomaly as a data value, or a flag to indicate that an admission to the 
SCN/NICU was for a reason other than a congenital anomaly, would capture the data 
needed for this indicator. 
In relation to the NHMD, even if data quality could be improved, the data are still limited in 
what they can provide in terms of other breakdowns, however, cross-checks could continue 
to be performed against these data to check the consistency between the two collections. 
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Recommendations for next steps 
• Consideration should be given to developing a Reason for admission to SCN/NICU data 
item that includes congenital anomaly as a data value, for inclusion in the Perinatal 
NMDS that will enable future reporting against the indicator ‘Babies born ≥37 completed 
weeks gestation admitted to a neonatal intensive care nursery or special care nursery for 
reasons other than congenital anomaly’. 
• Alternatively, a flag to indicate an admission to the SCN/NICU for a reason other than a 
congenital anomaly could be considered for inclusion in the Perinatal NMDS. 
• Cross-checks continue to be performed between NHMD and NPDC data to monitor 
consistency between the two collections. 
2.1.2 Indicator 13: Third and fourth degree tears for (a) all first 
births and (b) all births  
During discussions, ECG members noted that third and fourth degree tears cause significant, 
ongoing maternal morbidity and that rates suggest that tears have been increasing. It is 
important to measure what is actually occurring, as the increase may be due to better 
reporting or may be due to an actual increase in tears. ECG members also noted that 
differentiating between tears with and without episiotomy was important. 
The following technical specification incorporates these recommendations. 
13. Third and fourth degree tears for (a) all vaginal first births and (b) all vaginal 
births 
Indicator details 
Description The proportion of women who have a third or fourth degree perineal laceration after giving birth 
vaginally for (a) all first births and (b) all births. 
Purpose Third and fourth degree perineal lacerations cause significant ongoing maternal morbidity. This 
is an outcome indicator that measures their occurrence. 
Numerator part (a) The number of women who had a third or fourth degree perineal laceration after giving birth for 
the first time and who had a vaginal birth. 
Denominator part (a) The number of women who gave birth for the first time and who had a vaginal birth. 
Numerator part (b) The number of women who had a third or fourth degree perineal laceration after giving birth 
vaginally. 
Denominator part (b) The number of women who gave birth vaginally. 
Computation/Presentation Numerator/denominator x 100 
Presentation Percentage 
Notes and exceptions A birth is defined as the event in which a baby comes out of the uterus after a pregnancy of at 
least 20 weeks gestation or weighing 400 grams or more.  
Births included are vaginal births, including non-instrumental and instrumental births. A non-
instrumental vaginal birth is one in which the baby is born through the vagina without the 
assistance of instruments. An instrumental birth is a procedure that uses instruments (forceps or 
vacuum extraction) to assist the baby to come out through the vagina. 
Births excluded are caesarean sections. 
Postpartum perineal status is defined as: 
1st degree laceration/vaginal graze (Code 2)—Graze, laceration, rupture or tear of the 
perineal skin during delivery that may be considered to be slight or that involves one or more of 
the following structures: 
 fourchette 
 labia 
 vagina 
 vulva. 
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2nd degree laceration (Code 3)—Perineal laceration, rupture or tear as in Code 2 occurring 
during delivery, also involving: 
 pelvic floor 
 perineal muscles 
 vaginal muscles. 
Excludes laceration involving the anal sphincter. 
3rd degree laceration (Code 4)—Perineal laceration, rupture or tear as in Code 3 occurring 
during delivery, also involving: 
 anal sphincter 
 rectovaginal septum 
 sphincter not otherwise specified (NOS). 
Excludes laceration involving the anal or rectal mucosa. 
4th degree laceration (Code 7)—Perineal laceration, rupture or tear as in Code 4 occurring 
during delivery, also involving: 
 anal mucosa 
 rectal mucosa. 
Data collection details 
Data source National Perinatal Data Collection 
Data source type Perinatal NMDS or voluntarily-supplied items 
Data items—indicator Parity 
Method of birth 
Postpartum perineal status (under development) 
Data items— disaggregation 
factors 
Year of birth 
State or territory of birth 
Hospital annual number of births 
Hospital sector 
Remoteness category (from mother’s area of usual residence) 
Indigenous status of mother 
With and without episiotomy 
Mother’s country of birth 
Frequency of data source 
collection(s) 
Annual 
Additional details 
Comments Source of definition: CMIP indicator 5 modified to include all births; Perinatal National Minimum 
Data Set (Female [mother]–postpartum perineal status ref. 423659) 
Based on the technical specification, analysis of the NPDC was undertaken to inform the 
development of this indicator.  
Data analysis and results 
Parity 
• In 2007–2010, third and fourth degree tears combined occurred in 4.3% of first-time 
mothers and 2.3% of all mothers who had a vaginal birth (Figure 2.1). 
• The proportion of third and fourth degree tears combined was highest in mothers aged 
25–29 years compared with other age groups among both first-time and all mothers 
(5.1% of first–time mothers and 2.9% of all mothers respectively compared with 4.3% and 
2.3% for all age groups combined) (Figure 2.4). 
• For first-time mothers and all mothers, third/fourth degree tears were more common in 
non–Indigenous mothers than in Indigenous mothers (4.3% and 2.4% for first-time and 
all non-Indigenous mothers respectively, compared with corresponding figures of 3.7% 
and 1.6% for Indigenous mothers). 
• Among first-time mothers and all mothers internationally, proportions of third/fourth 
degree tears were highest in mothers born in India (10.6% and 8.1% respectively), the 
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Philippines (8.6% and 4.7%), and China and Hong Kong (combined) (7.2% and 5.1%) 
(Figure 2.4). 
Method of birth 
• The proportion of third/fourth degree tears among first-time mothers who had a vaginal 
birth increased marginally from 4.0% in 2007 to 4.6% in 2010, while among all mothers 
who had a vaginal birth the proportion rose from 2.2% in 2007 to 2.5% in 2010 (Figure 
2.1). 
• The proportion of third/fourth degree tears among first-time mothers who had a vaginal 
birth varied by jurisdiction and was lowest in Tasmania (2.4%) and highest in Western 
Australia (5.5%) (Figure 2.2). 
• 4.9% of first-time mothers and 2.6% of all mothers who had a vaginal birth in a public 
sector hospital had a third/fourth degree tear, compared with 2.6% of first-time mothers 
and 1.5% of all mothers who had a vaginal birth in a private sector hospital (Figure 2.2). 
• First-time mothers who had an instrumental vaginal birth were more likely than those 
who had a non–instrumental vaginal birth to have a third/fourth degree tear (6.7% and 
3.2% respectively) (Figure 2.3). There was a similar pattern among all mothers (6.0% 
instrumental and 1.6% non-instrumental respectively. 
Postpartum perineal status 
• The proportion of third/fourth degree tears with episiotomy among all mothers was 
higher than for mothers with third/fourth degree tears without episiotomy (4.0% 
compared with 2.0%) (Figure 2.3). First–time mothers were more likely than all mothers 
to have third/fourth degree tears with episiotomy (4.7% compared with 4.0%). However, 
4.1% of first-time mothers also had third/fourth degree tears without an episiotomy. 
• For all mothers, the proportion of third/fourth degree tears was lowest in Tasmania 
(1.3%) and highest in Western Australia, Northern Territory and the Australian Capital 
Territory (2.9%, 2.9% and 2.8% respectively). 
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Notes 
1. Data collection for third and fourth degree tears was not standardised during the reference period. 
2. Data on perineal status were not available for Victoria for 2009 and 2010. 
Source: AIHW National Perinatal Data Collection.  
Figure 2.1: Third and fourth degree tears for women who gave birth vaginally, 2007–2010  
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All mothers First-time mothers 
  
  
  
  
Notes: 
1. Data collection for third and fourth degree tears was not standardised during the reference period. 
2. Remoteness was assigned using the ABS Australian Standard Geographical Classification (ASGC) remoteness structure applied to 
Statistical Local Area or postal area of mother’s area of usual residence. 
Source: AIHW National Perinatal Data Collection. 
Figure 2.2: Third and fourth degree tears for all women who gave birth vaginally, all mothers and 
first-time mothers, by geographic and hospital characteristics, 2007–2010 
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All mothers First-time mothers 
  
  
Notes 
1. Data collection for third and fourth degree tears was not standardised during the reference period. 
2. Data on perineal status were not available for Victoria for 2009 and 2010. 
Source: AIHW National Perinatal Data Collection. 
Figure 2.3: Third and fourth degree tears for all women who gave birth vaginally, all mothers and 
first-time mothers, by delivery characteristics, 2007–2010 
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Note: Data collection for third and fourth degree tears was not standardised during the reference period. 
Source: AIHW National Perinatal Data Collection. 
Figure 2.4: Third and fourth degree tears for all women who gave birth vaginally, all mothers and 
first-time mothers, by maternal characteristics, 2007–2010 
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Quality of data 
• Data collection for third and fourth degree tears was not standardised during the 
reference period.  
• Data on perineal status were not available for Victoria for 2009 and 2010 at the time of 
preparing this report. 
• There are some differences across jurisdictions in the response categories (Table 2.4) and 
response category definitions (Table 2.5) for third and fourth degree tears. The ACT 
records third and fourth degree tears in its hospital adverse incident system which may 
explain higher reporting of the condition. 
• Data collection for determining if the woman was a first-time mother was not 
standardised during the reference period. Some jurisdictions used Parity which was 
defined as the total number of previous pregnancies experienced by the woman that 
have resulted in a live birth or a stillbirth. However, some jurisdictions (such as Western 
Australia) used other data items to determine if a woman who is currently pregnant has 
had no previous infants born. 
Table 2.4: Summary of jurisdictional response categories for perineal status 
Response categories NSW Vic Qld WA SA Tas ACT NT 
3rd degree tear/laceration
(a)
 X  X X X X X X 
4th degree tear/laceration
 (a)
 X  X X X X X X 
Degree/type (specify)
(b)
  X       
(a) There are differences across jurisdictions in terminology. Some use the term ‘tear’, others use ‘laceration’. 
(b) Some jurisdictions have separate codes/tick boxes for 1st, 2nd, 3rd and 4th degree tears, but others ask midwives to specify degree/type in 
a single field. 
Table 2.5: Summary of jurisdictional definitions for perineal status 
Jurisdiction 3rd degree tear 4th degree tear 
NSW A perineal laceration or tear involving the anal 
sphincter or recto vaginal septum 
A third degree perineal laceration or tear that also 
involves the anal mucosa or rectal mucosa 
Vic Perineal laceration: Only refers to lacerations of the 
perineum which does not include vaginal wall, labial, 
cervical or clitoral lacerations. The degree of the 
laceration should be reported in Degree/type (specify) 
Perineal laceration: Only refers to lacerations of the 
perineum which does not include vaginal wall, labial, 
cervical or clitoral lacerations. The degree of the 
laceration should be reported in Degree/type (specify) 
Qld Tear or laceration involving the anal sphincter or recto 
vaginal septum 
Third degree tear or laceration also involving the anal 
mucosa or rectal mucosa 
WA No definitions specified No definitions specified 
SA No definitions specified No definitions specified 
Tas Involves the external sphincter, and the anal mucosa Includes the anal canal/rectum 
ACT No definitions specified No definitions specified 
NT No definitions specified No definitions specified 
Source: Maternity Information Matrix. 
Feasibility of standardising existing data sources 
An endorsed national standard data item Postpartum perineal status has been included in the 
Perinatal NMDS since 1 July 2013. The technical specification for this NCMI (Indicator 13) 
incorporates the definitions and guidelines from this data item. Data based on the national 
standard will be available from December 2015. 
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No further development work is required for this Indicator. 
Recommendations for next steps 
• Data currently available for this indicator are considered to be of sufficient quality for 
reporting purposes.  
• It is recommended that this indicator be added to the set of NCMIs for reporting and be 
accompanied by clinical commentary. 
2.1.3 Indicator 14: Blood loss of (i) >1,000 mL and <1,500 mL and 
(ii) ≥1,500 mL during first 24 hours after the birth of the baby 
for (a) vaginal births and (b) caesarean sections  
A concurrent AIHW and NPESU project, the NMDDP, involves undertaking work on 
options to enhance nationally consistent and comprehensive maternal and perinatal data 
collection in Australia. As part of this project, a data item Severe primary postpartum 
haemorrhage (PPH) has been prioritised for data development and inclusion in a Perinatal 
Data Set Specification (DSS) and eventually the Perinatal NMDS. The NMDDP established a 
Clinical and Data Reference Group (CDRG) to inform and make decisions on national 
standards for this and other data items. To maximise alignment between the NMDDP and 
NCMI projects, information has been shared between the ECG and CDRG and has informed 
discussions and recommendations. Following is a summary of the information and issues 
discussed by both groups. 
Current collection 
There is considerable variation in the way jurisdictions currently collect information about 
blood loss in the NPDC. Some jurisdictions collect primary and secondary PPH and measure 
it according to estimated millilitres (mL) lost, while others collect transfusion alone or in 
conjunction with mL lost. In many jurisdictions there is no way to distinguish between 
severe and non-severe PPH (see Table 2.6). 
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Source: Unpublished perinatal data. 
Figure 2.5: Example of frequency of blood loss (mL), 2011 
Those jurisdictions that do collect blood loss in an open numeric field report that it works 
well. Figure 2.5 shows the results for one jurisdiction for the frequency of blood loss to the 
nearest mL, demonstrating how accurately it is being collected, and how it allows for the 
data to be cut to different severity categories depending on the purpose, including the 
categories specified for this indicator. 
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Table 2.6: Postpartum haemorrhage response categories used in jurisdictions(a) 
Response category NSW Vic Qld WA SA Tas ACT NT 
Postpartum haemorrhage requiring blood 
transfusion—no units specified 
X X       
PPH/Blood loss—no volume categories or 
only one category for >500mL
(b)
 
 X
(c)
  X  X
(d)
 X X 
PPH/Blood loss (mL)—with 2 or more 
volume categories 
  X
(e)
  X    
Notes         
Can distinguish between severe and non-
severe
(f)
 
 X X  X    
Separates primary and secondary PPH  X
(g)
 X  X
(g)
 X
(g)
   
(a) The response categories listed here are as shown on perinatal forms (except for NT which only has electronic data capture). Additional 
information may be collected in those jurisdictions with electronic maternity information systems.  
(b) Without specifying volume categories it is not currently possible to distinguish Severe PPH from PPH (except in Victoria where there is a 
field for entering the number of mL).  
(c) Victoria does not have volume categories but is the only state to record any amount of blood loss and hence it should be possible to create 
categories from the raw data. Note that no minimum blood loss is specified. 
(d) Jurisdictional feedback indicated Tasmania also collects 4 volume categories electronically, but this does not appear on the PDC form. 
(e) Queensland collect Primary PPH with volume categories under Labour and Delivery Complications but collect Secondary PPH under 
Discharge Details with only a tick box and no volume. 
(f) This depends on how ‘severe’ is defined. For the purposes of the table above ‘severe’ is >1,000mL and ‘non-severe’ is ≤1,000mL.  
(g) Only collects primary. In Victoria, although there is no specification on the form, the guidelines state that the item is for blood loss at the time 
of birth and in the following 24 hours, or up until the time of discharge if occurring before 24 hours. 
Volume and transfusion measures 
Consideration was given to the best way to obtain a consistent measure of PPH, via a volume 
of blood lost or by a measure of blood transfusion, or both.  
Historical information on the selection of the volume measure for this NCMI is available in 
the Women’s Hospitals Australasia (WHA) report on the development of the core maternity 
indicators. Despite the acknowledged problems of estimating blood loss accurately, the 
volume measure was preferred to transfusion as ‘the need for transfusion is not wholly 
dependent upon the volume of blood loss. It is very individual and may occur with small 
blood losses in women with pre-existing conditions’ (WHA 2007). 
Amount of blood loss 
The WHA report noted that the choice of 1,000 mL as the lower threshold for blood loss was 
related to the fact that this volume ‘corresponds to the 95th percentile for blood loss 
associated with spontaneous vaginal delivery’, and that blood loss of this amount is 
‘associated with significant maternal morbidity and a small but consistent maternal mortality 
rate’ (WHA 2007).  
The ECG commented during initial development of this NCMI that >1,000 mL was also 
preferred because if >1,500 mL was selected this implied that a blood loss of 1,500 mL was 
acceptable, which is not the case. The ECG noted, however, that in caesarean births blood 
loss of 1,000 mL is fairly common.  
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Severity measures 
This NCMI is for ‘significant’ primary PPH, whereas the NMDDP item is for ‘severe’ 
primary PPH. There were discussions around the importance of aligning the NMDDP item 
and the indicator. 
CDRG members indicated that blood loss of over 1,500 mL would better capture severe 
primary PPH. They also noted that most women with a normal haemoglobin level for 
pregnancy at term will tolerate a PPH of 1,000 mL well.  
The ECG recommended that the lower threshold of 1,000 mL be retained but that the 
indicator include categories of blood loss for both >1,000 mL but <1,500 mL and (b) 
≥1,500 mL. 
It was noted that the use of categories has the disadvantage of estimation around the 
margins being difficult.  
An open numeric field for estimated blood loss was discussed. This could be coded to 
whichever categories were required for NCMI or other reporting, and removes the issue of 
having to choose a range. However, it does not eliminate all difficulties as the clinician still 
has to make decisions about the amount of blood loss. 
Recommendations 
Following discussions at their meeting in May 2013, the CDRG recommended a volume 
measure that records the mL of blood loss in an open numeric field and a data item to 
capture whether a transfusion occurred. All volume measures will have the limitation of 
accurate measurement of blood loss. The addition of a transfusion item would be an 
indication of whether the woman was compromised or not (except for women who refuse 
transfusion). The item cannot account for the different policies and practices of hospitals in 
relation to transfusion; however the combination of measures (volume and transfusion) 
would assist to provide a clearer picture of the severity of the haemorrhage for most women. 
This approach aligns with the NCMI and allows for the data to be grouped into different 
qualitative categories as required, for example ‘severe’ and ‘significant’. The item to capture 
whether a transfusion occurred will enable additional information on severity to be 
provided. 
On the basis of this recommendation for an open numeric field, this NCMI should be revised 
to be ≥ 1,000 mL, as there will be a tendency for rounded estimates such as 1,000 mL or 
1,500 mL. Based on the current definition, if a clinician enters 1,000 mL it would not be 
included in this indicator.  
Following consultation with the MSIJC, they recommended that this Indicator align with the 
data items in the 2014–15 Perinatal DSS. 
The following technical specification incorporates these recommendations. 
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14. Blood loss of (i) ≥1,000 mL and <1,500 mL and (ii) ≥1,500 mL during first 24 
hours after the birth of the baby for (a) vaginal births and (b) caesarean 
sections 
Indicator details 
Description The proportion of women with blood loss of (i) ≥1,000 mL and <1,500 mL and (ii) ≥1,500 mL 
during the first 24 hours after the birth of the baby for (a) vaginal births and (b) caesarean 
sections 
Purpose This is an outcome indicator. 
Numerator part (i) (a) The number of women who had blood loss of ≥1,000 mL and < 1,500 mL during the first 24 
hours after giving birth vaginally. 
Denominator part (i) (a) The number of women who gave birth vaginally. 
Numerator part (ii) (a) The number of women who had blood loss of ≥1,500 mL during the first 24 hours after giving 
birth vaginally. 
Denominator part (ii) (a) The number of women who gave birth vaginally. 
Numerator part (i) (b) The number of women who had blood loss of ≥1,000 mL and <1,500 mL during the first 24 
hours after giving birth by caesarean section. 
Denominator part (i) (b) The number of women who gave birth by caesarean section. 
Numerator part (ii) (b) The number of women who had blood loss of ≥1,500 mL during the first 24 hours after giving 
birth by caesarean section. 
Denominator part (ii) (b) The number of women who gave birth by caesarean section. 
Computation/Presentation Numerator/denominator x 100 
Presentation Percentage 
Notes and exceptions A birth is defined as the event in which a baby comes out of the uterus after a pregnancy of 
at least 20 weeks gestation or weighing 400 grams or more. 
Blood loss is defined as blood loss of (i) ≥1,000 mL and < 1,500 mL and (ii) ≥1,500 mL within 
24 hours of the birth of the baby. 
All women who gave birth are included. 
Data collection details 
Data source National Perinatal Data Collection 
Data source type Perinatal NMDS and voluntarily-supplied items 
Data items—indicator Method of birth 
Primary postpartum haemorrhage indicator (item under development) 
Estimated blood loss due to primary postpartum haemorrhage (item under development) 
Blood transfusion due to primary postpartum haemorrhage indicator (item under 
development) 
Data items— disaggregation 
factors 
Year of birth 
State or territory of birth 
Hospital annual number of births 
Hospital sector 
Remoteness category (from mother’s area of usual residence) 
Indigenous status of mother 
Frequency of data source 
collection(s) 
Annual 
Additional details 
Comments Source of definition: CMIP 9, modified to include all births and major and severe PPH. 
Based on the technical specification, analysis of the NHMD was undertaken to inform the 
development of this indicator. In the future, data will be available to support the reporting of 
this indicator from the NPDC—see ‘Feasibility of standardising existing data sources’ section 
below. 
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Data analysis and results 
ICD-10-AM diagnostic codes recorded in maternity episodes were used to identify maternity 
episodes with PPH, and ACHI codes to identify blood transfusion procedures in the NHMD 
in the period 2008–2011 (Box 2.1). These codes do not provide information about the amount 
of blood loss. Use of blood transfusion during the maternity episode suggests substantial 
blood loss. However, this is a blunt measure because transfusion may have commenced 
before the baby was born, and the need for transfusion may reflect other conditions such as 
anaemia, antepartum or intrapartum bleeding. Caesarean birth can be identified both from 
ICD-10-AM codes and ACHI codes associated with maternity episodes (Box 2.1). 
Box 2.1: Codes used in NHMD analysis 
ICD-10-AM codes for PPH and transfusion 
O72.0 Third-stage haemorrhage 
O72.1 Other immediate postpartum haemorrhage 
O72.2 Delayed and secondary postpartum haemorrhage 
O72.3 Postpartum coagulation defects 
ACHI codes for transfusion 
13706–01 Administration of blood 
13706–02 Administration of packed cells 
13706–03 Administration of platelets 
38588–00 Administration of erythrocytes 
92060–00 Administration of autologous blood 
92061–00 Administration of coagulation factors 
92062–00 Administration of fresh frozen plasma 
92063–00 Administration of plasma expander  
ICD-10-AM and ACHI codes for caesarean section 
ACHI 
16520–00 Classical elective  
16520–01 Classical emergency  
16520–02 Lower segment elective  
16520–03 Lower segment emergency 
ICD-10-AM 
O82 Single delivery by caesarean section 
O84.2 Multiple delivery, all by caesarean section 
O84.82 Multiple delivery by combination of methods 
• PPH is vaginal bleeding after the baby is born. The third stage of labour is the period 
from the birth of the baby to the expulsion/removal of the placenta. Third-stage 
haemorrhage (O72.0 in Box 2.1) and immediate PPH (O72.1) together align most closely 
with PPH in the first 24 hours. 
• There can be more than 1 type of PPH diagnosis in a maternity episode. 
• Hierarchical categories aggregate PPH category combination(s) according to the timing 
after birth, which is broadly associated with underlying pathology: third-stage 
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haemorrhage associated with retained placenta/membranes or uterine atony; delayed 
haemorrhage with infection; coagulopathy with other conditions, for example,  
pre-eclampsia. 
• Delayed haemorrhage diagnosis is usually bleeding 48 hours or more after giving 
birth—most commonly 2–10 days later. Most will not be captured within the maternity 
episode, but are included here for completeness. 
• Table 2.7 shows the number and proportion of maternity episodes by PPH and 
hierarchical categories in the 2008–2011 reference period. The proportion of maternity 
episodes with PPH immediately after birth was highest (7.5%). 
Table 2.7: PPH categories, 2008–2011 
PPH category Number Per cent 
3rd stage 13,133 1.12 
3rd stage and delayed 75 0.01 
3rd stage and coagulopathy 55 0.00 
Total 3rd stage 13.263 1.13 
Immediate 86,895 7.43 
Immediate and delayed 231 0.02 
Immediate and coagulopathy 230 0.02 
Immediate, delayed and coagulopathy 2 0.00 
Total immediate 87,358 7.47 
Delayed 4,779 0.41 
Delayed and coagulopathy 20 0.00 
Total delayed 4,799 0.41 
Coagulopathy 566 0.05 
Any PPH 105,986 9.07 
No PPH 1,063,004 90.93 
Total 1,168,990 100.0 
Note: There can be more than one type of PPH diagnosis in a maternity episode. 
Source: AIHW National Hospital Morbidity Database. 
• Table 2.8 shows the number and proportion of transfusion (blood or blood products) by 
the PPH category in the 2008–2011 reference period. (Note: Transfusion can be carried 
out in maternity episodes without a PPH diagnosis, as PPH is not the only reason for 
transfusion.) 
• The proportion transfused was highest in maternity episodes with PPH immediately 
after birth (25.4%). 
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Table 2.8: PPH and transfusion, 2008–2011 
PPH 
category 
Transfused Not transfused Total % transfused 
3rd stage 3,118 10,145 13,263 12.1 
Immediate 10,565 76,793 87,358 25.4 
Delayed 1,221 3,578 4,799 23.9 
Coagulopathy 135 431 566 23.5 
None 5,684 1,057,320 1,063,004 0.5 
Total 20,723 1,148,267 1,168,990 1.8 
Notes 
1. Transfusion includes the use of blood, blood products and plasma expanders. 
2. There can be more than one type of PPH diagnosis in a maternity episode. 
Source: AIHW National Hospital Morbidity Database. 
 
Notes 
1. Transfusion includes the use of blood, blood products and plasma expanders. 
2. There can be more than one type of PPH diagnosis in a maternity episode. 
Source: AIHW National Hospital Morbidity Database. 
Figure 2.6: Maternity episodes with third-stage and immediate PPH, 2008–2011 
• There was a small increase, from 8.4% to 8.9%, over the period 2008–2011 for women 
having a PPH. This may reflect a diagnostic shift, and changes in coding standards and 
policies (Figure 2.6). 
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Table 2.9: Maternity episodes with third-stage and immediate PPH, by selected characteristics, 
2008–2011 (per cent) 
 Not transfused
 
 Transfused
 
 All 
 2008 2009 2010 2011  2008 2009 2010 2011  2008 2009 2010 2011 
State or territory of birth 
NSW 6.2 6.4 6.5 7.0  0.9 1.0 1.0 1.1  7.1 7.4 7.5 8.1 
Vic 8.8 9.0 8.9 8.8  1.3 1.3 1.3 1.4  10.1 10.3 10.2 10.2 
Qld 5.0 5.3 5.8 5.9  1.0 1.0 1.1 1.2  6.0 6.4 7.0 7.1 
WA 11.4 10.4 9.1 9.2  1.2 1.3 1.2 1.2  12.6 11.7 10.2 10.4 
SA 7.7 7.9 7.6 8.0  1.7 1.5 1.5 1.5  9.4 9.4 9.0 9.5 
Tas 5.8 5.7 5.6 7.1  0.9 0.8 0.9 1.2  6.7 6.5 6.5 8.2 
ACT 7.2 8.2 8.9 8.2  1.3 1.2 1.4 1.4  8.5 9.5 10.3 9.6 
NT 11.0 12.0 13.5 13.1  2.1 2.1 2.1 2.6  13.1 14.1 15.6 15.7 
Australia 7.3 7.4 7.4 7.6  1.1 1.1 1.2 1.3  8.4 8.5 8.6 8.9 
Hospital sector 
Public 8.8 8.8 8.8 9.0  1.3 1.4 1.4 1.5  10.1 10.2 10.2 10.5 
Private 3.6 3.7 3.7 3.9  0.6 0.6 0.6 0.6  4.2 4.3 4.4 4.5 
Maternal age 
Less than 
20 7.3 8.2 8.2 7.9 
 
1.6 1.9 1.9 1.9 
 
8.9 10.1 9.9 10.1 
20–24 8.1 8.2 8.2 8.5  1.4 1.4 1.3 1.3  9.5 9.6 9.8 10.0 
25–29 8.0 7.9 7.9 8.0  1.0 1.1 1.2 1.2  9.0 8.9 9.2 9.6 
30–34 7.0 7.0 7.0 7.0  1.0 1.0 1.0 1.0  7.9 8.0 8.0 8.3 
35–39 6.3 6.7 6.7 6.5  1.0 1.1 1.1 1.1  7.3 7.8 7.6 7.9 
40 and 
over 7.4 7.2 7.2 6.6 
 
1.4 1.2 1.5 1.5 
 
8.7 8.3 8.0 8.8 
Type of birth 
Caesarean 6.2 6.1 5.8 5.7  1.1 1.1 1.2 1.3  7.3 7.2 6.9 7.0 
Vaginal 7.8 8.0 8.2 8.6  1.1 1.2 1.2 1.3  8.9 9.2 9.3 9.8 
Notes 
1. Transfusion includes the use of blood, blood products and plasma expanders. 
2. There can be more than one type of PPH diagnosis in a maternity episode. 
Source: AIHW National Hospital Morbidity Database. 
• Overall, for 2008–2011 combined, there was marked variability across jurisdictions in 
maternity episodes with third-stage and immediate PPH. Proportions varied from 6.6% 
in Queensland to 14.6% in the Northern Territory, with the range of variation being 
higher in the non-transfused group. If the Northern Territory is excluded due to its 
unique demographics, the variation for all episodes (transfused and not transfused) is 
from 6.6%% to 11.2% (Table 2.9). 
• PPH shortly after birth is more common in maternity episodes reported from public 
hospitals (10.3%) compared with private hospitals (4.3%) for the 2008–2011 period. 
Trends over time suggest that rates have remained stable in both public and private 
hospitals. 
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• Younger women (less than 24) have higher rates of PPH shortly after birth than older 
women (30–39), for PPH with and without transfusion. Maternal age differences most 
likely reflect differences in the method of birth and hospital sector. 
• PPH shortly after birth does not appear to be diagnosed as commonly in maternity 
episodes where the birth was by caesarean. PPH is not the same as intrapartum blood 
loss, which varies markedly between vaginal and caesarean birth. Reliable assessment of 
third-stage haemorrhage in caesarean birth may be limited, as this would be difficult to 
distinguish from operative blood loss.  
Quality of data 
• The number of maternity episodes identified in the NHMD aligns closely with the 
number of mothers in the NPDC data. 
• Although data from the NHMD show less variability than NPDC data, there is still 
substantial variation in rates across jurisdictions, with two-fold differences being 
observed overall, and for third-stage and immediate PPH associated with a transfusion. 
The smaller difference in rates with the NHMD most likely reflects the use of a common 
coding standard used for data submitted to the NHMD. 
• The data from the NHMD are limited as there is no information on severity, although 
transfusion can be used as a crude measure. In addition, the ‘immediate’ PPHs are (by 
exclusion) up to 48 hours so do not correspond to the 24 hours definition in the indicator. 
• Although data in the NHMD are based on the ACS, those standards do not include a 
definition of PPH, and how the coding is done in practice relies on the quality of the 
record-keeping, which can differ markedly.  
• NPDC data are currently very poor due to marked differences in definitions and 
collection methods, but NMDDP work should assist to standardise collection. 
Feasibility of standardising existing data sources 
As outlined above there is currently significant variation in practice across jurisdictions in 
how they define and collect PPH. Based on the recommendations of the CDRG, the NMDDP 
has developed data items to support the national collection and reporting of primary PPH 
against a national standard. These include a flag for whether primary postpartum 
haemorrhage occurred, a flag for whether a blood transfusion occurred and a volume 
measure that records the mL of blood loss using a categorical field (500–999 mL,  
1,000–1,499 mL and 1,500 mL or more). These data items have been incorporated in the 
Perinatal DSS; however, timeframes for the implementation of these national standards in 
the NPDC have not been agreed. 
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Recommendations for next steps 
• The NPDC still remains the best option for reporting against this indicator, particularly 
as the NPDC has the capacity to identify the severity of PPH, and this information can be 
used in conjunction with other information, such as duration of pregnancy, that are not 
available from the NHMD. 
• Development of the data items to support the national collection and reporting of 
primary PPH as part of the NMDDP is monitored to inform the timeframe for reporting 
against this indicator. This work is currently underway and data items have been 
incorporated into the Perinatal DSS. Work to include them within the NMDS is 
continuing. 
• Data are reported for this indicator on an annual basis when available and be 
accompanied by clinical commentary. 
2.1.4: Indicator 15: Women having their second birth vaginally 
whose first birth was by caesarean section  
During discussions, ECG members recommended that for clarity the title for Indicator 15 be 
altered from ‘Women delivering vaginally who have had one baby by caesarean section 
previously and no other pregnancies of more than 20 weeks gestation’ to ‘Women having 
their second birth vaginally whose first birth was by caesarean section’. Members also 
recommended that only singleton second births should be included in the scope of this 
Indicator. The following technical specification incorporates these recommendations. 
15. Women having their second birth vaginally whose first birth was by 
caesarean section 
Indicator details 
Description The proportion of women having their second birth vaginally whose first birth was by 
caesarean section. 
Purpose This indicator is used to benchmark practice for vaginal birth following caesarean section. 
Numerator The number of women having their second birth vaginally whose first birth was by caesarean 
section. 
Denominator The number of women having their second birth whose first birth was by caesarean section. 
Computation/Presentation Numerator/denominator x 100 
Presentation Percentage 
Notes and exceptions A birth is defined as the event in which a baby comes out of the uterus after a pregnancy of at 
least 20 weeks gestation or weighing 400 grams or more. 
Women included are those who are having a singleton for their second birth and whose first 
birth was by caesarean section. 
Women excluded are those whose second birth is a multiple birth, those who are not having 
their second birth, and those who are having their second birth and whose first birth was a 
vaginal delivery. 
Data collection details 
Data source National Perinatal Data Collection 
Data source type Perinatal NMDS and voluntarily-supplied items 
Data items—indicator Parity 
Method of birth 
Caesarean section indicator (last previous birth) (item under development) 
Data items—disaggregation 
factors 
Year of birth 
State or territory of birth 
Hospital annual number of births 
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Hospital sector 
Remoteness category (from mother’s area of usual residence) 
Indigenous status of mother 
Indigenous status of baby 
Frequency of data source 
collection(s) 
Annual 
Additional details 
Comments Source of definition: Modified from ACHS indicator 2.1; WHA indicator 2a. 
 
Based on the technical specification, analysis of the NPDC was undertaken to inform the 
development of this indicator. 
Data analysis and results 
• In 2007–2010, 13.8% of mothers giving birth for the second time with a history of 
caesarean section had a vaginal birth. 
• Over the four years there was a marginal but progressive increase in the rate of vaginal 
birth following caesarean section among women giving birth for the second time, from 
13.3% in 2007 to 14.1% in 2010 (Figure 2.7). This increase is statistically significant. 
 
Notes 
1. Data collection for vaginal birth following caesarean was not standardised during the reference period. 
2. Data on previous caesarean birth was not available for Victoria during the reference period. 
Source: AIHW National Perinatal Data Collection. 
Figure 2.7: Women having their second birth vaginally whose first birth was by caesarean section, 
2007–2010 
• Over 2007–2010, there were differences among states and territories in vaginal birth rate 
following caesarean section for women giving birth for the second time. These ranged 
from 10.3% in South Australia to 20.0% in the Australian Capital Territory (Figure 2.8). 
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• There was no substantial difference by remoteness of the mother’s area of residence in 
the proportion of women giving birth for the second time who had a vaginal birth 
following caesarean section (Figure 2.8). 
• There was a marked difference by hospital sector. The vaginal birth rate following 
caesarean section was 18.1% among women giving birth for the second time in a public 
hospital, compared with 8.1% among women giving birth for the second time in a 
private hospital (Figure 2.8). 
  
  
  
Notes 
1. Data collection for vaginal birth following caesarean was not standardised during the reference period. 
2. Data on previous caesarean birth was not available for Victoria during the reference period. 
3. Remoteness was assigned using the ABS Australian Standard Geographical Classification remoteness structure applied to Statistical Local 
Area or postal area of mother’s area of usual residence. 
Source: AIHW National Perinatal Data Collection. 
Figure 2.8: Women having their second birth vaginally whose first birth was by caesarean section, 
by selected characteristics, 2007–2010 
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• The proportion of women giving birth for the second time who had a vaginal birth 
following caesarean section declined with advancing women’s age, with rates ranging 
from 20.8% for women aged 20 or younger to 8.0% for women aged 40 or older (Figure 
2.8).  
• Indigenous mothers giving birth for the second time with a history of caesarean section 
were more likely than non-Indigenous mothers to have a vaginal birth (18.0% and 13.2% 
respectively) (Figure 2.8). 
Quality of data 
• With the exception of Method of birth, data collection for vaginal birth following 
caesarean section was not standardised for the items required for deriving this indicator 
during the reference period, for the following reasons: 
– Data collection for determining if the woman was having their second child was not 
standardised. Some jurisdictions used Parity, which was defined as the total number 
of previous pregnancies experienced by the woman that have resulted in a live birth 
or a stillbirth. However, some jurisdictions (such as Western Australia) used other 
data items to determine if a woman who is currently pregnant has had no previous 
infants born. 
– In this analysis, Caesarean section for last birth was defined as whether a caesarean 
section was performed for the woman’s last birth. Only New South Wales, Victoria 
and South Australia have definitions for this term, and these appear to conform to 
the definition in METeOR. 
Feasibility of standardising existing data sources 
National standards for Caesarean section indicator (last previous birth) and Parity have recently 
been added to the Perinatal NMDS and will be collected from 2014–15. 
Recommendations for next steps 
• Data currently available for this indicator are considered to be of sufficient quality for 
reporting purposes. It is recommended that this indicator be added to the set of NCMIs 
for reporting and be accompanied by clinical commentary. When reporting against this 
indicator it will be important to be clear about the purpose of the indicator and for the 
analysis to be presented together with caesarean section and morbidity rates. 
2.1.5 Indicator 18: Caesarean sections <39 completed weeks (273 
days) without obstetric/medical indication 
This indicator was considered by ECG members, as well as by key experts and stakeholders 
engaged via a consultation process. A number of issues were considered in relation to this 
indicator, including:  
• the title and purpose of the indicator 
• rationale and evidence to support the indicator 
• measurement issues, including how to identify whether pre-term delivery was 
conducted without any medical or obstetric indications, and data collection options. 
Details of these issues are outlined below. 
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Purpose of the indicator 
Neonatal respiratory morbidity can be reduced by minimising early delivery. This indicator 
is used to benchmark practice. 
Evidence and rationale for the indicator 
Babies born at late pre-term (between 34 0/7 and 36 6/7 weeks of gestation) and early-term 
(between 37 0/7 and 38 6/7 weeks of gestation) are at increased risk of adverse health 
outcomes, largely due to increased risk of respiratory morbidity (Morrison et al. 1995; 
Hansen et al. 2008; Hibbard et al. 2010), including increased likelihood of ventilator use 
(Madar et al. 1999) and increased admission to neonatal intensive care (Clark et al. 2009). The 
risk is higher at 37 than 38 completed weeks of gestation, which has a higher risk than 39 
completed weeks of gestation (Hansen et al. 2009; Morrison et al. 1995).  
Studies have also shown increased risk of poor neonatal outcome at 37 and 38 completed 
weeks compared with 39 completed weeks of gestation (Tita et al. 2009) and increased 
incidence of composite adverse neonatal outcome for infants born at late pre-term and  
early-term (34 0/6 to 38 6/7) compared with infants born at 39 0/7 to 40 6/7 weeks of 
gestation, even in the presence of a positive fetal lung maturity result (Kamath et al. 2011). 
In addition to increased neonatal morbidity, increases in neonatal mortality have also been 
reported for babies born early-term compared with those born at 39 0/7 to 41 6/7 weeks of 
gestation. Neonatal mortality for babies born at 37 weeks or more was highest at 37 and 
lowest at 40 completed weeks of gestation (Reddy et al. 2011). 
One study showed that elective caesarean delivery at 37 or 38 completed weeks of gestation 
did not improve adverse maternal outcomes compared with delivery at 39 completed weeks 
of gestation (Tita et al. 2011). Additionally, early elective delivery was associated with a  
two-fold increased frequency of maternal hospitalisation for 5 days or more, and this 
appeared to be more attributable to prolonged neonatal hospitalisation rather than increased 
maternal morbidity (Tita et al. 2011). 
Although there is strong evidence for adverse neonatal outcomes as a result of early-term 
delivery, several studies have reported high rates of planned deliveries (either induction of 
labour or caesarean delivery) prior to 39 completed weeks of gestation. A large multicentre 
study in the US found that more than one-third of elective repeat caesarean deliveries at term 
were performed before 39 weeks of gestation (Tita et al. 2009). Similarly, between 1992 and 
2002 in the US, the proportion of births classified as occurring by medical intervention 
increased from 28.9% in 1992 to 33.9% in 1997, and 41% in 2002. For medical intervention 
births, a larger proportion of infants in 2002 were born at earlier gestational ages than in 
1992, with the mean gestational age decreasing from 39.2 weeks to 38.8 weeks (Davidoff et al. 
2006). In England, elective caesarean rates have increased from 5% of all births in 1990 to 10% 
in 2008 (Gurol-Urganci et al. 2011). 
A similar trend was seen in New South Wales, with the rate of planned birth (either 
caesarean or induction of labour) before the due date increasing between 2001 (19.2%) and 
2009 (26.2%). The rate of pre-labour caesarean section increased over the same time period 
from 10.3% to 14.9% of all live births at 33 or more weeks of gestation (Morris et al. 2012). 
The rate of caesarean sections has been increasing in Australia, from 25.4% in 2001 to 31.6% 
in 2010 (Li et al. 2012). Caesarean section rates are higher in older mothers, with 40.3% of 
women aged 35–39 having a caesarean section and 48.0% of women aged 40 and over (Li et 
al. 2012). Of the women who gave birth by caesarean section without labour, 60.3% delivered 
at a gestational age of less than 39 completed weeks (Li et al. 2012). 
 National core maternity indicators—stage 2 report: 2007–2011 35 
There are varying opinions expressed in clinical guidelines and recommendations. Some 
recommend that planned caesarean section not be routinely carried out before 39 completed 
weeks of gestation (ACOG 2013; NICE 2011). Others recommend that the timing of elective 
or pre-labour caesarean section at term should be decided with consideration given to both 
maternal and neonatal factors (RANZCOG 2012). 
Measurement issues 
A concurrent AIHW and NPESU project, the NMDDP, is undertaking work on options to 
enhance nationally consistent and comprehensive maternal and perinatal data collection in 
Australia. A data item, Indications for caesarean section, has been prioritised by this project for 
data development and inclusion in a Perinatal DSS and eventually the Perinatal NMDS. The 
NMDDP established the CDRG to inform and make decisions on national standards for this 
and other data items. To maximise alignment between the NMDDP and NCMI projects 
information has been shared between the ECG and CDRG and has informed discussions and 
recommendations. 
Following is a summary of the information and issues discussed by both groups, which 
largely focused on the measurement issues for this indicator: 
• ECG members recommended that for clarity the title be altered to ‘Caesarean sections 
<39 weeks (273 days) without obstetric/medical indication’ and that the purpose of the 
indicator is to reduce neonatal respiratory morbidity by minimising early delivery. 
• The Indications for caesarean section item under development as part of the NMDDP is 
relevant to caesarean delivery at any gestation, not specific for deliveries prior to 39 
completed weeks, so would need to be modified to apply to pre-term babies. 
• Measurement of this indicator requires data on method of delivery and gestational age, 
which are available in the NPDC, and data on whether the early delivery was conducted 
without any medical or obstetric indications, which are not currently available. 
Currently, some data on maternal morbidities and reasons for caesarean section are 
available in state and territory perinatal data collections, although there are no consistent 
data available at the national level. 
• The CDRG developed a list of indications for caesarean section, which was considered 
by the ECG to inform discussion of this indicator in relation to the identification of those 
indications that would justify a pre-term caesarean section, that is, those indications that 
would be excluded from the analysis for this NCMI.  
• Table 2.10 provides the list of indications developed by the CDRG that is now included 
in the Perinatal DSS.  
• During consultation, it was proposed to the ECG that in the absence of labour, codes 03, 
11, 15, 16, 17 and 20 could provide the basis on which analysis for this indicator could be 
done in the future, and in the presence of labour, code 20 could provide the basis for 
analysis. However it was noted that: 
– Codes 03, 11, 15, 16 and 17 (see Table 2.10) will not always be inappropriate before 
labour and should be applied only when there is no documentation to support 
informed decision-making. However this is not likely to be possible and, in that case, 
only code 20 should apply. 
– Distinguishing between labour and non-labour is best left as a separate item to add 
context when analysed in conjunction with other information on the indication for 
the caesarean section. 
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– Although the recommendation for gestation of an elective caesarean section is 
‘approximately 39 weeks’ gestation’, because of hospital scheduling issues, it is very 
common that an elective caesarean section would be done at any time from 38.4 to 
39.3 weeks’ gestation. 
– The following indicators for possible early delivery were used as exclusions for an 
audit for caesarean section performed prior to 39 weeks in singleton pregnancies in 
Western Australia—pre-eclampsia, pre-existing hypertension, APH/ placenta 
praevia, SROM, and pre-existing and gestational diabetes. 
Table 2.10: List of codes for Indications for caesarean section NMDDP data item 
Code Description 
01 Fetal compromise 
02 Suspected fetal macrosomia 
03 Malpresentation 
04 Lack of progress; less than or equal to 3 cm cervical dilatation 
05 Lack of progress in the first stage; 4 cm to less than 10 cm cervical dilatation 
06 Lack of progress in the second stage 
07 Placenta praevia 
08 Placental abruption 
09 Vasa praevia 
10 Antepartum/intrapartum haemorrhage  
11 Multiple pregnancy 
12 Unsuccessful attempt at assisted delivery 
13 Unsuccessful induction 
14 Cord prolapse 
15 Previous caesarean section 
16 Previous shoulder dystocia 
17 Previous perineal trauma/4th degree tear 
18 Previous adverse fetal/neonatal outcome  
19 Other obstetric, medical, surgical, psychological indications 
20 Maternal choice in the absence of any obstetric, medical, surgical, psychological indications 
99 Not stated/inadequately described 
Internationally, lists of indications that may justify early delivery exist in a range of contexts 
—performance indicator measurement, specialist medical college committee opinion, and 
research studies. The US Joint Commission (2012) has developed a set of 5 perinatal care 
measures, including 1 measure of elective deliveries at ≥ 37 and < 39 completed weeks of 
gestation. This measure includes both elective vaginal deliveries and elective caesarean 
sections in the absence of obstetric/medical indication. The conditions justifying elective 
delivery prior to 39 completed weeks’ gestation are given as ICD-9-CM codes (see Table D1 
in Appendix D). The US Joint Commission chose to use ICD-9 codes so that the measure was 
not overly labour-intensive to collect (Main et al. 2010). It should be noted that the rate of this 
indicator will never be zero, as the diagnosis-related group codes cannot capture all valid 
reasons for performing an early-term caesarean section (Clark et al. 2012). 
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The American College of Obstetricians and Gynecologists recently released Committee 
Opinion number 560 titled Medically indicated late-preterm and early-term deliveries (ACOG 
2013). This paper includes a list of conditions that complicate pregnancy (see Table D2 in 
Appendix D), with suggested timing of delivery (late pre-term or early-term). The list is not 
meant to be all-inclusive, but includes indications commonly encountered in clinical practice. 
A research study by Tita and others (2009) used a list to determine which caesarean 
deliveries were elective in their study population (see Figure 1 in Appendix D). 
Options for data collection 
Three options were suggested to support the collection of data for this indicator: 
• Use of a comprehensive list of indications, such as one based on ICD-10-AM, similar to 
that used in the US Joint Commission (2012) indicator. 
• Use of a list that covers the common indications, including those for pre-term delivery, 
based on the item currently under development as part of NMDDP for indications for 
caesarean section.  
• Use of a flag for ‘without medical or obstetric indications’. This could be achieved by 
using code 20 from the Indications for caesarean section item developed under the 
NMDDP. Although the NMDDP item allows for both a main and additional indications 
to be selected, the guide for use states that code 20 is for use on its own.  
The benefits, issues and limitations of each option are outlined in Table 2.11. 
Table 2.11: Summary of benefits and issues/limitations of data collection options 
Data collection method Benefits Issues/limitations 
Comprehensive list of indications Detailed information on indication 
available. 
Disaggregation by indication possible. 
Feasibility/practicality of implementing. 
Response burden. 
List of common indications Most common indications available. 
Disaggregation by indication possible. 
If using a subset of the list being 
developed for the NMDDP, then no 
additional data collection burden. 
Does the proposed NMDDP list of 
indications for caesarean section cover 
appropriate indications for delivery prior to 
39 completed weeks of gestation? 
Flag for ‘without medical or 
obstetric indications’ 
Minimal data collection burden. Very limited information available. 
No disaggregation by indication possible. 
Conclusions from initial scoping 
The list of common indications appears to offer the most benefits with few limitations. The 
list of indications for caesarean section currently being developed by the NMDDP (see Table 
2.10) includes many of the items found in the international lists (US Joint Commission 2012; 
ACOG 2013; Tita et al. 2009), but does not include maternal hypertension or diabetes. 
Separate items are being developed through the NMDDP to capture information in the 
perinatal data collection on maternal hypertension and diabetes, potentially allowing, in 
conjunction with other information, derivation of the reason for the pre-term delivery. 
At their meeting in June 2013 the NMDDP Advisory Group considered the NMDDP item for 
indications for caesarean section and concluded that the list of indications was appropriate 
for use for pre-term deliveries, and that the addition of maternal morbidity conditions to the 
item was not required on the basis that these conditions are contributing/underlying factors, 
not the indication for a caesarean section. 
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Consultation outcomes 
This indicator was further considered by key experts and stakeholders engaged via a 
consultation process. A summary of the results is provided below (further details are 
available in Appendix B). 
Title 
Around three-quarters of respondents (77%, n=17) agreed with the proposed title for this 
indicator: ‘Caesarean sections <39 weeks (273 days) without obstetric/medical indication’. 
Other comments provided by respondents regarding the gestation period covered by the 
indicator were: 
• elective caesarean section is ‘approximately 39 weeks’ gestation’ (as recommended by 
RANZCOG), because of hospital scheduling issues 
• it is very common that an elective caesarean section would be done at any time from 38.4 
to 39.3 weeks, therefore the indicator should be less than 38.4 weeks gestation 
• less than 39 completed weeks is simply wrong and encouraging bad practice. 
Purpose 
The majority of respondents (86%, 19 respondents) supported the proposed purpose of the 
indicator: ‘Neonatal respiratory morbidity can be reduced by minimising early delivery. This 
indicator is used to benchmark practice’. 
Additional comments provided by respondents on the purpose of this indicator included: 
• data presented at FIGO from UK suggest that this presumption is not valid in a 
prospective study—not seen in print yet, but potentially important 
• not simply respiratory morbidity that increases with decreasing gestational age, many 
organs undergo maturation shortly before natural birth—neonatal jaundice is another 
example 
• suggest use ‘birth’ rather than ‘delivery’ 
• also useful to note that this has to be balanced against the increased rates of death and 
disability by delaying the delivery, that is, ‘approximately 39 weeks’ achieves this 
balance. 
Measurement issues 
The most common preference to capture indications that may justify caesarean section 
delivery prior to 39 completed weeks’ gestation was the ‘List of common indications based 
on the NMDDP list of indications for caesarean section’ (48%, 11 respondents). This was 
followed by the ‘Comprehensive list of indications based on ICD-10-AM’ (30%, 7 
respondents) and the ‘Flag for ‘without medical or obstetric indication’’ (22%, 5 
respondents). 
The most common theme in the comments received on the list of indications (Table 2.10) was 
regarding the distinction between pre-labour and labour. Several respondents felt that the 
labour indications do not apply to this indicator and should be excluded, as the indicator 
relates only to planned caesarean sections prior to 39 completed weeks gestation (rather than 
elective). 
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Remaining issues 
The main issues arising from the consultation fall into two areas: 
1. Labour/no labour—should this indicator be restricted (in the indicator wording) to cases 
where there is no labour? Several comments consistently made the point that the reasons 
for having a caesarean section before 39 weeks when a woman has already gone into 
labour are different to those where the caesarean section is an elective procedure before 
39 weeks. The purpose of the indicator is to monitor, and reduce, the rate of unnecessary 
procedures that have been shown to potentially affect a baby’s respiratory health. 
2. The definition of ‘no obstetric/medical indication’—while there is good support for use 
of a standardised list of the most common indications for caesarean section, such as the 
one developed for the NMDDP, there is debate whether selection by a clinician of code 
20 Maternal choice in the absence of any obstetric, medical, surgical, psychological indications 
would sufficiently capture the number of caesarean sections for which there is 
inadequate justification where the birth was pre-term.  
Stakeholders suggested that other indications on the NMDDP list would need to be 
analysed in conjunction with code 20. Although there was not complete consensus, in 
general they noted that:  
– Where there is no labour, the following codes would not justify a pre-term or  
early-term caesarean section delivery: 
02 Suspected fetal macrosomia 
03 Malpresentation 
11 Multiple pregnancy  
15 Previous caesarean section  
16 Previous shoulder dystocia 
17 Previous perineal trauma/4th degree tear 
18 Previous adverse fetal/neonatal outcome.  
– The following codes would be irrelevant if the indicator was restricted to cases 
where there is no labour:  
04 Lack of progress; less than or equal to 3 cm cervical dilatation ≤ 3 cm 
05 Lack of progress in the first stage 4 cm to less than 10 cm cervical dilatation  
06 Lack of progress in the second stage 
12 Unsuccessful attempt at assisted delivery 
13 Unsuccessful induction 
14 Cord prolapse. 
– This would leave only the following codes in the list as adequate justification for  
pre-term or early-term caesarean section where there is no labour: 
01 Fetal compromise 
07 Placenta praevia 
08 Placental abruption 
09 Vasa praevia 
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10 Antepartum/intrapartum haemorrhage 
19 Other obstetric, medical, surgical, psychological indications. 
Related to the list of justifiable indications, and still unresolved, is the issue of whether 
certain maternal morbidities, such as hypertension and diabetes, are valid indications for a 
pre-term or early-term caesarean section, and should be added to the NMDDP list. There has 
been strong opinion that these should not be included in the NMDDP list as they are 
underlying conditions and not the reason for the actual caesarean section procedure. 
However there also seems to be opinion to the contrary. 
In making a decision about this, alternative ways of capturing information on maternal 
morbidities should be considered such as the: 
• analysis of other data in the NPDC on maternal morbidities  
• selection of code 19 as an additional indication that maternal morbidities were believed 
to be associated with the need for the caesarean section—however, another relevant code 
from the list would still need to be selected as the main indication. 
Can existing data help inform decisions around this indicator? 
Data from the NPDC were analysed to inform the development of this indicator. Data 
quality varies by jurisdiction, and results should be interpreted with caution due to varying 
data completeness and data collection practices as follows: 
• Data on main reason for caesarean were not available for Western Australia and the 
Australian Capital Territory for 2007–2010, and not available for Victoria for 2009 and 
2010. 
• In the NPDC, data on reasons for caesarean section are limited to the main reason for 
caesarean section. 
• The range of categories for main reason for caesarean varies substantially among 
jurisdictions. 
Figure 2.9 shows that, where there was no labour, Previous caesarean section was reported as 
the main reason for caesarean section in nearly 35% of these births. This should be 
considered with the information above about whether previous caesarean section is a 
justifiable reason for pre-term caesarean section. Psychosocial/elective/patient choice, Other and 
to some extent Malpresentation were the other main reasons for cases of no-labour caesarean 
section. 
Table 2.12 shows the main reason for the caesarean section for women who had pre-term 
caesarean section deliveries where a maternal morbidity had also been reported in the 
perinatal data: 
• For women who had pre-existing hypertension, the main reason for caesarean section 
was reported to be hypertension/pre-eclampsia in 20% of cases. Where the underlying 
medical condition was pregnancy-induced hypertension, this rose to nearly 50% of cases.  
• Diabetes was not in the list of main reasons for caesarean section reported to the NPDC. 
For women who had pre-existing diabetes or gestational diabetes mellitus, Other was 
reported to be the main reason for caesarean section in 26% and 20% of cases 
respectively.  
• There were high rates of reporting of Previous caesarean section as the main reason for 
caesarean section for all these women—of the selected maternal morbidities also 
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reported with this main reason, the lowest was 22% with pregnancy-induced 
hypertension, and highest was 52% with gestational diabetes. 
Given the caveats on the data, it is difficult to say how well they can inform the discussion 
and decisions for this indicator. There is a strong case for standardisation of these data. 
 
Note: Data quality varies by jurisdiction and results should be interpreted with caution due to varying data completeness and data collection 
practices. 
Source: AIHW National Perinatal Data Collection. 
Figure 2.9: Women with a singleton birth by caesarean section at less than 39 completed weeks (273 
days) gestation, by onset of labour and main reason for caesarean, 2007–2010 
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Table 2.12: Women with selected maternal medical and obstetric conditions who gave birth to a singleton by caesarean section (where there was no 
labour) at less than 39 completed weeks (273 days) gestation, by main reason for caesarean section, 2007–2010 (per cent) 
 Main reason for caesarean section 
Selected condition 
Previous 
CS 
Failure to 
progress/ 
CPD 
Fetal 
distress Malpresentation 
Psychosocial/elective/ 
patient choice 
Antepartum 
haemorrhage 
Hypertension/ 
pre-
eclampsia IUGR Other 
Not 
stated  
Total 
(incl. not 
stated) 
Pre-existing 
hypertension 44.3 0.5 5.8 7.4 4.1 3.3 20.3 3.5 10.6 0.3 100.0 
Pregnancy-induced 
hypertension 21.8 0.7 5.4 7.2 2.5 1.7 48.6 2.4 9.5 0.2 100.0 
Pre-existing diabetes 42.6 1.0 8.3 6.4 2.8 1.4 9.6 1.7 26.2 0.1 100.0 
Gestational diabetes 51.5 0.7 2.7 10.3 4.5 3.7 5.2 1.3 20.0 0.2 100.0 
Epilepsy (before 
pregnancy) 52.8 0.3 5.3 9.9 4.3 3.1 5.0 2.8 16.1 0.3 100.0 
Antepartum haemorrhage           
 Placenta praevia 8.6 0.1 1.2 4.2 2.2 76.7 0.6 0.4 6.1 0.0 100.0 
 Abruptio placenta 7.1 0.3 10.4 2.1 2.1 70.1 2.1 0.5 5.3 0.0 100.0 
 Antepartum 
Haemorrhage 
(unspecified) 33.0 0.6 6.8 11.0 3.7 25.3 3.8 2.7 13.0 0.0 100.0 
 Placenta praevia & 
abruptio placenta 5.0 0.0 10.0 5.0 0.0 70.0 5.0 0.0 5.0 0.0 100.0 
Any of above 
conditions 37.0 0.7 4.9 8.5 3.5 7.6 21.0 2.0 14.6 0.2 100.0 
None of the above 
conditions 61.6 1.6 2.0 12.6 6.4 0.5 0.1 1.7 13.4 0.1 100.0 
Notes 
1. Data quality varies by jurisdiction, and results should be interpreted with caution due to varying data completeness and data collection practices. 
2. Only includes data for Vic, Qld, SA, Tas, and NT. Data on main reason for caesarean birth was not available for Victoria for 2009 and 2010. 
Source: AIHW NPDC. 
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Recommendations for next steps 
• The indicator should be used only in ‘no labour’ cases. 
• As justification for pre-term and early-term caesarean section and no labour, use the 
Indications for caesarean section item developed as part of the NMDDP, and the following 
codes: 
 01 Fetal compromise 
 07 Placenta praevia 
 08 Placental abruption 
 09 Vasa praevia 
 10 Antepartum/intrapartum haemorrhage 
 19 Other obstetric, medical, surgical, psychological indications. 
• Certain maternal morbidities, such as hypertension and diabetes, do not need to be 
captured in the Indications for caesarean section data item, on the basis that they are 
underlying conditions and not the reason for the actual caesarean section procedure. 
• This indicator be added to the set of NCMIs for reporting and be accompanied by clinical 
commentary.  
2.2 Indicators requiring scoping and development  
The indicators in this section required extensive scoping and consultation on the most 
appropriate developmental pathway. Evidence to support each indicator was obtained 
through literature review, and scoping of existing definitions and clinical criteria/guidelines, 
both national and international, was undertaken. The purpose of each indicator was initially 
based on the evidence obtained and discussions of the ECG, then further refined through 
wider consultation. Advice was sought from the ECG and via the consultation on definitional 
and measurement issues, including potential data sources. Findings for each indicator are 
outlined below. 
2.2.1 Indicator 11: High risk women undergoing caesarean section 
who receive appropriate pharmacological thromboprophylaxis  
This indicator was considered by ECG members, as well as by key experts and stakeholders 
engaged through a consultation process.  
The main issues were:  
• purpose, including whether the existing rationale for the ACHS indicator was appropriate 
or adaptable, and difficulties associated with identifying improved outcomes  
• rationale and evidence to support the indicator, including whether, despite the lack of 
evidence, the indicator is still considered to be critical  
• definitional and measurement issues, including how to define high risk and appropriate 
pharmacological thromboprophylaxis. 
Purpose of the indicator 
There is an existing Australian Council on Healthcare Standards (ACHS) indicator that 
includes the following statements, and which were proposed for use in this NCMI (Indicator 
11): 
• Thromboembolism is a major cause of maternal morbidity. Pregnancy is a risk factor for 
venous thromboembolism and the risk is higher if birth is by caesarean section, especially 
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emergency (non-elective) caesarean section. A fall in deaths from venous 
thromboembolism after caesarean section was observed in the UK after introduction of 
the Royal College of Obstetricians and Gynaecologists guidelines for thromboprophylaxis 
in 1995. 
• These guidelines are consensus guidelines as there is a paucity of adequately conducted 
trials on which to base recommendations. 
• The rate for this indicator will not be 100% as there will be some women where the 
clinician does not deem it appropriate for the patient to receive pharmacological 
thromboprophylaxis (ACHS 2013a). 
The latest available ACHS report includes information on desirable level and type of indicator 
(Table 2.13) which are important components to consider in developing Indicator 11. The rate 
of health-care organisations providing appropriate pharmacological thromboprophylaxis to 
high-risk women undergoing caesarean section increased from 62% in 2008 to 82% in 2012. 
Table 2.13: Findings for ACHS indicator on pharmacological thromboprophylaxis and caesarean 
section, 2008–2012 
Numerator Number of high-risk women undergoing caesarean section who receive appropriate pharmacological 
thromboprophylaxis 
Denominator 
Number of high-risk women undergoing caesarean section 
Desirable level:  Low  High  Not specified 
Type of indicator:  Process  Outcome  Structure 
Year No. 
HCOs
(a)
 
Total 
numerator 
Total 
denominator 
Rate
(b)
 Rate
(b)
 
(20th 
centile) 
Rate
(b)
 
(80th 
centile) 
Centile 
gains
(c)
 
Stratum 
gains
(d)
 
Outlier 
gains
(e)
 
2008 40 1,049 1,698 61.8 19.1 85.6 405 309 217 
2009 56 1,456 2,814 51.7 26.4 88.7 1,039 849 378 
2010 57 2,230 3,545 62.9 36.8 88.7 914 574 408 
2011 70 3,145 4,295 73.2 50.1 93.0 848 – 293 
2012 69 3,358 4,083 82.2 66.9 95.7 549 374 240 
(a) HCOs = health-care organisations. 
(b) per 100 caesareans. 
(c) Centile gains show the number of units that would benefit if the overall level of performance achieved by all organisations combined was the 
same as that of the better performing 20% of organisations (as defined by the 80th centile rate). 
(d) Stratum gains show the number of units that would benefit if the performance of organisations outside the better performing stratum was lifted 
to that level. Strata can only be considered for these comparisons when there are sufficient data (at least five organisations contributing to 
each stratum). Stratum differences may represent the contrast between either metropolitan or non-metropolitan organisations, between any 
single jurisdiction and the others, or between organisations belonging to the public and private sectors. Only the largest stratum gain is 
recorded in this table. 
(e) Outlier gains show the number of units that would benefit if those organisations with results that are more than three standard deviations 
poorer than average could achieve the average level of performance. 
Source: ACHS 2013b. 
Venous thromboembolism (VTE) is a rare cause of death in pregnancy, causing 14 (15%) direct 
maternal deaths in Australia over the period 1997–2005 (Sullivan et al. 2008). It may be 
difficult to detect improved outcomes for this indicator, as apparently significant changes in 
the number of maternal deaths due to VTE may be due to random variation. It should also be 
noted that increased morbidity has been recorded, due to increased risk of bleeding and 
wound complications, when using pharmacologic thromboprophylaxis (Tooher et al. 2010). 
Neither maternal deaths nor morbidity are captured within the set of NCMIs. 
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Evidence and rationale for the indicator 
A recent Cochrane review concluded that there is insufficient evidence available from 
randomised controlled trials (RCTs) on which to base recommendations for 
thromboprophylaxis during pregnancy and the early postnatal period, and that in the absence 
of clear RCT evidence, practitioners must rely on consensus-derived clinical practice 
guidelines (Tooher et al. 2010). Despite limited evidence to support the use of 
thromboprophylaxis following caesarean section, clinical guidelines recommend its use in 
women with additional risk factors (Bates et al. 2008). Further information on clinical 
guidelines is given in ‘Definitional and measurement issues’ below. 
Factors that increase the risk of venous thromboembolism after a caesarean section include 
older maternal age, prior venous thromboembolism, obesity, thrombophilia, immobilisation, 
lower limb paralysis, pre-eclampsia, medical comorbidities and surgery during pregnancy or 
the puerperium (RCOG 2009; Bates et al. 2008; Tooher et al. 2010). 
Definitional and measurement issues 
The following components of this Indicator need to be defined: 
• high VTE risk women 
• appropriate pharmacological thromboprophylaxis. 
High VTE risk women 
There are a number of risk factors for VTE in pregnancy as outlined earlier. For the purpose of 
this Indicator, what constitutes high risk must be established, which will include 
consideration of whether there is a minimum number of risk factors that must be present from 
a selection of risk factors, or whether a predetermined list of risk factors must always be 
present.  
Table 2.14 outlines the risk factors common across the sets of clinical guidelines examined, 
and can be used as the basis for determining what is critical for this Indicator. Shaded cells 
indicate consistency across all guidelines. 
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Table 2.14: Mapping of risk factors for VTE during pregnancy relevant to caesarean section across guidelines 
 ACHS UK RCOG Qld SA
(a)
 WA
(b)
 Vic
(c)
 NSW
(d)
 
High risk factors 
Extended major pelvic or abdominal surgery (caesarean 
hysterectomy)
(e)
 
 ? 
Surgical 
procedure in 
pregnancy or 
puerperium 
   
Recent surgical 
procedures, but 
especially abdominal 
and pelvic surgery 
  
Family or personal history of deep vein thrombosis 
(DVT); pulmonary embolism (PE) or thrombophilia 
(including antiphospholipid syndrome); paralysis of lower 
limbs
(e)
 
     
Separate risk factors 
of ‘previous VTE’, 
‘lower limb paralysis’ 
and ‘inherited or 
acquired 
thrombophilias’ 
 ? 
Family history of 
thromboembolism 
in a first degree 
relative is a 
moderate risk 
factor; includes 
varicose veins with 
phlebitis; does not 
include lower limb 
paralysis 
Moderate risk factors 
Age > 35
(e)
        
Age ≥35 
Initial weight > 80kg
(e)
   
BMI>30 
 
or BMI>30 
 
BMI>30  
(major risk factor)  
 
BMI>30 
 
BMI>30 
 
BMI ≥30 
Parity of 4 or more   
Parity ≥3 
  X  X 
Gross varicose veins
(e)
        
(continued) 
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Table 2.14 (continued): Mapping of risk factors for VTE during pregnancy relevant to caesarean section across guidelines 
 ACHS UK RCOG Qld SA
(a)
 WA
(b)
 Vic
(c)
 NSW
(d)
 
Current infection   
Systemic 
infection 
 See ‘Major current 
illness’ 
See ‘Major current 
illness’ 
 See ‘Major current 
illness’ 
Pre-eclampsia
(e)
     
Major risk factor 
   
Immobility prior to surgery (>4 days)
(e)
   
≥3 days 
  
Includes 
paraplegia (major 
risk factor) 
 
Prolonged or severe, 
but no time frames 
given. Includes 
prolonged travel 
  
No time frame 
given 
Major current illness (heart or lung disease, cancer, 
inflammatory bowel, nephritic syndrome, recent surgery 
in pregnancy)
(e)
 
  
Also SLE, 
inflammatory 
conditions, 
sickle cell 
disease, 
intravenous 
drug user 
 
Also sickle cell 
disease 
 
Medical co-
morbidity 
(inflammatory, 
infective or 
malignant) (major 
risk factor) 
 
Acute medical 
illness (for example 
severe infection, 
maternal heart or 
respiratory disease). 
‘Active or occult 
malignancy’ is a 
separate risk factor 
 
‘Nephrotic 
syndrome, 
sickle cell 
disease’ is a 
separate risk 
factor 
? 
‘Admission to acute 
care’ is a moderate 
risk factor 
(continued) 
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Table 2.14 (continued): Mapping of risk factors for VTE during pregnancy relevant to caesarean section across guidelines 
 ACHS UK RCOG Qld SA
(a)
 WA
(b)
 Vic
(c)
 NSW
(d)
 
Other risk factors 
Smoking        
Multiple pregnancy         
Assisted reproductive therapy        
Prolonged labour (>24 hours)    
≥12 hours 
    
Hyperemesis, dehydration        
Hyperemesis 
gravidarum  
Long-distance travel (>4 hours)      
Prolonged travel part 
of immobility 
  
(a) Thromboprophylaxis considered for: emergency caesarean section; 2 or more major risk factors; 1 major and 2 or more minor risk factors. 
(b) King Edward Memorial Hospital guidelines (KEMH 2010). These do not state the number of risk factors that place a woman at increased risk of VTE and therefore treatment with thromboprophylaxis. 
(c) Royal Women’s Hospital guidelines (2013a). 
(d) Royal Hospital for Women guidelines (2011). High risk is defined as 2 or more moderate risk factors or 1 high risk factor. 
(e) Consensus across all guidelines. 
Notes 
1. Women at high risk of VTE are those with 3 or more moderate risk factors or 1 high risk factor unless otherwise stated. 
2. BMI = Body Mass Index (weight in kg/(height in m)2).
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Appropriate pharmacological thromboprophylaxis 
The following guidelines exist in relation to the use of pharmacological thromboprophylaxis 
to prevent VTE in pregnancy: 
• The National Health and Medical Research Council’s Clinical practice guideline for the 
prevention of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in 
patients admitted to Australian hospitals (2009) notes the lack of formal evidence to guide 
recommendations regarding prevention of VTE in pregnancy and the early postnatal 
period for women admitted to hospital. The document includes steps for undertaking a 
VTE risk assessment that incorporates an assessment of individual patient risk factors, 
risks related to an acute medical illness, risks related to an injury or surgical procedure, 
and the bleeding risk (NHMRC 2009). Section 5.5 on pregnancy and childbirth within 
this document makes the following recommendations for pharmacological 
thromboprophylaxis based on consensus, and graded as Good Practice Points: 
– where pharmacological thromboprophylaxis is appropriate and not contraindicated, 
use low molecular weight heparin after caesarean delivery for five to seven days or 
until the patient is fully mobile 
– extend pharmacological thromboprophylaxis with low molecular weight heparin or 
adjusted therapeutic dose warfarin for six weeks for high-risk women, after 
caesarean or vaginal delivery. 
• RANZCOG has not published any guidelines on thromboprophylaxis in the 
puerperium; however, the College has endorsed the position statement ‘Anticoagulation 
in pregnancy and the puerperium’ published by Hague and others (2001). This position 
statement recommends the use of low molecular weight heparin or unfractionated 
heparin for at least 5 days postpartum in women at high risk of VTE. 
• The Society of Obstetric Medicine of Australia and New Zealand (SOMANZ) has 
endorsed the recommendations of a group of experts that women at high risk of VTE 
receive low molecular weight heparin or unfractionated heparin for at least 5 days 
postpartum (McLintock et al. 2012). 
• Guidelines used in Queensland, South Australia, Western Australia, Victoria and New 
South Wales recommend the use of low molecular weight heparin for 
thromboprophylaxis after caesarean section in high-risk women, unless contraindicated. 
• The ACHS indicator on pharmacological thromboprophylaxis and caesarean section 
refers to ‘prophylaxis that is concordant with the recommendations in locally agreed 
guidelines which have been endorsed by the Drugs and Therapeutics Committee or 
other appropriate committee’ (ACHS 2013a). 
Table 2.15 provides an overall picture of what various guidelines state in relation to the use 
of pharmacologic thromboprophylaxis to prevent VTE in pregnancy. Shaded cells indicate 
consistency across all guidelines. All guidelines recommend low molecular weight heparin 
(LMWH), with some also including unfractionated heparin (UH). However, there are 
variations among the guidelines in relation to timing of the first dose, removal of epidural 
when LMWH is used, and minimum treatment length.
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Table 2.15: Mapping of guidelines in relation to the use of pharmacologic thromboprophylaxis to prevent VTE in pregnancy 
 
NHMRC (2009) UK RCOG (2009) 
RANZCOG-
endorsed
(a)
 
(2001) 
SOMANZ- 
endorsed
(b)
 
(2012) State guidelines 
Recommended pharmacologic agent
(c)
 LMWH LMWH LMWH or UH LMWH or UH LMWH or UH 
Timing of first dose—no epidural or removed shortly 
after delivery 
ASAP >4 hrs after 
delivery/epidural 
removal 
By 4 hrs after 
delivery/epidural 
removal 
  Within 6 hrs of delivery (Qld) 
6–8 hrs after delivery (SA) 
At least 4 hrs after delivery (WA) 
No sooner than 4 hrs, no later than 24 
hrs after delivery (Vic) 
Timing of first dose—epidural left in place for 
postpartum analgesia 
No sooner than 2 hrs 
after epidural removal 
and no sooner than 
10 hrs after a 
previously 
administered dose 
   At least 4 hrs after epidural removal 
(SA) 
Removal of epidural when LMWH is used  No sooner than 12 
hrs after a 
previously 
administered dose 
and at least 4 hrs 
before the next 
dose 
No sooner than 
12hrs after a 
previously 
administered dose 
and at least 4 hrs 
before the next 
dose 
No sooner than 12hrs 
after a previously 
administered dose 
and at least 2 hrs 
before the next dose 
No sooner than 12 hrs after a 
previously administered dose and at 
least 2 hrs before the next dose (Qld, 
SA, NSW, NSW) 
No sooner than 12 hrs after a 
previously administered dose and at 
least 2 hrs, but preferably 4 hrs, before 
the next dose (WA) 
Minimum treatment length 5–7 days 7 days 5 days 5 days 4 days (Vic) 
5 days (Qld, SA) 
5–7 days (WA) 
(continued) 
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Table 2.15 (continued): Mapping of guidelines in relation to the use of pharmacologic thromboprophylaxis to prevent VTE in pregnancy 
 
NHMRC (2009) UK RCOG (2009) 
RANZCOG-
endorsed
(a)
  
(2001) 
SOMANZ-
endorsed
(b)
 
(2012) State guidelines 
Dosage (prophylactic dose for women 50–90 kg)      
 Enoxaparin
(c)
  40 mg daily 40 mg daily 40 mg daily 40 mg daily (Qld, SA, WA) 
 Dalteparin
(c)
  5,000 IU daily 5,000 IU daily 5,000 IU daily 5,000 IU daily (SA, Vic) 
 Tinzaparin  4,500 IU daily  4,500 IU daily  
 UH    5,000 IU twice daily 5,000 IU twice daily (Qld, NSW) 
(a) Hague et al. 2001. Anticoagulation in pregnancy and the puerperium. 
(b) McLintock et al. 2012. Recommendations for the prevention of pregnancy-associated venous thromboembolism. 
(c) Consensus across all guidelines. 
Note: Shaded cells show consensus across all guidelines. 
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Consultation outcomes 
The ECG concluded that: 
• there is a lack of consensus on the definition of high risk women and that it may not be 
feasible to reach consensus 
• there is considerable variation in practice for thromboprophylaxis after caesarean section 
• it is unclear what the appropriate rate for this indicator would be; however, it would be 
less than 100%, as clinicians will consider thromboprophylaxis inappropriate for some 
women 
• the rate may only be around 50–60% and not vary over time, therefore the value of 
collecting this indicator was questioned 
• based on these issues, the ECG recommended that further development of this indicator 
not be pursued at this time. 
The majority of experts and stakeholders surveyed through the further consultation process 
(83%, 19 respondents) agreed with the recommendation that further development of this 
Indicator not be pursued at this stage. Four respondents (17%) did not agree, and provided 
responses to subsequent open-ended questions around definitional and measurement issues 
(see to Appendix B for details). 
Recommendations for next steps 
• It is recommended that further development of this indicator not be progressed. 
2.2.2 Indicator 16: Separation of baby from the mother after birth 
for additional care 
This indicator was considered by ECG members, as well as by key experts and stakeholders 
engaged through a consultation process. The main issues were:  
• purpose, including what is the most appropriate focus for the indicator 
• rationale and evidence to support the indicator, including the importance of mother and 
baby attachment, contributed to by rooming-in and breastfeeding 
• definitional and measurement issues, including how to define ‘separation’, ‘after birth’ 
and ‘additional care’. 
Purpose of the indicator 
The purpose of this indicator is to measure the separation of mother and healthy baby in the 
first 24 hours after birth, with the aim of minimising separation and enhancing mother–baby 
attachment. 
Evidence and rationale for the indicator 
The evidence supports that reducing the separation of mothers and babies enhances 
attachment and promotes breastfeeding. 
Closeness is the first step in facilitating attachment between the mother and baby, and also 
promotes maternal confidence. This proximity needs to start at birth. Frequent time together 
between mothers and babies enables mothers to learn and recognise their baby’s needs, 
establishing a connection that lasts a lifetime (Crenshaw 2007). When mother and baby are 
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separated, this process is interrupted for them both (Dumas et al. 2013), and regardless of 
whether the separation time is limited or delayed, it may have a harmful effect on their 
relationship (Enkin et al. 2000). 
Research to study the influence of birth routine on mother–infant interactions showed that 
mothers who were separated from their babies for the first two hours after birth, and then 
experienced rooming-in, showed a similar behaviour pattern to mothers who were separated 
and whose babies remained in a nursery. These mothers were rougher with their babies 
during a breastfeeding session than mothers who experienced skin-to-skin contact after birth 
followed by rooming-in (Dumas et al. 2013). The study concluded that immediate and 
uninterrupted skin-to-skin contact at birth, and rooming-in during postpartum, be 
encouraged, as recommended in the World Health Organization/UNICEF document Ten 
steps for successful breastfeeding. 
Although standard hospital practices have changed from those described by Barnett et al. 
(1970) and no longer involve routine separation of mother and baby, babies with additional 
care needs (such as admission to a neonatal intensive care unit) may be separated from their 
mothers. When efforts are made to include parents in the care of their babies, parents feel 
closer to their baby and have a more positive experience (Flacking et al. 2012; Erlandsson & 
Fagerberg 2005). 
Separation of the baby from the mother after a caesarean birth is more common than after a 
vaginal birth, with mothers often recovering in a separate room from their baby. A pilot 
study to minimise maternal–infant separation after caesarean section found that infants 
remaining in the operating room had no detrimental effect on infant thermoregulation and in 
some cases, thermoregulation was improved compared with controls (Nolan & Lawrence 
2009). However, providing skin-to-skin contact can be more challenging after delivery by 
caesarean section, where maternal nausea and vomiting may limit the time spent in  
skin-to-skin contact (Nolan & Lawrence 2009). 
The negative effects of separation appear to be long-lasting, with decreased maternal 
sensitivity, infant self-regulation, and dyadic mutuality and reciprocity observed 1 year after 
birth in infants who were separated from their mothers immediately after birth. 
Interestingly, rooming-in of infants did not compensate for a 2-hour separation immediately 
after birth (Bystrova et al. 2009). 
Rooming-in 
Rooming-in, that is keeping mother and baby together continuously during the day and 
night, has a number of benefits. For the mother it enables them to quickly learn their baby’s 
needs and how best to care for and comfort their newborn, and makes breastfeeding easier. 
While babies are with their mothers they cry less, sooth more quickly, feed better, gain more 
weight per day and are less likely to develop jaundice. Research also suggests that rates of 
child abuse, neglect, and abandonment are lower for mothers who have frequent and 
extended contact with their newborns during the early postpartum period (Crenshaw 2007). 
Studies have also shown that mothers who are with their babies for longer periods of time, 
including during the night, have higher scores on tests that measure the strength of a 
mother’s attachment to her baby (Klaus et al. 1972; Norr et al. 1989; Prodromidis et al. 1995). 
Breastfeeding 
Separation can also negatively impact on breastfeeding. Babies who stayed in a nursery at 
the maternity ward and were taken to their mother’s room for breastfeeding ingested less 
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milk than babies who were rooming-in and had access to breastfeeding on demand 
(Bystrova et al. 2007). An earlier study showed that separation of the baby from the mother 
in the first week after birth has a negative impact on breastfeeding duration, with 37% of 
separated mothers breastfeeding at 3 months compared with 72% of non-separated mothers 
(Elander & Lindberg 1984). 
Definitional and measurement issues 
Existing measures 
Two existing measures used internationally include the WHO/UNICEF Baby-Friendly 
Hospital Initiative (BFHI) and the Canadian Maternity Experiences Survey (Public Health 
Agency of Canada 2009).  
The WHO/UNICEF Ten steps to successful breastfeeding referred to earlier are the foundation 
of the BFHI and summarise the maternity practices necessary to support breastfeeding. One 
of the steps is relevant to Indicator 16: rooming-in to allow mothers and babies to remain 
together 24 hours a day. Suggestions for monitoring this recommendation include an infant 
feeding record, which records the baby’s location (‘rooming-in’ is one of the options), and a 
questionnaire for mothers at discharge which asks where the baby was while the mother was 
in maternity services after giving birth (‘my baby was with me both day and night’ is one of 
the options) (WHO / UNICEF 2009). 
The Canadian Maternity Experiences Survey included questions relevant to the  
Baby-Friendly Hospital Initiative. The survey asked mothers where their baby was during 
most of the first hour after birth (response options were ‘in bed with you’, ‘in the same room 
as you, but not in your bed’, and ‘not in the same room as you’) and how long their baby was 
in another room during the first 24 hours after birth (responses options of ‘less than 1 hour’, 
‘1 hour to less than 6 hours’, and ‘6 hours or more’) (Public Health Agency of Canada 2009). 
Defining ‘additional care’ 
The ECG agreed that the purpose of Indicator 16 is to measure the separation of a healthy 
baby from the mother after birth, with the aim of minimising separation and enhancing 
mother–baby attachment, particularly in circumstances where additional care can be 
provided in the mother’s room (for example, intravenous antibiotics or blood glucose 
monitoring).  
A data item to capture whether a neonate is transferred to a special care nursery or neonatal 
intensive care unit (Neonate transfer to high care) is currently under development for 
inclusion in the Perinatal NMDS. This item is based on the Australian and New Zealand 
Neonatal Network definitions of high-level neonatal care units: 
• A special care nursery (SCN) is a Level II nursery which generally cares for babies born 
at 32–36 weeks gestation weighing around 1,500 to 2,500 grams at birth. It includes care 
for babies who require intravenous therapy or antibiotics, and/or those who are 
convalescing after intensive care, and/or those who need their heart rate or breathing 
monitored, and/or those who need short-term oxygen therapy. 
• A neonatal intensive care unit (NICU) is a Level III unit which cares for newborn infants 
who require more specialised care and treatment. It includes most babies born at less 
than 32 weeks gestation or less than 1,500 grams birthweight, and others who may 
require such interventions as intravenous feeding, and/or surgery, and/or 
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cardiorespiratory monitoring for management of apnoea or seizures, and/or require 
assisted ventilation, and/or supplemental oxygen over 40% or long-term oxygen. 
The ECG recommended that ‘additional care’ be defined as care not requiring admission to 
an SCN (level II nursery) or NICU (level III nursery); however this may need further 
consideration in view of the definitions above, noting that the examples provided where 
additional care could be provided in the mother’s room included intravenous antibiotics and 
blood glucose monitoring. 
In addition, it may also be important to consider whether it will be difficult to detect 
improved outcomes for this indicator as babies admitted to an SCN or NICU attract funding 
for the hospital (as the days spent in SCN or NICU count as patient days) whereas babies 
treated on the wards do not attract funding for the hospital. 
Related indicator 
Overlap with Indicator 12, ‘Babies born ≥37 completed weeks gestation admitted to a 
neonatal intensive care nursery / unit or special care nursery for reasons other than 
congenital anomaly’, also needs to be considered in relation to the scope of this Indicator. 
Consultation outcomes 
The ECG concluded that: 
• this is an important indicator to collect, and that the purpose is to measure the separation 
of a healthy baby from the mother after birth, with the aim of minimising separation and 
enhancing mother–baby attachment, particularly in circumstances where additional care 
can be provided in the mother’s room (for example, intravenous antibiotics or blood 
glucose monitoring) 
•  ‘additional care’ be defined as care not requiring admission to a special care nursery 
(level II nursery) or a neonatal intensive care nursery/unit (level III nursery) 
• ‘after birth’ be defined as within the first 24 hours 
• this indicator be further developed with wider consultation to provide advice 
• skin-to-skin contact is also important and should be developed as a separate indicator. 
Following is a summary of the results of the wider consultation process. 
Purpose 
The majority of experts and stakeholders consulted (91%, 20 respondents) supported the 
proposed purpose of the indicator: ‘To measure the separation of a healthy baby from the 
mother after birth, with the aim of minimising separation and enhancing mother–baby 
attachment’. 
However, it was noted that reliable collection would be difficult. 
Separation 
Around three-quarters (76%, 16 respondents) agreed that a timeframe should be used for 
defining separation.  
Of those who agreed, 38% (6 respondents) supported ‘1–3 hours’ as an appropriate and 
feasible timeframe. One respondent added that this should be 1–3 hours over the entire  
24-hour period, with the aim to keep each episode of separation at less than an hour. The 
remainder of respondents supported a ‘3–4 hour’ timeframe (25%, 4 respondents), ‘6 hours 
or more’ (25%, 4) or another timeframe (13%, 2). 
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Further consultation with state and territory NPDDC members was undertaken to seek 
additional input in relation to the parameters for the period of separation. Feedback 
indicated no definitive agreement for the period of separation, with most unsure as to 
whether the lower bound of the definition of separation should be 1 hour and the upper limit 
capped at 3 hours. In addition, most were unsure whether non-continuous periods of 
separation with the 24-hour period (or up to discharge) should be aggregated to determine 
whether separation had occurred. The following comments were provided: 
• From birth, the first hour of life is the most crucial for newborns in terms of attachment, 
establishing breastfeeding and for outcomes from the labour process. Separation from 
the mother, for example, to be admitted to a special care nursery or neonatal intensive 
care for additional care is useful as a proxy indicator for the quality of intrapartal care. It 
would also include separation for women having caesarean births who should not be 
separated from their newborns immediately following the procedure in theatre, and in 
the recovery area prior to returning to the ward when it is safe for the mother and baby 
to do so. Too often, newborns are separated from their mothers in first hour following 
caesarean section due to staffing or unit processes, rather than quality of care. 
• Any separation is undesirable, though sometimes necessary. Why not record any 
separation which could be operationalised as more than 5 minutes? Reporting anything 
longer than 5 minutes would simplify the need to aggregate non-continuous periods of 
separation. The burden (and consequent misreporting) will be substantial unless it is 
easy to identify and record. 
• Propose that the period of separation be capped at 4 hours. Newborns are most 
commonly observed intensively for 4 hours following birth. 
• It would be most efficient if separation was defined categorically, that is, ‘yes/no’—in 
which case any separation of the minimum amount of time would be flagged as ‘yes’. 
After birth 
A majority of respondents (62%, 13 respondents) reported that the period ‘after birth’ should 
be defined as the first 24 hours after birth. One-third of respondents (33%, 7) supported ‘up 
to discharge’, and only 1 respondent supported ‘within the first hour’. 
Respondents highlighted difficulties in collecting and comparing data with a time period of 
more than 24 hours, as significant differences in length of hospital stay could skew the 
results. 
Additional care 
A majority of respondents (82%, 18 respondents) agreed with the proposed definition of 
‘additional care’ (see below). The proportions who somewhat agreed and did not agree were 
9% each (2 in each group).  
The proposed definition of ‘additional care’ is: 
Care not requiring admission to a special care nursery (level II nursery) or a neonatal 
intensive care nursery/unit (level III nursery) (based on the Australian and New 
Zealand Neonatal Network definitions below). 
Level II refers to a nursery that generally has babies born at 32–36 weeks gestation 
weighing around 1,500 to 2,500 grams at birth. It includes care for babies who require 
intravenous therapy or antibiotics, and/or those who are convalescing after intensive 
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care, and/or those who need their heart rate or breathing monitored, and/or those who 
need short-term oxygen therapy. 
Level III or intensive care refers to the care of newborn infants who require more 
specialised care and treatment. It includes most babies born at less than 32 weeks 
gestation or less than 1,500 grams birthweight, and others who may require such 
interventions as intravenous feeding, and/or surgery, and/or cardiorespiratory 
monitoring for management of apnoea or seizures, and/or require assisted ventilation, 
and/or supplemental oxygen over 40% or long-term oxygen. 
Scope 
Table 2.16 outlines the types of additional care that were considered by respondents to not 
require admission to a special care or neonatal intensive care nursery for babies born at or 
after 37 completed weeks gestation. 
Table 2.16: Suggested types of additional care not requiring admission to a special care or neonatal 
intensive care nursery for babies born at or after 37 completed weeks gestation 
Type of additional care No. of respondents 
Phototherapy/jaundice 4 
Intravenous antibiotics 4 
Blood glucose measurement 3 
Narcotic/drug withdrawal 2 
Intrauterine growth restriction 1 
Small for gestational age 1 
Nasogastric intubation 1 
Observation (not further defined) 1 
Most respondents (87%, 20 respondents) agreed that this indicator (Indicator 16) should be 
restricted to babies born at or after 37 completed weeks gestation. 
Detection of improved outcomes 
More than half of respondents (13, or 57%) agreed that it would be difficult to detect 
improved outcomes for this Indicator, given that babies receiving medical care when 
admitted to an SCN or NICU attract funding for the hospital whereas those on the wards do 
not. A further 6 respondents (26%) ‘somewhat agreed’ with this statement and 4 respondents 
(17%) disagreed. 
The ECG highlighted that this is the very reason this indicator should be captured, as babies 
should only be separated from their mothers for clinical indications, not financial reasons.  
Collection 
Regarding the best method of collecting data for this indicator, 7 respondents (39%) 
supported the NPDC, 7 respondents supported ‘other’ mechanisms, and 4 respondents (22%) 
supported an audit of labour ward records. 
The following additional comments were provided: 
• Where possible, all data required to support the reporting of this NCMI should be part of 
the NPDC. However, capturing this information would rely on staff recording in the 
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clinical record when a baby is separated from its mother and why, and midwives 
reviewing the record at the point of collating the data for the NPDC. 
• Of those that supported ‘other’, the mechanisms suggested were: patient experience 
survey, collection on local/onsite clinical databases, Australian and New Zealand 
Neonatal Network collection, and a pilot study to inform the best method. 
• Overall, there were difficulties in collecting this information. 
Further consultation with state and territory NPDDC members was undertaken to seek 
additional input in relation to current data collection practices and the best method of 
collection. Feedback indicated that currently 1 jurisdiction collects data on newborns 
requiring additional care during admission for birth episode (excluding babies of less than 37 
completed weeks gestation, non-cephalic presentation, multiple births and those with birth 
defects), via the diagnosis related groups in their admitted episodes dataset.  
NPDDC members considered that a survey conducted on an ad hoc basis would be the best 
method to collect these data, noting that: 
• New data items in the NPDC would be required to support this Indicator. 
• A manual collection via audit of labour ward records may not be appropriate, as it places 
a data collection burden on health service staff. 
• A baseline survey could be carried out and repeated one year later to examine progress. 
However, obtaining satisfactory levels of participation would be challenging and require 
active co-ordination. But equally, if midwives are overburdened with data collection, 
they may ‘guess’ the reason that a baby was admitted to an SCN or NICU if collected as 
part of the routine perinatal data collection. 
• Much depends how much information is to be collected. ‘Yes/no’ responses are collected 
well in the perinatal data collection, but if multiple questions need to be answered, then 
an audit or survey would be better. 
• All options for collection of these data should be assessed and the most appropriate 
method selected. Collection of these data nationally should not occur via the Perinatal 
NMDS. Every proposal to add to or modify items in the Perinatal NMDS places a 
significant burden on state and territory departments, software vendors and health 
services. In this case, a good survey design will yield the same information, or better. 
NPDDC members also raised the following significant issues in implementing collection of 
these data in jurisdictions: 
• Funding would be required to enable co-ordination and resourcing of hospitals to 
undertake collection, or to have the collection undertaken by independent researchers. 
• If more than a ‘yes/no’ categorical question is required in the perinatal data collection, 
collection would be difficult. 
• Sufficient business justification would need to be made—the proposed benefit should be 
equal to or greater than data collection and implementation burden. There are significant 
costs for health services to implement a new data item into their clinical and 
administrative systems and regulatory reporting processes.  
• Difficult item to capture, particularly if the mother and baby have several episodes of 
separation. 
• It would be unacceptably burdensome for midwives to scour the baby’s record at the 
time of discharge to add up all periods of separation to see if they summed to more than 
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60 minutes, but less than 180 minutes. A 5 minute cut-off would be easier because 
identifying a single instance would not require further investigation. 
• There may not be adequate record keeping in the mother’s or baby’s patient notes to 
allow determination of the amount of separation. 
Recommendations for next steps 
• While Indicator 16 is considered to be important by some to bring about changes in 
practice, others are not convinced about its feasibility. Many definitional and collection 
issues could not be resolved conclusively, either by reference to the evidence base or 
through the stakeholder consultation process. These issues include the parameters for 
defining the period of separation, the quality and availability of information, the 
response burden, and resource implications associated with the collection of information 
for this indicator.  
• It is recommended that further development of this indicator not be progressed. 
2.2.3 Proposed new indicator: Skin-to-skin contact between 
mother and baby after birth  
During the discussion of Indicator 16 ‘Separation of baby from the mother after birth for 
additional care’, ECG members suggested that skin-to-skin contact was also important and 
that it be developed as a separate indicator.  
This proposed new indicator has been considered by ECG members, and by key experts and 
stakeholders engaged via a consultation process. The main issues considered were:  
• level of support for the development of the indicator 
• purpose 
• rationale and evidence to support the indicator 
• definitional and measurement issues, including how to define after birth. 
Details of these issues are outlined below. 
Level of support  
The ECG concluded that: 
• development of the indicator is important, for the reasons given below (see ‘Purpose of 
the indicator’ and ‘Evidence and rationale for the indicator’ sections below) 
• it was feasible to collect information on whether skin-to-skin contact occurred within 60 
minutes of birth. 
Key experts and stakeholders also supported the development of the indicator (see 
‘Consultation outcomes’ section for details). 
Purpose of the indicator 
Placing the baby in skin-to-skin contact with the mother immediately after birth promotes 
mother–baby attachment and breastfeeding. This indicator is used to benchmark practice. 
Evidence and rationale for the indicator 
Skin-to-skin contact between mother and baby immediately after birth can help to regulate 
infant temperature and increases the natural progression to breastfeeding. A recent Cochrane 
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review showed that skin-to-skin contact between the mother and baby immediately after 
birth increased the likelihood of the mother’s breastfeeding in the first 1 to 4 months and 
increased the duration of breastfeeding (Moore et al. 2012). In a recent survey of infant 
feeding in Australia, 98% of children who were placed in skin-to-skin contact with their 
mothers around the time of birth had ‘any breastfeeding’ compared with 89% of children not 
placed in skin-to-skin contact (AIHW 2011). 
Research suggests that women who hold their babies skin-to-skin following birth are more 
confident and able to recognise their baby’s needs sooner than mothers who are separated 
from their babies (Widstrom et al. 1990). 
Skin-to-skin contact has other benefits for the baby, such as improved breathing, lower levels 
of stress hormones, higher and more stable blood sugar levels, less crying, protection from 
harmful germs and therefore sickness due to exposure to normal bacteria on the mother’s 
skin (Crenshaw 2007), increased quiet sleep duration and decreased autonomic activity 
compared with sleeping in a bassinette next to the mother’s bed (Morgan et al. 2011). The 
benefits are also greater if the contact continues beyond the first hour, that is, longer and 
more frequent skin-to-skin contact (Crenshaw 2007). 
A study of the influence of birth routine on mother–infant interactions showed that mothers 
who experienced skin-to-skin contact after birth followed by rooming-in were less rough 
with their babies during a breastfeeding session on day 4 than mothers who were separated 
from their babies for 2 hours following birth and then experienced rooming-in (Dumas et al. 
2013). The study concluded that immediate and uninterrupted skin-to-skin contact at birth, 
followed by rooming-in during postpartum be encouraged, as recommended in the World 
Health Organization/UNICEF Ten steps for successful breastfeeding. 
Definitional and measurement issues 
Existing measures 
Searches using the National Quality Measures Clearinghouse, Medline and Google found 
indicators measuring skin-to-skin contact after birth such as the Optimality Index US, which 
defines skin-to-skin contact as:  
Placement of the unwrapped newborn infant in direct contact with maternal 
skin as immediately as possible or appropriate following birth; both infant and 
mother are then covered with a thermal conservation cover/blanket (Murphy 
& Fullerton 2012). 
The Ten steps to successful breastfeeding are the foundation of the WHO/UNICEF  
Baby-Friendly Hospital Initiative (BFHI) and summarise the maternity practices necessary to 
support breastfeeding. The step that is relevant to this indicator is ‘promotion of skin-to-skin 
contact between mother and baby immediately after birth for at least one hour’. Suggestions 
for monitoring this recommendation include: an infant feeding record, which records 
whether mother and baby experienced skin-to-skin contact from within 5 minutes of birth for 
at least an hour (unless delay in contact is justified); and a questionnaire for mothers at 
discharge which asks how soon after birth the mother held her baby, the reason if there was 
a delay of more than 5 minutes, whether there was skin-to-skin contact, and how long she 
held her baby the first time (WHO/UNICEF 2009). 
What mothers say: the Canadian maternity experiences survey (Public Health Agency of Canada 
2009) includes questions relevant to the Baby-Friendly Hospital Initiative. The survey asks 
mothers how soon after birth they first held their baby, the reason for any delay in first 
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holding their baby, whether the contact was skin-to-skin, and where their baby was during 
the first hour after birth. 
Maternity—towards normal birth in NSW (NSW Health 2010) requires all maternity services to 
undertake an annual audit of skin-to-skin contact within 1 hour of birth, with a target of 90% 
by 2015. 
Clinical guidelines and recommendations 
A number of local and international guidelines recommend skin-to-skin contact immediately 
after birth. The Royal Australian and New Zealand College of Obstetricians and 
Gynaecologists recommends that ‘maternity services should adhere to the principles and 
work toward the recommendations of UNICEF/WHO Baby-Friendly status’ and that  
‘skin-to-skin (contact) should last until after the first breastfeed or until the mother chooses 
to end it’ (RANZCOG 2011). Similarly, the UK National Institute for Health and Clinical 
Excellence recommends that ‘women should be encouraged to have skin-to-skin contact with 
their babies as soon as possible after the birth’ and that ‘separation of a woman and her baby 
within the first hour of the birth for routine postnatal procedures, for example weighing, 
measuring and bathing, should be avoided unless these measurements are requested by the 
woman, or are necessary for the immediate care of the baby’ (NICE 2006). 
Australian state guidelines (Queensland, South Australia and Western Australia) 
recommend that babies be placed in skin-to-skin contact immediately after birth and that the 
contact should continue for a minimum of 1 hour (Queensland Maternity and Neonatal 
Clinical Guidelines Program 2012; South Australian Perinatal Practice Guidelines 
Workgroup 2012; Department of Health, Western Australia 2009). Individual hospital 
guidelines make similar recommendations (Royal Women’s Hospital 2013b; KEMH 2012). 
Consultation outcomes 
The majority of respondents in the wider consultation process: 
• supported the development of a new indicator to measure skin-to-skin contact between 
mother and baby after birth (78%, 18 respondents), noting that there is good evidence for 
its benefit, that data is relatively easy to collect, and that it is already collected for BFHI. 
However, 1 respondent was not sure of its value as a clinical indicator. 
• supported the proposed purpose of the indicator (91%, 20 respondents): ‘Placing the 
baby in skin-to-skin contact with the mother immediately after birth promotes mother–
baby attachment and breastfeeding. This indicator is used to benchmark practice.’ 
• agreed that the timeframe for skin-to-skin contact should be within 60 minutes of birth 
(95%, 21 respondents); however, 1 respondent noted that it would be also important to 
determine how much time spent in skin-to-skin contact would qualify as a ‘yes’? That is, 
what is the minimum portion of the first 60 minutes that would qualify as a ‘yes’? 
• agreed that data for this indicator would be best collected from the midwife completing 
the labour ward summary (95%, 19 respondents).  
Following consultation with the MSIJC, it was recommended that the WHO/UNICEF BFHI 
definition for skin-to-skin contact between mothers and babies be used. 
A draft technical specification incorporating the results from the consultation is provided in 
Appendix C. 
Further consultation with state and territory NPDDC members was undertaken to seek 
additional input on current data collection practices and the best method for collection. New 
 62 National core maternity indicators—stage 2 report: 2007–2011 
South Wales currently collects data for this indicator at the baby level, capturing skin-to-skin 
contact within 1 hour of birth in their ObstetriX system—but are yet to report on this data. 
The data item requires recording of any skin-to-skin contact in the first hour of life and does 
not specify continuous contact, or any relationship to feeding. Responses for the data item 
are yes/no/not applicable. In addition, individual hospitals involved with BFHI may require 
documentation that skin-to-skin contact occurred within the first 15 minutes, and this 
indicator could be incorporated into this accreditation process. 
There was no consensus on the best method for collecting the information or the frequency 
of collection. Some considered an audit of labour wards records to be the best method, while 
others felt a survey was most appropriate. Likewise, some considered that data should be 
collected annually, while others thought that it should be on an ad hoc basis. 
NPDDC members also raised some concerns in relation to this indicator, as follows: 
• It is not worthwhile to include this in a routine data collection at a national level. 
• New data items in the NPDC would be required. 
• For those hospitals involved with BFHI, this would be the most appropriate source of 
data—but not all hospitals are BFHI, so they may not be documenting this information. 
• All options for the collection of this data should be assessed and the most appropriate 
selected. Collection of this data nationally should not be via the Perinatal NMDS. Every 
proposal to add or modify items in the Perinatal NMDS places a significant additional 
burden on state and territory departments, software vendors and health services. A good 
survey design will yield the same information, or better. 
• Sufficient business justification would be needed, that is, proposed benefit should be 
equal to or greater than the data collection and implementation burden. There are 
significant costs for health services in incorporating a new data item into their clinical 
and administrative systems and regulatory reporting processes. 
Recommendations for next steps 
• While this indicator is considered to be important by some to bring about change in 
practice, as well as to measure compliance with existing practice, others are not 
convinced about its usefulness as a clinical indicator. One jurisdiction currently collects 
data on skin-to-skin contact. While definitional issues have been largely resolved, there 
appear to be remaining issues associated with the best method for collecting the data, 
response burden and resource implications. 
• It is recommended that further development of this indicator should be pursued using 
the WHO/UNICEF Baby-Friendly Hospital Initiative (BFHI) definition for skin-to-skin 
contact between mothers and babies. 
2.2.4 Indicator 17: One-to-one care in labour 
ECG members have considered this indicator, as well as key experts and stakeholders 
engaged via a consultation process. The main issues were:  
• purpose, including what is the most appropriate focus for the indicator 
• rationale and evidence to support the indicator 
• definitional and measurement issues, including how to define one-to-one care. 
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Purpose of the indicator 
The purpose of this indicator is to measure one-to-one midwifery care in labour, with the 
aim of optimising normal birth and minimising unnecessary interventions. 
Evidence and rationale for the indicator 
A recent Cochrane review by Hodnett and others (2012) of continuous support for women 
during childbirth found that women with continuous, one-to-one support were more likely 
to experience a spontaneous vaginal birth and a shorter labour, less likely to use analgesia in 
labour, and less likely to have a baby with a low Apgar score at 5 minutes. The person 
providing the support was either trained (such as a midwife or doula) or untrained (such as 
a family member, spouse or friend) in providing labour support. This review concluded that 
continuous, one-to-one support in labour should be offered to all women. However, it 
should be noted that the effectiveness of the support provided by hospital staff members 
appeared to be less than that provided by caregivers not employed by an institution. Reasons 
proposed for this included divided loyalties, additional duties besides labour support, and 
the constraints of institutional policies and routine practices (Hodnett et al. 2012). 
Evidence from another Cochrane review by Hatem and others (2008) showed increased rates 
of spontaneous birth and reduced intervention during labour with midwifery-led models of 
care, where the midwife is the lead provider of care during pregnancy, delivery and in the 
postnatal period. Women who received midwife-led models of care were more likely to have 
a spontaneous vaginal delivery, have a known midwife attend the birth and initiate 
breastfeeding, and were less likely to have an episiotomy, instrumental delivery or regional 
analgesia (Hatem et al. 2008). It should be noted that this study included all types of 
midwifery-led care, which included team midwifery as well as caseload models.  
Midwifery-led models of care encompass more than just one-to-one care in labour. Also, 
women in other models of care, such as private obstetrics with public hospital maternity 
care, can still get one-to-one care in labour by a midwife if the public hospital maternity unit 
is staffed accordingly.  
A recent study in Australia found that women receiving caseload midwifery care, where 
women are more likely to have one-to-one care, were more likely to have a spontaneous 
vaginal birth, and less likely to have a caesarean delivery, epidural analgesia, an episiotomy 
or to have their baby admitted to a special care nursery or neonatal intensive care unit. 
Women assigned to caseload midwifery care received antenatal, intrapartum and 
postpartum care from a primary midwife with some care by ‘back-up’ midwives (McLachlan 
et al. 2012).  
In Australia, Queensland is the only jurisdiction to recommend one-to-one care by a 
registered midwife for all women in established labour (Queensland Health 2012). New 
South Wales requires one-to-one midwifery care for all women experiencing their first 
labour, undergoing induction of labour using oxytocics, and undertaking a vaginal birth 
after caesarean section, vaginal breech, or vaginal twin birth. This is a key measure for 
improvement in New South Wales, and will be reported on from 2011 (NSW Health 2010). 
When the Healthcare Commission in the UK carried out a survey in 2007, they found that 
26% of women ‘were left alone during labour at a time when it worried them to be alone’ 
(Healthcare Commission 2007). In the UK, a number of government policies for maternity 
services contain a commitment to continuity of midwifery care, which incorporates 
providing individual support to women throughout their labour and birth. For example, the 
Keeping Childbirth Natural and Dynamic program in Scotland supports one-to-one care 
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during the first and second stages of labour; and the National Service Framework for 
Children, Young People and Maternity Services in Wales sets a standard for women to 
receive one-to-one care (one woman receiving the dedicated time of a midwife) once labour 
is established.  
A review of evidence on continuity of carer and which aspect of continuity matters most to 
women was carried out by Green and others (2000). These authors found no evidence to 
support the notion that women cared for in labour by a midwife whom they had already met 
were more satisfied than those who had not previously met their midwife. The authors 
concluded that women wanted consistent care from a caregiver whom they trust, but not 
continuity of a carer for its own sake.  
Sosa et al. (2011), systematically examined the research literature to answer the ‘who, what, 
when, where, and how’ for providing one-to-one support in labour, as well as reviewing the 
meaning of the concept and definitions of one-to-one care. They found that the term  
‘one-to-one support in labour’ is used in a range of research reports and policy documents 
without a clear consensus on its definition. These authors found that despite strong evidence 
for the benefits of one-to-one support in labour, the utility of the evidence base is limited by 
failure to specify what is meant by one-to-one support, leading to a lack of comparability 
among the various studies. 
Relationship to models of care 
An important consideration for this indicator is how it relates to models of care. Models of 
care was proposed for inclusion as an NCMI by the MSIJC Expert Working Group (Indicator 
20), and is a component of the National Maternity Data Development Project (NMDDP).  
As part of the NMDDP, the AIHW National Perinatal Epidemiology and Statistics Unit 
developed the Maternity Care Classification System (MaCCS) to enable the identification and 
description of current and future models of care in Australia. The MaCCS describes models 
of care, not the experiences of individual women. As such, it is possible that some women 
may not receive the level or type of care set out by their chosen model of care due to changes 
in individual circumstances requiring different care plans.  
Including ‘one-to-one care in labour’ within the MaCCS data items was considered as part of 
the MaCCS project, but the project team concluded that there was too much variability 
between the intention of a model and the actual care received by individuals. It is possible 
for women to receive one-on-one care when it is not specified in their model of care, and vice 
versa. 
Definitional and measurement issues 
Existing measures 
The UK report Safer childbirth: minimum standards for the organisation and delivery of care in 
labour (RCA, RCM, RCOG & RCPCH 2007) recommends that every woman in established 
labour receives one-to-one care from a midwife—however, no direct measures of this are 
detailed in the report. The report suggests that the appropriate staffing level of midwives to 
women in labour is between 1.0 and 1.4 full-time equivalent midwives, depending on case 
mix. The NHS program for increasing normal birth (reducing the caesarean section rate) has 
an indicator for one-to-one care in labour for all women during their first pregnancy. The 
Maternity Dashboard, a clinical performance and governance scorecard, developed to allow 
monitoring ‘on the ground’ on a monthly basis, records the overall ratio of midwives to 
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births, and suggests a level of 1.3 full-time equivalents, but does not directly measure  
one-to-one care in labour (RCOG 2008).  
In Australia, NSW Health uses its Birthrate Plus tool to determine midwifery staffing levels 
for women to receive one-to-one care in labour. London’s Maternity Services Commissioning 
Improvement Project (no date) suggests some methods for auditing one-to-one midwifery 
care in established labour, such as an audit sheet completed by the labour ward coordinator 
and qualitative surveys of staff and women. 
Consultation outcomes 
ECG conclusions that were included in the wider consultation were: 
• the focus of this indicator was having a midwife, rather than a nurse, present for the 
duration of labour (i.e. continuous care during labour) and that a woman in labour is not 
left alone 
• continuity of carer was not considered to be as important, and it was noted that this is 
very difficult to collect 
• the purpose be defined as a measure of one-to-one care in labour with the aim of 
optimising normal birth (that is, physiological birth) and decreasing unnecessary 
interventions 
• ‘one-to-one care’ be defined as ‘A woman in established labour receives care from an 
assigned midwife for the whole of that labour, or the midwife’s whole shift, whichever is 
the shorter. This midwife will be available to care for the woman 100% of the time. At the 
end of the shift, if necessary, care will be handed over to another assigned midwife, who 
will continue the one-to-one care of that woman.’(based on the definition used in 
London’s Maternity Services Commissioning Improvement Project, no date) 
• all women in labour be included, but that it could be restricted to primiparas 
• this indicator be further developed with wider consultation to provide advice. 
The majority of respondents in the wider consultation process agreed that the focus of this 
indicator is about continuous care during labour, that is, having a midwife, rather than a 
nurse, present for the duration of labour and that a woman in labour is not left alone  
(95%, 21 respondents).  
Just over half of respondents (52%, 12) agreed, and almost one-third somewhat agreed  
(30%, 7) that continuity of carer is not as important as continuity of care. In their comments, 
respondents acknowledged the difficulty of collecting information on continuity of carer, as 
well as the practical issues involved in providing continuous care from the same midwife for 
the duration of labour. They noted that while continuity of carer is ideal and desired by 
women, continuity of care is most important and consistent care can be provided by multiple 
caregivers. 
Most respondents supported (77%, 17) or somewhat supported (14%, 3) this proposed 
purpose of the indicator: ‘To measure one-to-one midwifery care in labour, with the aim of 
optimising normal birth (that is, physiological birth) and minimising unnecessary 
interventions’. 
Nearly two-thirds of respondents (64%, 14) preferred the definition of one-to-one care based 
on London’s Maternity Services Commissioning Improvement Project guidance notes (no 
date): 
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A woman in established labour receives care from an assigned midwife for the whole of 
that labour, or the midwife’s whole shift, whichever is the shorter. This midwife will be 
available to care for the woman 100% of the time. At the end of the shift, if necessary, 
care will be handed over to another assigned midwife, who will continue the one-to-one 
care of that woman. 
Most respondents thought that the indicator should not be restricted to low risk women 
(87%, 20), noting that all women in established labour would benefit from receiving  
one-to-one midwifery care. 
In terms of data collection, the majority of respondents agreed that the best mechanism was 
from the midwife completing the labour ward summary (95%, 20). 
Further consultation with state and territory NPDDC members was undertaken to seek 
additional input in relation to current data collection practices and the best method of 
collection. New South Wales is currently developing an item to capture data to report against 
Step 9 of Maternity—towards normal birth in NSW, which recommends one-to-one care for 
women experiencing their first labour, or undertaking vaginal birth after caesarean, vaginal 
breech or vaginal twin birth (NSW Health 2010). The item will either include these categories 
only, or be filtered for reporting purposes from all births, and be captured in their ObstetriX 
system. 
There was no consensus on the best method for collecting the information or the frequency 
of collection. Some NPDDC members thought a survey to be the best method, while others 
felt the NPDC was most appropriate. Likewise some felt that data should be collected on an 
ad hoc basis, while others said that it was too hard to collect. 
Other concerns raised in relation to this indicator by NPDDC members were: 
• It is difficult to collect genuine data for this indicator, and it is not clear how the data 
would be validated. 
• Not sure this data should be collected, as there are other better indicators measuring 
quality of care in the existing set of national maternity indicators. 
• Not convinced a hospital survey would provide more than aspirational responses here. 
Perhaps a survey of women would be most appropriate. Auditing labour ward records 
would not capture times when the midwife was absent from the room. 
• Collection of this data would place undue strain on already overworked labour wards 
and midwives. 
• All options for the collection of this data should be assessed and the most appropriate 
selected. Collection of this data nationally should not be via the Perinatal NMDS. Each 
proposal to add or modify items in the Perinatal NMDS places a significant additional 
burden on state and territory departments, software vendors and health services. A good 
survey design will yield the same information, or better. 
Recommendations for next steps 
• Although one-to-one care in labour is an important goal for maternity care, there is 
widespread acknowledgement of the difficulty in collecting information to report against 
this indicator. While definitional issues have been largely resolved, there appear to be 
remaining issues associated with the best method for collecting the data, response 
burden and resource implications. 
• It is recommended that further development of this indicator not be progressed. 
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3 Summary of next steps 
Recommendations for next steps for each of the indicators are summarised in Table 3.1. 
Broadly, we recommend that: 
• Indicators 13, 15 and 18 are added to the set of NCMIs for reporting, accompanied by 
clinical commentary.  
• Because Indicator 14 aligns with the data items on postpartum haemorrhage added to 
the 2014–15 Perinatal DSS, Indicator 14 should be added to the set of NCMIs for 
reporting, accompanied by clinical commentary.  
• Data items for reporting against Indicator 12 and the new proposed indicator  
‘Skin-to-skin contact between mother and baby after birth’ be developed further so that 
both Indicators can be included in the NCMIs.  
• Indicators 11, 16 and 17 not be pursued further at this time.  
Table 3.1: Summary of recommendations for Indicators 
Indicator Recommendation 
11 High risk women undergoing caesarean section who 
receive appropriate pharmacological thromboprophylaxis 
Further development of this indicator should not be 
progressed. 
12 Babies born ≥37 completed weeks gestation admitted to a 
neonatal intensive care nursery or special care nursery for 
reasons other than congenital anomaly 
Consideration is given to the development of a Reason for 
admission to SCN / NICU data item, which would include 
congenital anomaly as a data value, in consultation with the 
NPDDC, for inclusion in the Perinatal NMDS. Alternatively, 
a flag to indicate that an admission to the SCN/NICU was 
for a reason other than a congenital anomaly could be 
considered for inclusion in the Perinatal NMDS. 
Cross-checks continue to be performed between NHMD 
and NPDC data to check the consistency between the two 
collections. 
13 Third and fourth degree tears for (a) all first births and (b) 
all births 
This indicator be added to the set of NCMIs for reporting 
and be accompanied by clinical commentary. 
14 Blood loss of (i) ≥1,000 mL and <1,500 mL and (ii) ≥1,500 
mL during first 24 hours after the birth of the baby (that is, 
major primary PPH) for (a) vaginal births and (b) caesarean 
sections 
The NPDC still remains the best option for reporting against 
this indicator, particularly as the NPDC has the capacity to 
identify the severity of PPH, and this information can be 
used in conjunction with other information, such as duration 
of pregnancy, that are not available from the NHMD. 
Data items have been standardised and included in the 
Perinatal DSS to support the national collection and 
reporting of primary PPH as part of the NMDDP. Indicator 
14 has been amended to align with these data items (lower 
limit of blood loss included is now greater than or equal to 
1,000 mL). Work to include the NMDDP data items in the 
NMDS is continuing. 
This indicator be added to the set of NCMIs for reporting 
and be accompanied by clinical commentary.  
15 Women having their second birth vaginally whose first birth 
was by caesarean section 
This indicator be added to the set of NCMIs for reporting 
and be accompanied by clinical commentary.  
When reporting against this indicator it will be important to 
be clear about the purpose and for the analysis to be 
presented together with caesarean section and morbidity 
rates. 
(continued) 
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Table 3.1 (continued): Summary of recommendations for indicators 
 Indicator Recommendation 
16 Separation of baby from the mother after birth for additional 
care 
Further development of this indicator should not be 
progressed. 
17 One-to-one care in labour Further development of this indicator should not be 
progressed. 
18 Caesarean sections <39 weeks (273 days) This indicator be added to the set of NCMIs for reporting 
and be accompanied by clinical commentary.  
The indicator should only refer to ‘no labour’. 
Use the Indications for caesarean section item developed 
as part of the NMDDP, and use the following codes as 
justification for pre-term caesarean section and no labour: 
01 Fetal compromise 
07 Placenta praevia 
08 Placental abruption 
09 Vasa praevia 
10 Antepartum/intrapartum haemorrhage 
19 Other obstetric, medical, surgical, psychological 
indications. 
Certain maternal morbidities, such as hypertension and 
diabetes, do not need to be captured in the Indications for 
caesarean section data item on the basis that they are 
underlying conditions and not the reason for the actual 
caesarean section procedure. 
 Skin-to-skin contact between mother and baby after birth Further development of this indicator should be progressed. 
 
 
 National core maternity indicators—stage 2 report: 2007–2011 69 
Appendix A: List of stakeholders 
consulted 
The consultation process included experts and stakeholders from the following areas:  
• National Core Maternity Indicators Expert Commentary Group 
• Maternity Services Inter-Jurisdictional Committee Expert Working Group 
• National Maternity Data Development Project Advisory Group 
• National Maternity Data Development Project Clinical Data Reference Group 
• National Health Information Standards and Statistics Committee 
• Women’s Healthcare Australasia. 
People consulted included: 
Name Affiliation 
Mr John Agland Manager, Performance Reporting Health System Information and 
Performance Reporting, NSW Health 
Ms Terri Barrett Midwifery Director, Statewide Obstetric Support Unit, King Edward 
Memorial Hospital, Western Australia 
Mr Paul Basso Director, Health Intelligence, Department of Health, South Australia 
Professor Leonie Callaway Queensland Maternal and Perinatal Quality Council; Head, University of 
Queensland Royal Brisbane Clinical School 
Ms Helen Cook Australian College of Midwives 
Ms Suzanne Cornes Executive Director, Health Statistics Centre, Queensland Health; Chair, 
National Perinatal Data Development Committee 
Dr Mary-Ann Davey Faculty of Health Sciences, School of Nursing and Midwifery, Mother 
and Child Health Research Centre, LaTrobe University, Victoria 
Professor Jodie Dodd Chair, Maternal and Neonatal Clinical Network, South Australia 
Ms Louise Edmonds Senior Manager, Information Management Section, ACT Health 
Professor David Ellwood Professor, Obstetrics and Gynaecology, Griffith University; Director of 
Maternal-Fetal Medicine, Gold Coast Health District, Queensland 
Associate Professor Vicki Flenady Director, Centre for Translating Research into Practice, Mater Medical 
Research Institute, Queensland 
Mr Mark Gill Assistant Director, Health Information, Metropolitan Health and Aged 
Care Services, Department of Health, Victoria 
Professor Caroline Homer Faculty of Nursing, Midwifery and Health, University of Technology 
Sydney, New South Wales 
Dr Janet Hornbuckle Consultant in Maternal Fetal Medicine, King Edward Memorial Hospital; 
Honorary Senior Lecturer in Obstetrics and Gynaecology, University of 
Western Australia 
Professor Michael Humphrey Clinical Adviser, Office of Rural and Remote Health; Senior Medical 
Coordinator, Obstetrics Retrieval Services Queensland; Chair, 
Queensland Maternal and Perinatal Quality Council 
Mr Mark Johnson Acting Manager, Information Standards and Monitoring, Tasmania 
Department of Health and Human Services 
Associate Professor Rebecca Kimble Chair, Statewide Maternity and Neonatal Clinical Network, Queensland 
Ms Ann Kinnear Executive Officer, Australian College of Midwives 
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Name Affiliation 
Dr Michael Nicholl Senior Clinical Advisor, Obstetrics, Ministry of Health, New South Wales 
Professor Jeremy Oats Chair, Victorian Consultative Council on Obstetric and Paediatric 
Mortality and Morbidity; Medical Co-Director, Northern Territory 
Integrated Maternity Service; Professorial Fellow, Department of 
Obstetrics and Gynaecology, University of Melbourne 
Professor Michael Permezel President, Royal Australian and New Zealand College of Obstetrics and 
Gynaecology 
Mr Tim Reid Director, Information Management and Reporting Directorate, Health 
Information Networks, Department of Health, Western Australia 
Associate Professor Christine Roberts Clinical and Population Perinatal Health Research, The Kolling Institute, 
University of Sydney, New South Wales 
Emeritus Professor Jeffrey Robinson Emeritus Professor of Obstetrics and Gynaecology, University of 
Adelaide, South Australia 
Dr Wendy Scheil Head, Pregnancy Outcome Statistics Unit, Epidemiology Branch, SA 
Health 
Ms Veronica Snook Director, System Performance, Strategy and Reform,  
Department of Health, Northern Territory 
Ms Diana Stubbs Liaison Midwife, Department of Health, Victoria 
Dr Barbara Vernon Chief Executive Officer, Women's Healthcare Australasia 
Ms Desley Williams Coordinator, Darwin Midwifery Group Practice, Northern Territory 
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Appendix B: Summary of results of 
consultation 
The survey was distributed to 30 contacts based on membership of the MSIJC Expert 
Working Group, NMDDP AG and CDRG, plus additional experts and stakeholders 
previously involved in NMDDP consultation. 
There were 23 respondents to the survey, held between 28 June 2013 and 23 July 2013. 
Feedback was sought on aspects of Indicators 11, 16, 17, 18 and the proposed new NCMI 
‘Skin-to-skin contact between mother and baby after birth’. This Appendix summarises the 
survey responses and comments received in relation to each Indicator. 
NCMI 11: High risk women undergoing caesarean section who 
receive appropriate pharmacological thromboprophylaxis 
Background 
As outlined in the scoping document, a number of issues were identified when this indicator 
was discussed by the Expert Commentary Group (ECG). There is limited evidence available 
from randomised controlled trials on which to base recommendations for use of 
pharmacological thromboprophylaxis after caesarean section, and practitioners rely on 
consensus-based clinical practice guidelines, which, broadly, recommend the use of 
pharmacological thromboprophylaxis after caesarean section in women with additional risk 
factors for venous thromboembolism (VTE). However, there is a lack of consensus on what 
defines high-risk women and it may not be feasible to reach consensus on this aspect. In 
addition, considerable variation in practice for pharmacological thromboprophylaxis after 
caesarean section exists. The ECG suggested that the rate for this indicator may be 50–60%, 
and that it may not vary significantly over time. The Australian Council on Healthcare 
Standards (ACHS) collects data on this indicator. However, the ECG raised concerns about 
the value of collecting these data for the NCMIs, and recommended that further 
development of Indicator 11 not be progressed. 
Results 
The majority of respondents (83%, 19 respondents) agreed with the ECG recommendation 
that further development of this indicator not be progressed. 
Four respondents (17%) did not agree that indicator development should not progress, and 
went on to respond to subsequent open-ended questions around definitional and 
measurement issues. 
Rationale for the ACHS indicator 
The Australian Council on Healthcare Standards (ACHS) includes the following rationale for 
this indicator, proposed for possible adaptation and use for the NCMI: 
Thromboembolism is a major cause of maternal morbidity. Pregnancy is a risk factor for 
venous thromboembolism and the risk is higher if birth is by caesarean section, 
especially emergency caesarean section. A fall in deaths from venous thromboembolism 
after caesarean section was observed in the UK after introduction of the RCOG 
guidelines for thromboprophylaxis in 1995. 
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These guidelines are consensus guidelines as there is a paucity of adequately conducted 
trials on which to base recommendations. 
The rate for this indicator will not be 100% as there will be some women where the 
clinician does not deem it appropriate (ACHS 2013a). 
Three respondents provided comments on the rationale: 1 respondent agreed with the ACHS 
rationale (R1), while another thought that the rationale was dependent on the definition of 
high risk (R23): 
R1: ‘There is broad consensus that thromboprophylaxis should be administered following 
caesarean section for at risk women. I concur with the ACHS rationale.’ 
R23: ‘I think the rationale for using this indicator depends very much on how high risk is 
defined.’ 
The final comment was more general in nature, but appeared to be supportive of the 
rationale: 
R17: ‘…It is unlikely that high level evidence will ever be available from large prospective 
randomised clinical trials on thromboprophylaxis. Therefore, expert opinion may have to 
prevail for some time to come. It will be difficult to obtain national agreement on a useful 
indicator; however, I still maintain that this work needs to be done. If national agreement 
cannot be reached, then state collection of trial indicators should be encouraged.’ 
Expected variation in the indicator over time 
Two responses were received. R23 made the point that the expected variation in the indicator 
over time ‘…depends on how tight the [high-risk] definition is. If the high risk group is 
relatively small then less variation would be expected’. 
R1 provided the comment: ‘Would expect that the “compliance” rate will increase following 
the publication of the Maternity Indicator from current 73% to mid-90s%’.  However, the rate 
for the indicator will depend on the definition used, and this may or may not be the same as 
the ACHS indicator, so 73% will not necessarily be a suitable baseline. 
Definition of high-risk women 
Three responses were received relating to how high-risk women should be defined. One 
respondent commented that South Australia commenced work on this and that the lists were 
remarkably similar (R17). Further work may be able to build on this. 
The remaining two responses were conflicting. One respondent proposed a broad definition 
based on one or more risk factors from the RCOG Clinical Practice Guidelines (R1), while the 
other proposed a narrow definition to capture only those at very high risk of VTE (that is, 
previous deep vein thrombosis (DVT) or pulmonary embolism (PE), high body mass index 
(BMI) (>40), thrombophilia), with the comment that: 
Defining high risk as anyone with BMI>30 or age over 35 will inevitably lead to 
considerable variation as there is no consensus on the appropriate use of 
thromboprophylaxis and therefore it will not be useful as an indicator. (R23) 
Accounting for variation in current practice for pharmacological thromboprophylaxis 
Respondents proposed several reasons for the variation in current pharmacological 
thromboprophylaxis practice: 
• Lack of awareness among clinicians of current recommendations (R1) 
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• Perceived contra-indications to administration of anticoagulant therapy (R1) 
• Inadequate recording and reporting (R1) 
• Lack of high-level evidence (R17) 
• Lack of clear national position/guidelines (R17, R23) 
• Lack of consensus of who is high-risk (R23). 
Core elements relating to use of thromboprophylaxis 
Respondents were asked about the core elements relating to use of pharmacological 
thromboprophylaxis to prevent venous thromboembolism in pregnancy that need to be 
included. Two respondents provided elements that were broadly consistent: 
• Risk factors (yes/no) (R1)/list of recommended risk factors (R17) 
• Administration of an anticoagulant (R1)/recommended treatment (dose, duration) (R17). 
The third respondent provided a more general comment, that the indicator ‘…should be 
restricted to those in whom the evidence for their use is relatively strong’. (R23).  
Establishing a target rate 
Respondents were asked to comment on how a target rate for this indicator could be 
determined, given that it would be less than 100%, as clinicians will consider 
pharmacological thromboprophylaxis inappropriate for some women. 
Two responses were received, which both appear to suggest that the target rate for the 
indicator would be high. Respondent 1 proposed the 90th centile, while Respondent 23 
commented that ‘If a high-risk group is tightly defined then it will be a more meaningful 
indicator’, implying that the target rate would be high if this was done. 
NCMI 16: Separation of baby from the mother after birth for 
additional care 
Background 
ECG members discussed several issues and made several recommendations for defining this 
indicator, including its purpose. The ECG recommended that the term ‘after birth’ be defined 
as within the first 24 hours, and that ‘additional care’ be defined as not requiring admission 
to either a level II or level III nursery. 
Results 
Purpose of indicator 
A large majority of respondents (91%, 20 respondents) supported the proposed purpose of 
the indicator, ‘To measure the separation of a healthy baby from the mother after birth, with 
the aim of minimising separation and enhancing mother–baby attachment’. 
Additional comments on the purpose of this indicator were provided by 6 respondents. 
There was support for collecting this information; however, 2 respondents noted that reliable 
collection would be difficult and 3 respondents referred to definitional issues around 
‘separation’, ‘healthy baby’ and ‘additional care’ (some of these comments are presented 
below under ‘Definitions’). 
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One respondent did not support this indicator (Indicator 16):  
I don’t believe that healthy babies are separated from mothers. Failure to identify a valid 
reason is a defect of the data collection not of clinical management. I would drop this 
altogether. (R22) 
Definitions 
Respondents were asked specific questions regarding the definitions of, ‘separation’, ‘after 
birth’ and ‘additional care’. 
Separation 
Around three-quarters  of respondents (76%, 16 respondents) agreed that a timeframe should 
be used for defining separation. (Note: 2 respondents skipped this question, so percentages 
are based on the total number who responded to this question). 
Of those who agreed, 6 (38%) supported ‘1–3 hours’ as an appropriate and feasible 
timeframe. One respondent added that this should be 1–3 hours ‘over the entire 24-hour 
period [following birth]’, with the aim of keeping each episode of separation less at than 1 
hour (R10). The remaining respondents supported a ‘3–4 hour’ time frame (25%, 4 
respondents), ‘6 hours or more’ (25%, 4) or another timeframe (13%, 2) (Figure B1). 
One respondent who did not agree that a timeframe should be used to define separation 
commented that it was: 
‘Too hard to gather exact data on time of separation…If separation is necessary, data 
should be collected on the reason, including if the reason is insufficient staff to provide 
observation of mother and babe post-caesarean, neonatal blood tests or examinations, IV 
antibiotics etc’. (R18) 
 
 
Source: Responses to AIHW 2013 National Core Maternity Indicators Questionnaire. 
Figure B1: Preference for appropriate and suitable timeframe for measuring separation 
After birth 
The majority of respondents (62%, 13 respondents) reported that the period ‘after birth’ 
should be defined as the first 24 hours after birth. One-third of respondents (33%, 7) 
1–3 hours 
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3–4 hours 
25% 
6 hours or more 
25% 
Other 
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supported ‘Up to discharge’, and 1 respondent (representing 5% of all respondents) 
supported ‘Within the first hour’ (Figure B2). 
Respondents highlighted difficulties in collecting and comparing data with a time period of 
more than 24 hours, as significant differences in length of hospital stay could skew the 
results (R10 and R15). 
 
Source: AIHW 2013 National Core Maternity Indicators Questionnaire. 
Figure B2: Preference for how the time period ‘after birth’ should be defined 
Additional care 
A large majority of respondents (82%, 18 respondents) agreed with the proposed definition 
of ‘additional care’ (below). The proportions who ‘somewhat agreed’ and ‘did not agree’ 
were 9% each (2 in each group).  
Care not requiring admission to a special care nursery (level II nursery) or a neonatal 
intensive care nursery/unit (level III nursery) (based on the Australian and New 
Zealand Neonatal Network definitions below): 
– Level II refers to a nursery that generally has babies born at 32–36 weeks gestation 
weighing around 1,500 to 2,500 grams at birth. It includes care for babies who 
require intravenous therapy or antibiotics, and/or those who are convalescing after 
intensive care, and/or those who need their heart rate or breathing monitored, 
and/or those who need short-term oxygen therapy. 
– Level III or intensive care refers to the care of newborn infants who require more 
specialised care and treatment. It includes most babies born at less than 32 weeks 
gestation or less than 1,500 grams birthweight, and others who may require such 
interventions as intravenous feeding, and/or surgery, and/or cardiorespiratory 
monitoring for management of apnoea or seizures, and/or require assisted 
ventilation, and/or supplemental oxygen over 40% or long-term oxygen. 
R11: ‘This definition would appear to exclude babies who need only IV antibiotics, or regular 
observations. In some cases nursery admission would be appropriate, but in many places 
they could safely stay with their mother. What about phototherapy?’ 
R12: ‘Access to on-call paediatricians 24 hrs for level 2a nurseries, Level 2b as above, in 
addition to access to clinical and diagnostic subspecialties Level 2b to include provision of 
short-term mechanical ventilation pending transfer (CPAP) with facilities for arterial blood 
Within the first hour 
5% 
Within the first 24 
hours 
62% 
Up to discharge 
33% 
Other 
0% 
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gas monitoring. Access to a specialist Senior Registered Nurse. Happy with Level 3 
definition.’ 
R17: ‘Some states now use six levels of care and levels 5 and 6 correspond to Levels 2 and 3.’ 
R22: ‘Essential that admissions to NICU are collected and identified.’ 
R23: ‘You should not have to always separate a baby from its mother just to give antibiotics.’ 
Types of additional care in scope 
Five respondents provided valid responses regarding types of additional care that are not 
considered to require separation of the baby from the mother (types of care and number of 
respondents for each type summarised in Table B1). 
Table B1: Responses on types of additional care in scope 
Type of additional care Number of respondents 
Phototherapy/jaundice 4 
IV antibiotics 4 
Blood glucose measurement 3 
Narcotic/drug withdrawal 2 
Intrauterine growth restriction 1 
Small for gestational age 1 
Nasogastric intubation 1 
Observation (not further defined) 1 
R10: ‘Phototherapy and drug withdrawal may need to be considered in the definition 
alongside IV antibiotics and blood glucose monitoring.’ 
R11: ‘If this question means: which additional care should NOT exclude babies from this 
denominator? ...then phototherapy, observation, IV antibiotics, blood glucose measurement 
are all potential candidates. However it will vary from place to place, and depending on 
individual circumstances. If all of these are excluded we would have a comparable indicator, 
but would it be guiding care in the way intended?’ 
R13: ‘Phototherapy for jaundice IV antibiotics for suspected sepsis but not requiring 
admission.’ 
R15: ‘Treatment/observation for jaundice and narcotic withdrawal should be considered as 
to whether it is additional care in scope of the indicator.’ 
R18: ‘Babies requiring serial BGLs, IV antibiotics, NG feeds, IUGR and SGA babies.’ 
R22: ‘Essential that admissions to NICU are collected and identified.’ 
Restriction to babies born >37 completed weeks gestation 
Most respondents (87%, 20 respondents) agreed that this indicator should be restricted to 
babies born at greater than 37 completed weeks gestation; 3 respondents (13%) did not 
support this restriction.  
R6: ‘Iatrogenic prematurity needs to be collected but this may be very difficult to determine 
in the data collection. There may be a philosophy of earlier delivery at one institution than 
another which should be captured, for example.’ [did not support the restriction] 
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R7: ‘>/=.’ [greater than or equal to; supported the restriction] 
R18: ‘More and more babies formerly cared for in SCN are in the PN wards or Labour wards 
(where there is ‘bed block’) and many of these are under 37 completed weeks. That this care 
is provided in PN areas is a good thing so mother–baby separation does not occur; however 
hospitals have to be funded and staffed to cover the extra human and material resources 
required.’ [did not support the restriction] 
R22: ‘Always >= 37w; >37w might seem similar but is a major error.’ [supported the 
restriction] 
Detection of improved outcomes 
More than half of respondents (57%, 13 respondents) agreed that it would be difficult to 
detect improved outcomes for this indicator, given babies receiving medical care on the 
wards do not attract hospital funding compared with those admitted to a nursery. Just over 
one-quarter of respondents somewhat agreed (26%, n=6) and 17% (n=4) of respondents 
disagreed.  
R6: ‘Money gets in the way of rational decisions always.’ [Agreed] 
R11: ‘If that will affect the indicator greatly, its utility would be doubtful.’ [Somewhat 
agreed] 
R14: ‘However, this is the reason for it being captured. We should not be separating babies 
from their mothers for financial reasons, only for clinical indications—most of which can 
now be managed on a postnatal ward whereas previously they were only provided in a 
nursery.’ [Somewhat agreed] 
R23: ‘It’s something that hospitals can manage with limited additional funding—it may even 
be cheaper!’ [Disagreed] 
Data collection 
Regarding the best method of collection data for this indicator, 39% (7 respondents) 
supported the National Perinatal Data Collection, 39% (7) supported an ‘other’ mechanism 
and 22% supported an audit of labour ward records (Figure B3). 
Comments from those who responded ‘National Perinatal Data Collection’ included:  
R1: ‘Wherever possible all data that is required for Nat Mat Indicators should be routinely-
collected data items and the National Minimum Maternity Data should be revised 
accordingly.’ 
R18: ‘NPDC is ideal, but the reality is this is not always accurate and relies on individual 
midwives at d/c [discharge] of mother and baby to review records to see if separation did 
occur. Also requires staff to record that a baby was taken from its mother for whatever 
reason in the clinical record since generally it would be impractical to enter this information 
on the NPDC at or around the time of separation.’ 
There were no comments from those who responded ‘Audit of labour ward records’. 
Comments from those who responded ‘Other’ included: 
R5: ‘Patient experience survey.’ 
R10: ‘Clinical indicator with the hope that the information can be collected on local 
databases, as much of it is judgment. Complex to collect in NPDC and will need refining for 
specificity.’ 
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R15: ‘This type of indicator should be collected on on-site clinical databases by midwives. 
These data [are] then used to report and refine the indicator, its purpose and its ability to 
achieve the outcome expected. Collection in the NPDC should only be after some years of 
this type of collection and reporting.’ 
R11: ‘Labour ward records would not help, as most of the period is spent away from [the] 
labour ward. If collected through NPDC, how would it be systematically collected? e.g. 
Would the mother be asked to answer the question as she leaves hospital? Would the 
midwife discharging the woman be expected to comb the baby’s record? A pilot study 
would be informative.’ 
R14: ‘Needs to be determined as part of this project.’ 
R16: ‘Through ANZNN collection.’ 
Comments from those who did not respond directly to the question of the best method of 
data collection were: 
R17: ‘Is there a role for ANZNN data collection to include this?’ 
R7: ‘Unsure.’ 
R8: ‘I think that data will be difficult to collect as it may not be routinely and reliably 
documented on current observation charts or entered into electronic maternity patient record 
databases. Making this an indicator may not be enough impetus for hospitals to change 
practice to document this information routinely.’ 
R23: ‘This can probably best come from hospital discharge data.’ 
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Source: Responses to AIHW 2013 National Core Maternity Indicators Questionnaire. 
Figure B3: Preference for data collection method 
NCMI 17: One-to-one care in labour 
Background 
ECG members discussed several issues and made several recommendations for defining this 
indicator, including its focus, before conducting the consultation with experts and 
stakeholders. 
Results 
Focus of indicator 
Almost all respondents (96%, 21 respondents) agreed that the focus of this indicator should 
be about continuous care during labour (that is, having a midwife, rather than a nurse, 
present for the duration of labour and that a woman in labour is not left alone). This was 
further supported in comments from one respondent, who emphasised the weight of 
evidence for ‘continuous midwifery care and support during labour’ (R18). Only 1 respondent 
disagreed (4% of respondents), but did not provide additional comment. 
Respondents were further asked about the distinction between continuity of care versus 
continuity of carer. Specifically, the survey asked respondents whether they agreed or not 
with the statement that continuity of carer is not as important as continuity of care, noting 
that data on continuity of carer are very difficult to collect. Just over half of respondents 
agreed with the statement  that continuity of carer is not as important (52%, 12 respondents), 
while 30% (7 respondents) and 17% (4) ‘somewhat agreed’ and ‘disagreed’ respectively. In 
their comments, respondents acknowledged the difficulty in collecting information on 
continuity of carer, as well as the practical issues involved in the same midwife providing 
continuous care for the duration of labour. They noted that while continuity of carer is ideal 
and desired by women, continuity of care is most important, and consistent care can be 
provided by multiple caregivers: 
National Perinatal 
Data Collection 
39% 
Audit of labour ward 
records 
22% 
Other 
39% 
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R6: ‘Continuity of carer is important. It may be that there is some scope to doing this in 
individual hospitals and models of care should be included in outcomes. However, as a 
NCMI it would be difficult to capture due to the large number of models that are available. 
Does continuity of obstetric care at an elective c/s [caesarean section] count?’ [Somewhat 
agreed] 
R9: ‘Standard guidelines for care to be followed by all. Birthing women treated with the 
same philosophy will be just as good as same caregiver.’ [Agree] 
R11: ‘Importance and difficulty collecting are two different issues. Feasibility is also 
important. Have workforce stakeholders been consulted?’ [Somewhat agree] 
R17: ‘Although common sense indicates that changing shifts should continue to occur, 
continuity of carer is sought by women.’ [Disagree] 
R18: ‘Continuous care is paramount and having a known midwife provide that care is ideal. 
‘[Somewhat agree] 
Purpose of indicator 
More than three-quarters of respondents (77%, 17 respondents) supported the proposed 
purpose of the indicator: ‘To measure one-to-one midwifery care in labour, with the aim of 
optimising normal birth (that is, physiological birth) and minimising unnecessary 
interventions’. 
Fourteen per cent (3 respondents) did not support the proposed purpose, and 9% (2) 
‘somewhat’ supported it. 
Additional comments were provided by 3 respondents. One respondent who did not 
provide an answer on agreement (or not) with the purpose made this comment: 
R8: ‘I think this data is difficult to collect.’ 
Another respondent was concerned that the purpose did not specifically address continuity 
of carer (following on from the previous question): 
R22: ‘Continuity of carer is very important and now about to be obscured.’ [did not agree 
with the purpose] 
The final comment highlighted that the aim is not just to optimise normal birth and minimise 
unnecessary interventions, but ‘… is also important for high-risk women who are having 
multiple interventions’ [R23; did not agree with the purpose]. 
Definition of ‘one-to-one care’ 
Respondents were provided with 2 specific options for the definition of one-to-one care, as 
well as the option ‘Other’, and asked to choose which they preferred (Table B2).  
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Table B2: Proposed definitions of ‘one-to-one care’  
Definition Source 
Preference—
proportion (%) 
and no. of 
respondents 
1 A woman in established labour receives care from an assigned 
midwife for the whole of that labour, or the midwife's whole 
shift, whichever is the shorter. This midwife will be available to 
care for the woman 100% of the time. At the end of the shift, if 
necessary, care will be handed over to another assigned 
midwife, who will continue the one-to-one care of that woman. 
Based on the definition in London’s 
Maternity Services: Commissioning 
Improvement Project guidance notes 
64% (14) 
2 The midwife has one woman allocated to her care and no other 
allocated responsibility. 
Proposed by the Maternity Services 
Inter-Jurisdictional Committee 
23% (5) 
Other  — 14% (3) 
Definition 1 received majority support at 64% (14 respondents). 
Five respondents provided additional comments in relation to the definitions. 
Two respondents who responded ‘Other’ supported Definition 2 with the qualification that it 
be expanded to include that the midwife is available to the assigned woman 100% of the 
time: 
R10: ‘Definition 2 is good but needs expanding to include ‘and is with or available for that 
woman 100% of the time’.’ [responded ‘Other’] 
R15: ‘Like Definition 2 better than Definition 1. But it needs to be extended to state the 
midwife is available to her assigned woman 100% of her time on shift.’ [responded ‘Other’] 
Other comments were as follows: 
R9: ‘Women receive standardised care even if by different caregivers. Unable to achieve 
‘same midwife’ care in a busy labour ward.’ [responded ‘Other’] 
R11: ‘They are essentially the same. If the midwife has any other allocated responsibility she 
is not available 100% of the time.’ [responded ‘Definition 2’] 
R18: ‘You could shorten the first definition to include just the first two sentences if it was 
thought that it was ‘a given’ that if a woman was still in labour after her first midwife left, 
another midwife would replace her. Definition 2 would need the qualifier of one woman ‘in 
established labour’ allocated to her care and leave it like that. I think stipulating ‘No other 
allocated responsibility’ is tricky when we midwives all have a responsibility to the rest of 
our colleagues in terms of supporting them in emergency situations or providing 
guidance/support in the non-urgent situation, not to mention general ‘housekeeping’ 
without which all the women and staff in the labour ward are put at risk.’ [responded 
‘Definition 1’]. 
Restriction to low-risk women 
The majority of respondents (87%, 20 respondents) did not support the restriction of this 
indicator to low-risk women (that is, primiparas); only 13% (3) supported the restriction.  
Comments were provided by 3 respondents, all of whom did not support the restriction. 
Two of the comments disputed that primiparas were low-risk (R7 and R11), and one 
respondent noted that regardless of whether primiparas or multiparous, [or] low or high 
risk, all would benefit from one-to-one care (R11). The third respondent emphasised that 
one-to-one care is even more important for high-risk women: 
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R18: ‘Ideally all women in established labour should receive one-to-one midwifery, and 
high-risk women probably need that support even more—having them strapped to every bit 
of machinery possible does not replace midwifery!’ 
Data collection 
In terms of data collection, almost all respondents agreed that the best mechanism was 
through the midwife completing the labour ward summary (96%, 22 respondents). Three 
respondents provided supporting comments:  
R1: ‘And again added to Nat Mat Min Data set.’ 
R15: ‘Only person who knows the information.’ 
R18: ‘And the clinical record where more than one midwife (that is, ‘shift’ of midwives) has 
cared for the woman in labour.’ 
Only 1 respondent (4%) proposed a different mechanism: 
R11: ‘There would need to be a question at the end of each shift (something like ‘Since you 
took over the care of this woman, did you have any other allocated patient?’). The midwife 
completing the form would know what had happened on earlier shifts.’ 
NCMI 18: Caesarean sections <39 weeks (273 days) without 
obstetric/medical indication  
Background 
ECG members discussed the need to develop a list of indications that may justify early 
caesarean section (CS) prior to 39 completed weeks gestation. The National Maternity Data 
Development Project (NMDDP) has developed a list of indications for caesarean section for 
inclusion in the National Perinatal Data Collection. Although not specific to deliveries prior 
to 39 weeks gestation, this list could provide relevant data for this indicator.  
Results 
Title of indicator 
Around three-quarters of respondents (77%, 17 respondents) agreed with the proposed title 
for this indicator: ‘Caesarean sections <39 weeks (273 days) without obstetric/medical 
indication’. A further 14%(3 respondents) ‘somewhat agreed’ with the title and 9% (2) did 
not agree. Five respondents provided further comments as follows: 
• Two respondents provided additional comments regarding the gestation period (R22 
provided multiple comments on this issue):  
R14: ‘Need to include a lower gestation too, i.e. term CS <39 weeks otherwise will 
capture preterm CS (although these would have a medical indication I suppose)’ 
R22: ‘Should be less than 38.4 weeks gestation. Elective CS is ideally at 39 weeks but few 
units can schedule on that day. Going beyond 39 weeks is just as bad as being early by a 
few days. RANZCOG recommend ‘approximately 39 weeks’ to allow for this. Less than 
39.4 weeks would cover this issue adequately, less than 39 weeks is simply wrong and 
encouraging bad practice (that is, delaying till 39 and a few days when 39 is not possible 
because of scheduling issues).’ 
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R22: ‘…Very disappointing to be obsessed with <39w when delivery at ‘approximately 
39w’ is the recommendation—even in the absence of additional risk factors for perinatal 
morbidity and mortality.’ 
• One respondent suggested the addition of ‘completed’ to the timeframe, such that it 
would read ‘to <39 completed weeks’. (R20) 
• The remaining 2 comments related to definitional issues for the Indicator rather than its 
title, and are therefore included in more relevant sections below. 
Purpose of indicator 
A large majority of respondents (86%, 19 respondents) supported this proposed purpose of 
the indicator: ‘Neonatal respiratory morbidity can be reduced by minimising early delivery. 
This indicator is used to benchmark practice’. 
Additional comments on the purpose of the indicator were provided by 5 respondents: 
R7: ‘Data presented at FIGO [International Federation of Gynecology and Obstetrics] from 
UK suggested that this presumption is not valid in a prospective study—not seen in print yet 
but potentially important.’ 
R17: ‘It is not simply respiratory morbidity that increases with decreasing gestational age. 
Many organs undergo maturation shortly before natural birth. Neonatal jaundice is another 
example.’ 
R19: ‘Please use birth rather than delivery.’ 
R22: ‘Need to also say this has to be balanced against the increased rates of death and 
disability by delaying the delivery. ‘Approximately 39 weeks’ achieves this balance.’ 
R23: ‘There are many other reasons for trying to minimise early delivery without a good 
reason.’ 
Method of listing or recording indications that may justify caesarean section delivery 
prior to 39 completed weeks gestation 
Three options were presented (see Figure B4). The most common preference to capture 
indications that may justify caesarean section delivery prior to 39 completed weeks gestation 
was ‘List of common indications based on the NMDDP list of indications for caesarean 
section’ (48%, 11 respondents). This was followed by the ‘Comprehensive list of indications 
based on ICD-10-AM’ (30%, 7) and the ‘Flag for ‘without medical or obstetric indication’’ 
(22%, 5) (Figure B4).  
 84 National core maternity indicators—stage 2 report: 2007–2011 
 
Notes 
1. Comprehensive list of indications is based on ICD-10-AM codes. 
2. List of common indications is based on the NMDDP list of indications for caesarean section. 
3. Flag for ‘without medical or obstetric indication’ (using only code 19 ‘Maternal choice in the absence of any obstetric or medical (including 
psychological) indications’ from the NMDDP list of indications). 
Source: Responses to AIHW 2013 National Core Maternity Indicators Questionnaire. 
Figure B4: Preferred method to list or record indications that may justify caesarean section delivery 
prior to 39 completed weeks gestation 
Several respondents provided comments in full or partial support of the NMDDP: 
R1: ‘For consistency and reduction in confusion, use NMDDP list.’ 
R11: ‘Only planned CSs before labour are relevant here. Would not necessarily need a list of 
ICD-10 codes—general indications would suffice, for example 1, 7, 8, 9, 10, ?11, 17 on the 
NMDDP list. Is not the intent to delay all non-urgent CS until a safer gestation? The NMDDP 
includes a number of indications that should be included here, for example repeat CS, 
malpresentation, previous shoulder dystocia, macrosomia, previous perineal trauma and 
maternal choice (the ‘fail to progress’ ones—unsuccessful attempt at assisted delivery, 
unsuccessful induction—are irrelevant).’ 
One respondent provided a comment in relation to the unsuitability of the ICD-10-AM 
codes:  
R6: ‘In reality there are a number of indications that might not be able to fit into ICD-10-AM 
codes...or a combination of reasons and this may seem too prescriptive.’ 
Other respondents raised more general issues in relation to the method: 
R17: ‘Does ‘other obstetric indications’ include obstetricians choice?’ 
R22: ‘Impossible to be comprehensive, <39w is incorrect terminology anyway.’ 
R23: ‘The problem with any of these is that maternal choice will always be labelled as 
‘psychological’.’ 
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indications 
48% 
Flag for ‘without 
medical or obstetric 
indication’ 
22% 
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Indications justifying caesarean section delivery prior to 39 completed weeks gestation 
Figure B5 shows the level of support for each of the proposed indications. Table B3 groups 
the indications into categories based on the level of support. 
 
Source: Responses to AIHW 2013 National Core Maternity Indicators Questionnaire. 
Figure B5: Indications for caesarean section at <39 weeks gestation 
 
  
0 20 40 60 80 100
01 Fetal compromise
07 Placenta praevia
08 Placental abruption
10 Antepartum/intrapartum haemorrhage
11 Multiple pregnancy
09 Vasa praevia
12 Unsuccessful attempt at assisted delivery
05 Failure to progress in 1st stage 4–10 cm 
06 Failure to progress in 2nd stage
13 Unsuccessful induction
04 Failure to progress; ≤3cm 
17 Previous adverse fetal/neonatal outcome
18 Other obstetric or medical (inc.
psychological) indications
02 Fetal macrosomia
03 Malpresentation
16 Previous perineal trauma/4th degree tear
15 Previous shoulder dystocia
14 Previous caesarean section
19 Maternal choice in absence of any
obstetric or medical (inc. psychological)…
Per cent 
Yes
No
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Table B3: Support for indications justifying caesarean section at <39 weeks gestation  
Low support Moderate support Strong support Very strong support 
14 Previous caesarean section 
(20%, 4 respondents) 
02 Fetal macrosomia (38%, 8 
respondents) 
17 Previous adverse 
fetal/neonatal outcome 
(76%, 16 respondents) 
01 Fetal compromise (includes 
suspected or actual fetal 
compromise and IUGR) (100%, 
22 respondents) 
15 Previous shoulder dystocia 
(25%, 5) 
03 Malpresentation (38%, 8) 
19 Maternal choice in the 
absence of any obstetric or 
medical (including 
psychological) indications 
(15%, n=3) 
16 Previous perineal 
trauma/4th degree tear (33%, 
n=7) 
18 Other obstetric or 
medical (including 
psychological) 
indications (70%, 14) 
04 Failure to progress; ≤3cm 
(prolonged latent phase) (85%, 
17) 
 05 Failure to progress in the first 
stage 4–10 cm (95%, 19) 
  
 
06 Failure to progress in the 
second stage (95%, 19) 
   07 Placenta praevia (100%, 22) 
   08 Placental abruption (100%, 2) 
   09 Vasa praevia (95%, 1) 
  
 
10 Antepartum/intrapartum 
haemorrhage (100%, 22) 
   11 Multiple pregnancy (100%, 22) 
  
 
12 Unsuccessful attempt at 
assisted delivery (95%, 20) 
  
 
13 Unsuccessful induction (86%, 
8) 
Note: Low support (0% to 29%); Moderate support (30% to 59%); Strong support (60% to 79%); Very strong support (80% to 100%). 
Source: Responses to AIHW 2013 National Core Maternity Indicators Questionnaire. 
The most common theme in the comments received on the list of indications was regarding 
the distinction between pre-labour and labour indications. Several respondents believed that 
the labour indications do not apply to this indicator and should be excluded, as the indicator 
relates only to planned caesarean sections prior to 39 completed weeks gestation (rather than 
elective). 
R1: ‘Needs to be clear that the indicator refers to pre-labour CS, the above indications of 
course refer to all CSs and therefore the ‘intrapartum’ indicators per se do not apply.’ 
R6: ‘This is again a difficult question to answer as there are lots of times that some of these 
would apply and some that don’t depending on the circumstances. Not sure what is meant 
by ftp labour 4–10 cms.....are they supposed to go home? Suggest take out the labour versus 
non-labour reasons. Some of the answers will depend on what gestation the previous event 
occurred and the circumstances.’ 
R11: ‘Only planned CSs before labour are relevant here. The fail to progress ones, 
unsuccessful attempt at assisted delivery, unsuccessful induction are irrelevant as they are 
not pre-labour.’ 
Consistent with these comments, 2 respondents emphasised the inclusion of several  
non-labour codes: 
R10: ‘Think that codes 02, 03, 11, 14, 15, 16 and 17 should be included in this indicator as they 
are not reasons for elective C/S pre 39 weeks.’ 
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R15: ‘Like this indicator but should include reason for CS items 03, 11, 14, 15 or 16 as these 
should not be done before 39 weeks either.’ 
Other comments received on the list of indications were: 
R3: ‘I would also suggest to include placenta accrete.’ 
R8: ‘Previous shoulder dystocia is a difficult one as I would think this is a valid reason for 
caesarean section if the infant is significantly larger than the one where there is a shoulder 
dystocia but I would not necessarily undertake the c/section before 39/40.’ 
R17: ‘Can psychological and psychiatric reasons be separated from obstetric?’ 
R18: ‘MAY is the operative word—pun intended! Malpresentation may right itself by the 
time labour starts, who determines ‘macrosomia’ and at what gestation, who counsels the 
woman who wants a c/s because she had one last time, how real (that is, well documented) 
was the previous shoulder dystocia ???? I could go on.’ 
R20: ‘Fetal macrosomia is difficult—I don’t feel strongly either way.’ 
R22: ‘All reasonable. ‘ 
Proposed new NCMI: Skin-to-skin contact between mother and 
baby after birth 
Background 
During the discussion of NCMI 16, ‘Separation of baby from the mother after birth for 
additional care’, ECG members noted the importance of skin-to-skin contact and 
recommended it be developed as an additional indicator.  
Results 
The majority of respondents (78%, 18 respondents) supported the development of a new 
indicator to measure skin-to-skin contact between mother and baby after birth. Thirteen per 
cent (3 respondents) ‘somewhat supported’ the development of the indicator and 9% (2) did 
not support it. 
Five additional comments were received, four of which offered support for the indicator, 
citing the following justifications: 
• Already collected by many sites for BFHI (Baby-Friendly Health Initiative), and would 
be useful to obtain private hospital data for comparison. 
• Good evidence for benefit. 
• Relatively easy to collect. 
One comment from a respondent who ‘somewhat’ supported the indicator questioned its 
value as a clinical indicator (R23). 
No additional comments were received from respondents who did not support the 
development of this indicator. 
Purpose of indicator 
The large majority of respondents (91%, 20 respondents) supported the proposed purpose of 
the indicator: ‘Placing the baby in skin-to-skin contact with the mother immediately after 
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birth promotes mother–baby attachment and breastfeeding. This indicator is used to 
benchmark practice’. 
Only 1 respondent did not support the purpose, and 1 respondent ‘somewhat’ supported the 
purpose, stating that ‘It is a reasonable definition’ (R23). 
Timeframe for skin-to-skin contact  
There was very strong agreement that the timeframe for skin-to-skin contact should be 
within 60 minutes of birth (95%, 21 respondents). Only 1 respondent disagreed but did not 
provide additional comment. 
One respondent suggested that within 30 minutes would be even better, but expected high 
failure rates (R18). 
Another respondent highlighted definitional issues about the amount of time required for 
skin-to-skin contact within this 60 minute period: 
R11: ‘But how much time spent in skin-to-skin contact would qualify as a ‘yes’? Would 1 
minute suffice? Presumably not, but what is the minimum portion of the first 60 minutes that 
would qualify as a ‘yes’?’ 
Data collection 
There was very strong support (95%, 19 respondents) for collecting the data through the 
midwife’s completing of the labour ward summary. Two additional comments were received 
in support of this: 
R15: ‘Best person to know the answer.’ 
R18: ‘The midwife present at the birth and afterwards (presumably the midwife who 
completes the summary) is the most appropriate person to collect the data.’ 
One respondent commented that these data should also be added to the National Minimum 
Data Set (R1). 
A respondent who did not provide a response in relation to the preferred method of data 
collection stated that it would be ‘Difficult to collect data as this may not be documented. If 
collecting this data this indicator should be collected for babies 37 weeks gestation onwards 
and data grouped separately for vaginal and caesarean section births’ (R8). 
A respondent who did not support the development of this indicator commented that this 
data should not be collected (R22). 
General comments 
Four respondents provided additional general comments on the indicators (under 
development). One respondent expressed concern over the ability to consistently and 
reliably report on the indicators, as well as around definitional issues: 
R8: ‘I think the indicators need more work. I think these indicators are looking at data 
that may not be consistently or reliably documented, coded by medical records or fields 
in maternity electronic medical records, so returns on these indicators at present are 
limited. Also, there needs to be clearer definition of these indicators and coding criteria 
for it to work.’ 
Two respondents were interested to know how the indicators would be collected and 
reported, and the forum for reporting the results: 
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R10: ‘Interested to know how these indicators will be collected or reported and at which 
forums the results will be reported.’ 
R15: ‘Interested to know what forums will be receiving reports of these indicators and at 
what level they will be required to be collected and reported, that is, site, jurisdiction or just 
AIHW.’ 
A final respondent expressed support for the indicator development process to fix issues of 
nomenclature: 
R18: ‘I think I have probably said enough, but, at the risk of being boring, this is a golden 
opportunity to fix nomenclature—I know it is hard and there are lots of data collection 
lists that would have to be changed, but it would make such a difference to our birthing 
culture. Thanks for ‘listening’!’ 
 
 90 National core maternity indicators—stage 2 report: 2007–2011 
Appendix C: Draft technical specifications 
Skin-to-skin contact between mother and baby after birth 
Indicator details 
Description The proportion of babies placed in skin-to-skin contact with the mother immediately after birth. 
Purpose Placing the baby in skin-to-skin contact with the mother immediately after birth promotes 
mother–baby attachment and breastfeeding. This indicator is used to benchmark practice. 
Numerator The number of babies placed in skin-to-skin contact with the mother after birth. 
Denominator The number of live babies born. 
Computation/Presentation Numerator/denominator x 100 
Presentation Percentage 
Notes and exceptions A birth is defined as the event in which a baby comes out of the uterus after a pregnancy of at 
least 20 weeks gestation or weighing 400 grams or more. If the baby is alive the birth is a live 
birth. If the baby is not alive the birth is a stillbirth. 
‘After birth’ is defined as within 5 minutes following the birth event. If this is not possible for 
medical reasons following a caesarean section, skin-to-skin contact should be initiated within 10 
minutes of arriving in recovery. In the case of general anaesthesia, skin-to-skin contact should 
be initiated within 10 minutes of the mother being able to respond to her baby. 
Births excluded are stillbirths. 
Data collection details 
Data source To be determined 
Data source type To be determined 
Data items—indicator To be determined 
Data items—disaggregation 
factors 
To be determined 
Frequency of data source 
collection(s) 
To be determined 
Additional details 
Comments  
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18. Caesarean section <39 weeks (273 days) without obstetric/medical 
indication 
Indicator details 
Description The proportion of women who gave birth by caesarean section at less than 39 completed 
weeks (273 days) gestation without obstetric/medical indication. 
Purpose Neonatal respiratory morbidity can be reduced by minimising early delivery. This indicator is 
used to benchmark practice. 
Numerator The number of women who gave birth by caesarean section at less than 39 completed 
weeks (273 days) gestation without obstetric/medical indication. 
Denominator The number of women who gave birth by caesarean section at less than 39 completed 
weeks (273 days) gestation. 
Computation/Presentation Numerator/denominator x 100 
Presentation Percentage 
Notes and exceptions A birth is defined as the event in which a baby comes out of the uterus after a pregnancy of 
least 20 weeks gestation or weighing 400grams or more.  
Births included are caesarean deliveries (where there was no labour) at <39 completed 
weeks (273 days). 
Births excluded are: 
 caesarean deliveries at or after 39 completed weeks (273 days) gestation 
 where there was labour  
 all vaginal deliveries 
 those delivered pre-term by caesarean section (where there was no labour) for the 
following indications: 
– fetal compromise 
– placenta praevia 
– placental abruption 
– vasa praevia 
– antepartum/intrapartum haemorrhage 
– multiple pregnancy 
– other obstetric, medical, surgical, psychological indications. 
Data collection details 
Data source National Perinatal Data Collection 
Data source type Perinatal NMDS and voluntarily-supplied items 
Data items—indicator Gestational age  
Method of birth 
Onset of labour 
Main indication for caesarean section  
Data items—disaggregation 
factors 
To be determined 
Frequency of data source 
collection(s) 
Annual 
Additional details 
Comments  
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Appendix D: Indications for pre-term 
caesarean sections 
Table D1: Conditions possibly justifying elective delivery prior to 39 weeks gestation 
ICD-9-CM code Shortened description ICD-9-CM code Shortened description 
042  HUMAN IMMUNO VIRUS DIS  648.61  CV DIS NEC PREG-DELIVER  
641.01  PLACENTA PREVIA-DELIVER  648.62  CV DIS NEC-DELIVER W P/P  
641.11  PLACENTA PREV HEM-DELIV  648.81  ABN GLUCOSE TOLER-DELIV  
641.21  PREM SEPAR PLACEN-DELIV  648.82  ABN GLUCOSE-DELIV W P/P  
641.31  COAG DEF HEMORR-DELIVER  649.31  COAGULATION DEF-DELIV  
641.81  ANTEPARTUM HEM NEC-DELIV  649.32  COAGULATN DEF-DEL W P/P  
641.91  ANTEPARTUM HEM NOS-DELIV  651.01  TWIN PREGNANCY-DELIVERED  
642.01  ESSEN HYPERTEN-DELIVERED  651.11  TRIPLET PREGNANCY-DELIV  
642.02  ESSEN HYPERTEN-DEL W P/P  651.21  QUADRUPLET PREG-DELIVER  
642.11  RENAL HYPERTEN PG-DELIV  651.31  TWINS W FETAL LOSS-DEL  
642.12  RENAL HYPERTEN-DEL P/P  651.41  TRIPLETS W FET LOSS-DEL  
642.21  OLD HYPERTEN NEC-DELIVER  651.51  QUADS W FETAL LOSS-DEL  
642.22  OLD HYPERTEN-DELIV W P/P  651.61  MULT GES W FET LOSS-DEL  
642.31  TRANS HYPERTEN-DELIVERED  651.71  MULT GEST-FET REDUCT DEL  
642.32  TRANS HYPERTEN-DEL W P/P  651.81  MULTI GESTAT NEC-DELIVER  
642.41  MILD/NOS PREECLAMP-DELIV  651.91  MULT GESTATION NOS-DELIV  
642.42  MILD PREECLAMP-DEL W P/P  652.01  UNSTABLE LIE-DELIVERED  
642.51  SEVERE PREECLAMP-DELIVER  652.61  MULT GEST MALPRES-DELIV  
642.52  SEV PREECLAMP-DEL W P/P  655.01  FETAL CNS MALFORM-DELIV  
642.61  ECLAMPSIA-DELIVERED  655.11  FETAL CHROMOSO ABN-DELIV  
642.62  ECLAMPSIA-DELIV W P/P  655.31  FET DAMG D/T VIRUS-DELIV  
642.71  TOX W OLD HYPERTEN-DELIV  655.41  FET DAMG D/T DIS-DELIVER  
642.72  TOX W OLD HYP-DEL W P/P  655.51  FET DAMAG D/T DRUG-DELIV  
642.91  HYPERTENS NOS-DELIVERED  655.61  RADIAT FETAL DAMAG-DELIV  
642.92  HYPERTENS NOS-DEL W P/P  655.81  FETAL ABNORM NEC-UNSPEC  
646.21  RENAL DIS NOS-DELIVERED  656.01  FETAL-MATERNAL HEM-DELIV  
(continued) 
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Table D1 (continued): Conditions possibly justifying elective delivery prior to 39 weeks gestation 
ICD-9-CM code Shortened description ICD-9-CM code Shortened description 
646.22  RENAL DIS NOS-DEL W P/P  656.11  RH ISOIMMUNIZAT-DELIVER  
646.71  LIVER/BIL TRCT DISR-DEL  656.21  ABO ISOIMMUNIZAT-DELIVER  
648.01  DIABETES-DELIVERED  656.31  FETAL DISTRESS-DELIVERED  
648.51  CONGEN CV DIS-DELIVERED  656.41  INTRAUTER DEATH-DELIVER  
648.52  CONGEN CV DIS-DEL W P/P  656.51  POOR FETAL GROWTH-DELIV  
657.01  POLYHYDRAMNIOS-DELIVERED  659.71  ABN FTL HRT RATE/RHY-DEL  
658.01  OLIGOHYDRAMNIOS-DELIVER  663.51  VASA PREVIA-DELIVERED  
658.11  PREM RUPT MEMBRAN-DELIV  V08  ASYMP HIV INFECTN STATUS  
658.21  PROLONG RUPT MEMB-DELIV  V23.5  PREG W POOR REPRODUCT HX  
658.41  AMNIOTIC INFECTION-DELIV  V27.1  DELIVER-SINGLE STILLBORN  
Source: US Joint Commission 2012. Table 11.07, Appendix A, Specifications Manual for Joint Commission National Quality Core Measures 
(v2012b). 
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Table D2: Recommendations for the timing of delivery when conditions complicate pregnancy at 
or after 34 weeks of gestation 
Condition General timing Suggested specific timing 
Placental/uterine issues 
Placenta praevia* Late preterm/early-term 36 0/7–37 6/7 weeks of 
gestation 
Placenta praevia with suspected accreta, increta, 
or percreta* 
Late preterm 34 0/7–35 6/7 weeks of 
gestation 
Prior classical caesarean Late preterm/early-term 36 0/7–37 6/7 weeks of 
gestation 
Prior myomectomy Early-term/term (individualise) 37 0/7–38 6/7 weeks of 
gestation 
Fetal issues 
Growth restriction (singleton) 
Otherwise uncomplicated, no concurrent 
findings 
Concurrent conditions (oligohydramnios, 
abnormal Doppler studies, maternal co-
morbidity [e.g. pre-eclampsia, chronic 
hypertension]) 
 
Early-term/term  
 
Late preterm/early-term 
 
38 0/7–39 6/7 weeks of 
gestation 
34 0/7–37 6/7 weeks of 
gestation 
Growth restriction (twins) 
Di–Di twins with isolated fetal growth restriction 
 
Di–Di twins with concurrent condition (abnormal 
Doppler studies, maternal co-morbidity [e.g. 
pre-eclampsia, chronic hypertension]) 
 
Mo–Di twins with isolated fetal growth 
restriction 
 
Late preterm/early-term 
 
Late preterm 
 
 
 
Late preterm 
 
36 0/7–37 6/7 weeks of 
gestation 
32 0/7–34 6/7 weeks of 
gestation 
 
 
32 0/7–34 6/7 weeks of 
gestation 
Multiple gestations 
Di–Di twins 
 
Mo–Di twins 
 
Early-term 
 
Late preterm/early-term 
 
38 0/7–38 6/7 weeks of 
gestation 
34 0/7–37 6/7 weeks of 
gestation 
Oligohydramnios Late preterm/early-term 36 0/7–37 6/7 weeks of 
gestation 
Maternal issues 
Chronic hypertension 
Controlled on no medications 
 
Controlled on medications 
 
Difficult to control 
 
Gestational hypertension 
 
Pre-eclampsia–severe 
 
Pre-eclampsia–mild  
 
Early-term/term  
 
Early-term/term  
 
Late preterm/early-term 
 
Early-term 
 
Late preterm 
 
Early-term 
 
38 0/7–39 6/7 weeks of 
gestation 
37 0/7–39 6/7 weeks of 
gestation 
36 0/7–37 6/7 weeks of 
gestation 
37 0/7–38 6/7 weeks of 
gestation 
At diagnosis after 34 0/7 weeks 
of gestation 
At diagnosis after 37 0/7 weeks 
of gestation 
Diabetes 
Pregestational well-controlled* 
 
Pregestational with vascular complications 
 
Pregestational, poorly controlled 
Gestational – well controlled on diet or 
medications 
Gestational – poorly controlled 
 
Late preterm, early-term birth not 
indicated 
Early-term/term  
 
Late preterm or early-term 
Late preterm, early-term birth not 
indicated 
Late preterm or early-term 
 
 
 
37 0/7–39 6/7 weeks of 
gestation 
Individualised 
 
 
Individualised 
(continued) 
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Table D2 (continued): Recommendations for the timing of delivery when conditions complicate 
pregnancy at or after 34 weeks of gestation 
Condition General timing Suggested specific timing 
Obstetric issues 
PPROM Late preterm 34 0/7 weeks of gestation 
Abbreviations: Di–Di=dichorionic–diamniotic; Mo–Di=monochorionic–diamniotic; PPROM=preterm premature rupture of membranes. 
*Uncomplicated, thus no fetal growth restriction, superimposed preeclampsia, or other complications. If these are present, then the complicating 
conditions take precedence and earlier delivery may be indicated. 
Source: ACOG 2013. Committee Opinion number 560. Medically indicated late-preterm and early-term deliveries.  
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(a) HELLP denotes haemolysis, elevated liver-enzyme levels and low platelet count. 
(b) HIV human immunodeficiency virus. 
Source: Tita et al. 2009. 
Figure D1: Flowchart detailing exclusion criteria applied to identify elective caesarean sections 
 
28,867 women who had 
repeat caesarean deliveries 
4,790 were excluded owing to gestation <37 weeks 
24,077 had repeat caesarean 
deliveries at term 
10,819 (44.9%) were excluded 
263 (1.1%) had multiple gestations 
445 (1.8%) had major malformations 
3,737 (15.5%) had labour or attempted induction 
3,691 (15.3%) had medical or obstetrical conditions 
1,349 had preeclampsia, eclampsia, HELLP
(a)
, gestational 
hypertension or chronic hypertension 
790 had pre-gestational or medication-requiring diabetes 
mellitus 
210 had a history of cardiac disease 
168 had a history of myomectomy 
92 had renal disease 
90 had HIV
(b)
 infection 
67 had connective-tissue disorder 
20 had chorioamnionitis before delivery 
905 had spontaneous membrane rupture 
2,683 (11.1%) had indications for non-elective caesarean section 
1,512 had previous classic, vertical, T, J or unknown uterine 
incision 
491 had non-reassuring antepartum fetal testing or fetal heart-
rate tracing 
279 had suspected macrosomia 
78 had genital herpes 
86 had placenta praevia 
24 had placental abruption 
33 had non-vertex presentation with unsuccessful version 
180 had other indications 13,258 had elective repeat 
caesarean deliveries at term 
(with no other indication for 
immediate or early delivery) 
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Glossary 
Antenatal: The period covering conception up to the time of birth. Synonymous with 
prenatal. 
Birth: An event in which a baby comes out of the uterus after a pregnancy of at least 20 
weeks gestation or weighing 400 grams or more. 
Birthweight: The first weight of the baby (stillborn or liveborn) obtained after birth (usually 
measured to the nearest 5 grams and obtained within one hour of birth). 
Caesarean section: An operative procedure to remove the baby through a cut through the 
woman’s abdomen and uterus. 
Congenital: A condition that is recognised at birth, or that is believed to have been present 
since birth, including conditions that are inherited or caused by environmental factors. 
Diabetes (diabetes mellitus): A chronic condition in which the body cannot properly use its 
main energy source, the sugar glucose. This is due to a relative or absolute deficiency in 
insulin, a hormone that is produced by the pancreas and helps glucose enter the body’s cells 
from the bloodstream and then be processed by them. Diabetes is marked by an abnormal 
build-up of glucose in the blood, and it can have serious short- and long-term effects. 
Fetal death (stillbirth): Death before the complete expulsion or extraction from its mother of 
a product of conception of 20 or more completed weeks of gestation or of 400 grams or more 
birthweight. The death is indicated by the fact that after such separation the fetus does not 
breathe or show any other evidence of life, such as beating of the heart, pulsation of the 
umbilical cord, or definite movement of voluntary muscles. 
First degree laceration: Graze, laceration, rupture or tear of the perineal skin during delivery 
that may be considered to be slight or that involves fourchette, labia, vagina or vulva. 
Fourth degree laceration: Perineal laceration, rupture or tear as in third degree laceration 
occurring during delivery also involving anal mucosa or rectal mucosa. 
Gestational age: The duration of pregnancy in completed weeks, calculated from the date of 
the first day of a woman’s last menstrual period and her baby’s date of birth, or via 
ultrasound, or derived from clinical assessment during pregnancy or from examination of 
the baby after birth. 
Gestational diabetes: A form of diabetes that is first diagnosed during pregnancy 
(gestation). It may disappear after pregnancy, but signals a high risk of diabetes occurring 
later on. 
High blood pressure/hypertension: The definition of high blood pressure (also known as 
hypertension) can vary, but a well-accepted one is from the World Health Organization: a 
systolic blood pressure of 140 mmHg or more or a diastolic blood pressure of 90 mmHg or 
more, or [the person is] receiving medication for high blood pressure. 
Indigenous: A person of Aboriginal and/or Torres Strait Islander descent who identifies as 
an Aboriginal and/or Torres Strait Islander. 
Induction of labour: Labour started by artificial means. 
Intrauterine growth restriction: Poor growth of a fetus during pregnancy that is detected 
clinically during pregnancy or after birth. 
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Labour: The physiological process by which a vaginal birth occurs that commences at the 
onset of regular uterine contractions that act to produce progressive cervical dilatation, and 
is distinct from spurious labour or pre-labour rupture of membranes. 
Live birth: The complete expulsion or extraction from its mother of a product of conception, 
irrespective of the duration of the pregnancy, which, after such separation, breathes or shows 
any other evidence of life, such as beating of the heart, pulsation of the umbilical cord, or 
definite movement of voluntary muscles, whether or not the umbilical cord has been cut or 
the placenta is attached; each product of such a birth is considered liveborn (WHO 
definition). 
Parity: Number of previous pregnancies resulting in live births or stillbirths, excluding the 
current pregnancy. 
Perinatal: Pertaining to, or occurring in, the period shortly before or after birth (usually up to 
28 days after). 
Pre-term birth: Birth from 20 weeks and before 37 weeks gestational age. 
Primipara: A woman who has given birth for the first time. 
Second degree laceration: Perineal laceration, rupture or tear as in first degree laceration 
occurring during delivery also involving pelvic floor, perineal muscles or vaginal muscles. 
Term: Pregnancy duration between 37 and 41 weeks of gestational age. 
Third degree laceration: Perineal laceration, rupture or tear as in second degree laceration 
occurring during delivery also involving anal floor, rectovaginal septum, or sphincter not 
otherwise specified (NOS). 
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National core 
maternity indicators– 
stage 2 report
2007–2011
This report on stage 2 of the national core 
maternity indicators project describes the 
development of 8 indicators, including 
scoping and assessment of existing data 
items for reporting. Of the 8 indicators 
proposed, 3 will be added to the existing 
set of 10 national core maternity indicators, 
2 existing and 1 additional indicator will 
undergo further development and 3 will not 
undergo further development at this time.
